e10vkza
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K/A
(Amendment No. 1)
|
|
|
þ |
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the fiscal year ended December 31, 2010
or
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 001-15787
MetLife, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
13-4075851 |
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.) |
|
|
|
200 Park Avenue, New York, N.Y.
(Address of principal
executive offices)
|
|
10166-0188
(Zip Code) |
(212) 578-2211
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class |
|
Name of each exchange on which registered |
Common Stock, par value $0.01
|
|
New York Stock Exchange |
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01
|
|
New York Stock Exchange |
6.50% Non-Cumulative Preferred Stock, Series B, par value $0.01
|
|
New York Stock Exchange |
5.875% Senior Notes
|
|
New York Stock Exchange |
5.375% Senior Notes
|
|
Irish Stock Exchange |
5.25% Senior Notes
|
|
Irish Stock Exchange |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule
405 of the Securities Act. Yes þ No o
Indicate by check mark if the registrant is not required to file reports pursuant to
Section 13 or 15(d) of the Act. Yes o No þ
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files). Yes
þ No o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of
registrants knowledge, in definitive proxy or information statements incorporated by reference in
Part III of this Form 10-K or any amendment to this Form 10-K. o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
|
|
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act). Yes o No þ
The aggregate market
value of the voting and non-voting common equity held by non-affiliates of the registrant at
June 30, 2010 was approximately $31 billion. At February 18, 2011, 986,585,463 shares
of the registrants common stock were outstanding.
Explanatory Note
Pursuant to General Instruction G to Form 10-K, this Amendment No.1 (the Amendment) to
MetLife, Inc.s (MetLife or the Company) Annual Report on Form 10-K for the fiscal year ended
December 31, 2010, which was filed with the U.S. Securities and Exchange Commission (the SEC) on
February 24, 2011 (the Original Form 10-K), is being filed for the sole purpose of including
information in Part III, Items 10 through 14. The reference on the cover page of the Original Form
10-K to the incorporation by reference of portions of our definitive proxy statement into Part III
of the Original Form 10-K is hereby deleted.
In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the
Exchange Act), Part III, Items 10 through 14 of the Original Form 10-K have been amended and
restated in their entirety, and Part IV, Item 15 of the Original Form 10-K has been amended and
restated solely to include as exhibits the new certifications required by Rule 13a-14(a) under the
Exchange Act. This Amendment does not amend or otherwise update any other information in the
Original Form 10-K. Accordingly, this Amendment should be read in conjunction with the Original
Form 10-K and with our filings with the SEC subsequent to the Original Form 10-K.
2
Part III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
Directors
Class III
Directors:
Sylvia Mathews Burwell, age 45, is President of the
Global Development Program at The Bill and Melinda Gates
Foundation. Ms. Burwell joined the Foundation in 2001 as
Executive Vice President and served as its Chief Operating
Officer from 2002 to April 2006. Prior to joining the
Foundation, she served as Deputy Director of the Office of
Management and Budget in Washington, D.C. from 1998.
Ms. Burwell served as Deputy Chief of Staff to President
Bill Clinton from 1997 to 1998, and was Chief of Staff to
Treasury Secretary Robert Rubin from 1995 to 1997. She also
served as Staff Director for the National Economic Council from
1993 to 1995. Ms. Burwell was Manager of President
Clintons economic transition team. Prior to that, she was
an Associate at McKinsey and Company from 1990 through 1992. She
is a member of the Board of Directors of the Council on Foreign
Relations, a member of the Aspen Strategy Group, the Trilateral
Commission and the Nike Foundation Advisory Group, a member of
the Board of the Alliance for a Green Revolution in Africa, an
Advisory Board member for the Next Generation Initiative and the
Peter G. Peterson Foundation, and a member of the Professional
Advisory Board for the ALS Evergreen Chapter. Ms. Burwell
received a bachelors degree in government, cum laude, from
Harvard University in 1987 and a bachelors degree in
philosophy, politics and economics from Oxford University, where
she was a Rhodes Scholar. Ms. Burwell has been a Director
of MetLife and Metropolitan Life Insurance Company since 2004.
Ms. Burwells unique combination of experience in
financial consulting, government service and as a senior
executive of a charitable foundation with activities around the
world give her an informed perspective on global financial,
business and philanthropic activities and diverse cultural
considerations that may impact MetLife as a global provider of
insurance and financial products and services. Her background
and
experience also enhance her understanding of the Companys
and MetLife Foundations contributions to civic,
educational and charitable organizations.
Eduardo Castro-Wright, age 56, has been Vice
Chairman of Wal-Mart Stores, Inc. since November 2008 and
President and Chief Executive Officer of its Global.com and
Global Sourcing organizations since June 2010.
Mr. Castro-Wright joined Wal-Mart in 2001 and worked in
Mexico through 2005, first as President and later as Chief
Executive Officer of Wal-Mart de Mexico. He then joined Wal-Mart
in the U.S. as Chief Operating Officer of the Wal-Mart
Stores division in early 2005 and served as President and Chief
Executive Officer of the Wal-Mart Stores division from 2005 to
2010. Previously, he was the President and Chief Executive
Officer of Honeywell Transportation and Power Systems Worldwide.
Prior to that, he was President of Honeywell Asia/Pacific.
Mr. Castro-Wright also held several leadership positions at
Nabisco, Inc., including President of Nabisco Asia/Pacific, as
well as President and Chief Executive Officer of the
companys businesses in Venezuela and Mexico.
Mr. Castro-Wright is a member of the Boards of Directors of
the Retail Industry Leaders Association, and CARE USA. He
previously served as a Director of Dow Jones & Company
from 2006 to 2007. He received a bachelor of science degree in
mechanical engineering from Texas A&M University.
Mr. Castro-Wright has been a Director of MetLife and
Metropolitan Life Insurance Company since March 2008.
Mr. Castro-Wrights experience as a senior executive
of one of the worlds largest companies and as a leader of
businesses in a variety of countries and industries has given
him global experience and an understanding of issues, challenges
and risks of doing business in multiple jurisdictions in the
United States and internationally. In addition, as a senior
executive of a corporation with hundreds of thousands of
4
employees, he is knowledgeable about employee benefits. His
particular combination of knowledge and experience is relevant
to the Boards oversight of the management of the Company,
which is a major global provider of insurance and employee
benefit products and services.
Cheryl W. Grisé, age 58, was Executive Vice
President of Northeast Utilities, a public utility holding
company, from December 2005 until her retirement effective June
2007, Chief Executive Officer of its principal operating
subsidiaries from September 2002 to January 2007, President of
the Utility Group of Northeast Utilities Service Company from
May 2001 to January 2007, President of the Utility Group of
Northeast Utilities from May 2001 to December 2005, and Senior
Vice President, Secretary and General Counsel of Northeast
Utilities from 1998 to 2001. Ms. Grisé is a Director
of Pall Corporation and Pulte Homes, Inc. She also serves on the
Boards of the University of Connecticut Foundation and the
Kingswood-Oxford School, and is a Senior Fellow of the American
Leadership Forum. She previously served as a Director of Dana
Corporation from 2002 to 2008. She received a bachelor of arts
degree from the University of North Carolina at Chapel Hill
and a law degree from Thomas Jefferson School of Law, and has
completed the Yale Executive Management Program.
Ms. Grisé has been a Director of MetLife and
Metropolitan Life Insurance Company since 2004. She became the
Lead Director of MetLife on February 1, 2010.
Ms. Grisés experience as the chief executive
officer of a major enterprise subject to complex and multiple
regulatory requirements and constraints provided her with a
substantive understanding of the challenges of managing a highly
regulated business such as MetLife. The combination of her
executive experience and her earlier experience as a general
counsel and corporate secretary provide her with a unique
perspective on the Boards responsibility for overseeing
the management of a regulated business with global operations as
well as the Boards roles and responsibilities with respect
to the effective functioning of the Companys corporate
governance structures.
Lulu C. Wang, age 66, is Chief Executive Officer of
Tupelo Capital Management LLC, an investment management firm
which she founded in 1997.
Ms. Wang has been engaged in professional money management
since 1972. Prior to founding Tupelo Capital Management, she
served as Director and Executive Vice President of Jennison
Associates Capital Corporation. Before joining Jennison in 1988,
Ms. Wang oversaw equities management at Equitable Capital
Management as Senior Vice President and Managing Director.
Ms. Wang serves on the Boards of the Asia Society, Columbia
Business School, Metropolitan Museum of Art, Rockefeller
University, New York Public Radio and the Committee of 100. She
also serves as Trustee Emerita of Wellesley College and as a
Consulting Director of the New York Community Trust.
Ms. Wang received her bachelor of arts degree from
Wellesley College and her masters in business administration
from Columbia Business School. Ms. Wang has been a Director
of MetLife and Metropolitan Life Insurance Company since March
2008.
Ms. Wangs extensive experience in investment
management and financial services, her knowledge and
understanding of global markets for financial products,
particularly in Asia, and her service on the boards and
investment committees of major educational and civic
organizations have given her a perspective that is particularly
relevant to the MetLife Board of Directors oversight of
the Company, a global provider of insurance and financial
products and services, as well as a deep understanding of the
importance of MetLifes and MetLife Foundations
contributions to community institutions.
Class I
Directors:
C. Robert Henrikson, age 63, has been Chairman,
President and Chief Executive Officer of MetLife and
Metropolitan Life Insurance Company since April 25, 2006.
Previously, he was President and Chief Executive Officer of
MetLife and Metropolitan Life Insurance Company from
March 1, 2006, President and Chief Operating Officer of the
Company from June 2004, and President of its U.S. Insurance
and Financial Services businesses from July 2002 to June 2004.
He served as President of Institutional Business of MetLife from
September 1999 to July 2002 and President of Institutional
Business of Metropolitan Life Insurance Company from May 1999 to
June 2002. During his more than
38-year
career with
5
MetLife, Mr. Henrikson has held a number of senior
positions in the Companys Individual, Group and Pension
businesses. In July 2010, Mr. Henrikson was appointed by
President Barack Obama to the Presidents Export Council,
the principal national advisory committee on international
trade. Mr. Henrikson is a former Chairman and a current
Director of the American Council of Life Insurers, a former
Chairman and a current Board member of the Financial Services
Forum, a Director Emeritus of the American Benefits Council,
Chairman of the Board of the Wharton Schools
S.S. Huebner Foundation for Insurance Education, and a
Trustee of the American Museum of Natural History. He also
serves on the Board of Trustees of Emory University and the
Boards of Directors of The New York Philharmonic, The New York
Botanical Garden, and the Partnership for New York City.
Mr. Henrikson received a bachelors degree from the
University of Pennsylvania and a law degree from Emory
University School of Law. In addition, he is a graduate of the
Wharton Schools Advanced Management Program. He has been a
Director of MetLife since April 26, 2005 and a Director of
Metropolitan Life Insurance Company since June 1, 2005.
Mr. Henriksons more than 38 years of experience
with the Company, which includes diverse positions of increasing
responsibility, leading to his role as Chief Executive Officer,
have provided him with an in-depth understanding of the
Companys businesses and global operations and given him
insight into the Companys strategic direction and
leadership selection.
John M. Keane, age 68, is a Senior Partner of SCP
Partners, a venture capital firm, and President of GSI, LLC, an
independent consulting firm. General Keane served in the
U.S. Army for 37 years. He was Vice Chief of Staff and
Chief Operating Officer of the Army from 1999 until his
retirement in October 2003. He is a Director of General Dynamics
Corporation, MacAndrews & Forbes Holdings, Inc. and
Cyalume Technologies Holdings, Inc. He also is a military
contributor and analyst with Fox News, member of the United
States Department of Defense Policy Board, member of the Council
on Foreign Relations, and Chairman of the Senior Executive
Committee of the Army Aviation Association of America. He also
serves on the Boards of the Knollwood Foundation, the Army
Heritage Foundation, the George C. Marshall
Foundation, the Rand Corporation, the Welcome Back Veterans
Foundation, American Corporate Partners, the Center for
Strategic and Budgetary Assessments, and the Institute for the
Study of War. He previously served as a member of the Board of
Managers of Allied Security Holdings LLC from 2005 to 2008.
General Keane received a bachelors degree in accounting
from Fordham University and a masters degree in philosophy
from Western Kentucky University. General Keane has received
honorary doctorate degrees in law and public service from
Fordham University and Eastern Kentucky University,
respectively. General Keane has been a Director of MetLife and
Metropolitan Life Insurance Company since 2003.
General Keanes roles as chief operating officer of one of
the worlds largest military organizations and as an
advisor to high levels of government demonstrate and reflect his
recognized ability to understand, assess and communicate the
strategic leadership, organizational dynamics and managerial
capabilities which are particularly relevant to the Boards
role in overseeing the process for selecting, developing and
assuring appropriate continuity of the senior executive
leadership which is responsible for managing the Companys
businesses and operations.
Catherine R. Kinney, age 59, retired from NYSE
Euronext in March 2009. She had served in Paris, France from
July 2007 until 2009, responsible for overseeing the
companys global listing program, marketing and branding.
She was President and Co-Chief Operating Officer of the New York
Stock Exchange from 2002 to 2008. Ms. Kinney joined the New
York Stock Exchange in 1974 and held management positions in
several divisions, including responsibility for all client
relationships from 1996 to 2007, trading floor operations and
technology from 1987 to 1996, and regulation from 2002 to 2004.
Ms. Kinney serves on the Boards of Directors of NetSuite,
Inc., MSCI, Inc., Georgetown University, Catholic Charities, The
New York City Ballet, and Sharegift USA. She served on the Board
of Directors of Depository Trust Company from 2003 to 2007.
She is a member of the Economic Club of New York.
Ms. Kinney graduated Magna Cum Laude from Iona College and
completed the Advanced Management Program, Harvard Graduate
School of Business. She has received honorary degrees from
Georgetown University, Fordham University, and Rosemont College.
6
Ms. Kinney became a Director of MetLife and Metropolitan
Life Insurance Company in April 2009 after having
previously served on those Boards from 2002 to 2004.
Ms. Kinneys experience as a senior executive and
chief operating officer of a multinational regulated entity and
her key role in transforming the New York Stock Exchange to
a publicly held company together with her leadership in
developing and establishing the NYSE corporate governance
standards for its listed companies, including MetLife,
demonstrate a knowledge of and experience with issues of
corporate development and transformation and corporate
governance that are relevant to assuring that the Board
establishes and maintains effective governance structures that
are appropriate for a global provider of insurance and financial
products and services.
Hugh B. Price, age 69, has been the John L.
Weinberg/Goldman Sachs Visiting Professor of Public and
International Affairs at the Woodrow Wilson School of Princeton
University since August 2008. He also has been a Senior Fellow
of the Brookings Institution since February 2006. Previously, he
was a Senior Advisor to the law firm of DLA Piper Rudnick Gray
Cary US LLP from September 2003 until September 2005 and served
as President and Chief Executive Officer of the National Urban
League, Inc. from 1994 to April 2003. Mr. Price is a
Director of Verizon Communications, Inc. and a Director of the
Jacob Burns Film Center. Mr. Price received a
bachelors degree from Amherst College and received a law
degree from Yale Law School. He has been a Director of MetLife
since 1999 and a Director of Metropolitan Life Insurance Company
since 1994.
Mr. Prices management and leadership positions as the
chief executive officer of an historic civil rights organization
and at for-profit business enterprises and his prominence as an
advisor and expert on the development of positive community
values promoting achievement, diversity and inclusion as
business imperatives have provided Mr. Price with expertise
in enterprise management and corporate responsibility that is
relevant to the Boards oversight of the Companys
business management as well as its historic and current
commitment to community and civic values and development.
Kenton J. Sicchitano, age 66, was a Global Managing
Partner of PricewaterhouseCoopers LLP, an audit/assurance,
business advisory and tax services firm, until his retirement in
June 2001. Mr. Sicchitano joined Price Waterhouse LLP, a
predecessor firm of PricewaterhouseCoopers LLP, in 1970, and
after becoming a partner in 1979, held various leadership
positions within the firm until he retired in 2001. He is a
Director of PerkinElmer, Inc. and Analog Devices, Inc. At
various times from 1986 to 1995, he served as a Director
and/or
officer of a number of
not-for-profit
organizations, including as President of the Harvard Business
School Association of Boston, Director of the Harvard Alumni
Association and the Harvard Business School Alumni Association,
Director and Chair of the Finance Committee of New England
Deaconess Hospital and a Trustee of the New England Aquarium.
Mr. Sicchitano received a bachelors degree from
Harvard College and a masters degree in business
administration from Harvard Business School. Mr. Sicchitano
has been a Director of MetLife and Metropolitan Life Insurance
Company since 2003.
Mr. Sicchitanos experience as a managing partner in a
global advisory services firm and his oversight of the
firms audit practices as well as his oversight of the
firms Audit/Assurance, Business Advisory and Tax Services
have provided him with an understanding of the challenges and
opportunities of managing a global business enterprise and a
broad knowledge of the accounting and tax issues that are
relevant to the Boards oversight of the management of
MetLife, a global insurance and financial services firm.
Class II
Directors:
R. Glenn Hubbard, Ph.D., age 52, has been
the Dean of the Graduate School of Business at Columbia
University since 2004 and the Russell L. Carson Professor of
Economics and Finance since 1994. Dr. Hubbard has been a
professor of the Graduate School of Business at Columbia
University since 1988 and a professor of the Faculty of Arts and
Sciences of Columbia University since 1997. From 2001 to 2003,
Dr. Hubbard served as Chairman of the Presidents
Council of Economic Advisers and Chairman of the Economic Policy
Committee of the Organization for Economic Cooperation and
Development. He was Deputy Assistant Secretary
7
of the Treasury for Tax Analysis from 1991 to 1993.
Dr. Hubbard is a member of the Boards of Directors of
Automatic Data Processing, Inc., BlackRock Closed-End Funds and
KKR Financial Holdings LLC. He also is a member of the Panel of
Economic Advisors for the Federal Reserve Bank of New York,
member of the Council on Foreign Relations, and a member of the
Advisory Board of the National Center on Addiction and Substance
Abuse, and serves as an Elder of Fifth Avenue Presbyterian
Church, New York. He previously served as a Director of
Capmark Financial Corporation
(2006-2008),
Information Services Group, Inc.
(2006-2008),
Duke Realty Corporation
(2004-2008),
Dex Media, Inc.
(2004-2006),
and R.H. Donnelley Corporation (2006). Dr. Hubbard holds a
Ph.D. and masters degree in economics from Harvard
University, and a bachelor of arts degree and a bachelor of
sciences degree from the University of Central Florida. He has
been a Director of MetLife and Metropolitan Life Insurance
Company since February 2007.
Dr. Hubbards experience as an economic policy advisor
to the highest levels of governmental, academic and financial
regulatory bodies demonstrates his recognized deep knowledge and
understanding of the significance and impact of regulatory and
economic policy on business operations and management, which is
relevant to the Boards understanding of the impact of
global economic conditions and economic and regulatory policies
on MetLife, a global provider of insurance and financial
products and services.
Alfred F. Kelly, Jr., age 52, was the President
of American Express Company, where he had responsibility for the
companys global consumer businesses, including consumer
and small business cards, customer service, global banking,
prepaid products, consumer travel and risk and information
management, until his retirement in April 2010 after
23 years. Previously, he was a Group President responsible
for several key businesses, including U.S. consumer and
small business cards, U.S. customer service and risk
management. From 1985 to 1987, Mr. Kelly served as head of
information systems at the White House where he oversaw the
information processing functions for several government agencies
that comprise the Executive Office of the President. Prior to
that, he held various positions in information systems and
strategic
and financial planning at PepsiCo. He is a member of the Boards
of Trustees of New York-Presbyterian Hospital and St.
Josephs Seminary and College, and a member of the Board of
Directors of the New York Catholic Foundation. He also serves as
Vice Chairman of the Wall Street Charity Golf Classic, an event
that benefits the Cystic Fibrosis Foundation. He previously
served as a Director of The Hershey Company from 2005 to 2007.
Mr. Kelly holds bachelor of arts and masters degrees in
business administration from Iona College. Mr. Kelly has
been a Director of MetLife and Metropolitan Life Insurance
Company since June 2009.
Mr. Kellys experience as a senior executive of a
global financial services business together with his government
service have given him a sophisticated understanding of risk
management and mitigation, marketing, information technology and
data management and the considerations of shareholder value
creation that are relevant to the Boards oversight of the
management of an insurance company with global businesses and
operations.
James M. Kilts, age 63, has been a Partner,
Centerview Partners Management, LLC, a private equity and
financial advisory firm, since October 2006. He had been Vice
Chairman of the Board of The Procter & Gamble Company
from October 2005, following the merger of The Gillette Company
with Procter & Gamble, until October 2006. Previously
and, until October 2005, he had served as Chairman of the Board,
Chief Executive Officer and President of Gillette since January
2001, February 2001 and November 2003, respectively. Prior to
joining Gillette, Mr. Kilts was President and Chief
Executive Officer of Nabisco Group Holdings Corp. from December
1999 until it was acquired in December 2000 by Philip Morris
Companies Inc., now Altria Group Inc. He was President and Chief
Executive Officer of Nabisco Holdings Corp. and Nabisco Inc.
from January 1998 to December 1999. Before that, he was an
Executive Vice President, Worldwide Food, Philip Morris, from
1994 to 1997 and served as President of Kraft USA from 1989 to
1994. Previously, he served as President of Kraft Limited in
Canada and as Senior Vice President of Kraft International.
Mr. Kilts began his business career with General Foods
Corporation in 1970. Mr. Kilts is a member of the Boards of
Directors of Pfizer, Inc.
8
and MeadWestvaco Corporation, and Chairman of the Supervisory
Board of the Nielsen Company, a leading global and information
media company. He also is a member of the Board of Overseers of
Weill Cornell Medical College. He serves on the Boards of
Trustees of Knox College and the University of Chicago and is a
member of the Advisory Council of the University of Chicago
Booth School of Business. Mr. Kilts previously served as a
Director of Whirlpool Corporation from 1999 to 2005, Director of
May Department Stores Company from 1998 to 2005, and Director of
The New York Times Company from 2005 to 2008. He also is a past
Chairman of the Grocery Manufacturers Association. He is a
graduate of Knox College and earned a master of business
administration degree from the University of Chicago.
Mr. Kilts has been a Director of MetLife and Metropolitan
Life Insurance Company since 2005.
Mr. Kilts experience as a senior executive of several
major consumer product companies with global sales and
operations together with his experience as the founding partner
of a private equity and financial advisory firm have given him a
perspective on and a deep understanding of the business
challenges and opportunities of diversified global enterprises
and the related financial, risk management and shareholder value
creation considerations that are relevant to the Boards
oversight of the management of an insurance company with global
businesses and operations.
David Satcher, M.D., Ph.D., age 70, is the
Director of the Satcher Health Leadership Institute and the
Center of Excellence on Health Disparities at the Morehouse
School of Medicine (MSM), where he also occupies the
Poussaint-Satcher-Cosby Chair in Mental Health. From December
2004 to July 2006, Dr. Satcher served as the President of
MSM. From September 2002 to December 2004, Dr. Satcher was
the Director of the National Center for Primary Care at MSM.
Dr. Satcher completed his four-year term as the
16th Surgeon General of the United States in February 2002,
after which he served as a Senior Visiting Fellow with the
Kaiser Family Foundation until he assumed the post of Director
of the National Center for Primary Care. Dr. Satcher served
as the U.S. Assistant Secretary for Health from 1998 to
January 2001, and from 1993 to 1998, he was the Director of the
Centers for Disease Control and Prevention and the administrator
of the Agency for Toxic Substances and Disease Registry.
Dr. Satcher is a member of the Boards of Directors of
Johnson & Johnson, the Kaiser Family Foundation, the
Community Foundation of Greater Atlanta and the United Way of
Metropolitan Atlanta. Dr. Satcher has been a Director of
MetLife and Metropolitan Life Insurance Company since February
2007.
Dr. Satchers background in public health issues and
administration and his business and government service provide
him with a broad knowledge of health matters from a public
policy perspective, with expertise in fields that include the
study of aging and mortality profiles, which are relevant to the
Companys operations as a provider of life and dental
insurance, and to an understanding of the impact of governmental
health and insurance initiatives.
9
Executive Officers
The information called for by this Item pertaining to Executive
Officers appears in Part I Item 1.
Business Executive Officers of the Registrant
of the Original Form 10-K.
10
Corporate Governance
Corporate
Governance Guidelines.
The Board of Directors has adopted Corporate Governance
Guidelines that set forth the Boards policies on a number
of governance-related matters. Topics covered by the Guidelines
include:
|
|
|
Director qualifications, independence and responsibilities;
|
|
|
the identification of candidates for Board positions;
|
|
|
the Committees of the Board;
|
|
|
management succession;
|
|
|
Director access to management and outside advisors, including
certain restrictions on the retention by Directors of an outside
advisor that is otherwise engaged by the Company for another
purpose;
|
|
|
Director compensation;
|
|
|
Director stock ownership guidelines;
|
|
|
the appointment of a Lead Director by the Independent Directors;
|
|
|
Director orientation and continuing education;
|
|
|
Annual evaluation of the Boards performance; and
|
|
|
the Boards majority voting standard in uncontested
Director elections, which is also reflected in the
Companys By-Laws.
|
A printable version of the Corporate Governance Guidelines may
be found on MetLifes website at
www.metlife.com/corporategovernance under the link
Corporate Governance Guidelines.
Information About
the Board of Directors.
Responsibilities, Independence and Composition of the
Board of Directors. The Directors of MetLife
are individuals upon whose judgment, initiative and efforts the
success and long-term value of the Company depend. As a Board,
these individuals review MetLifes business policies and
strategies and oversee the management of the Companys
businesses by the Chief Executive Officer and the other most
senior executives of the Company (Executive Officers or
Executive Group). The Board currently consists of
13 Directors, 12 of whom are both Non-
Management Directors and Independent Directors. A
Non-Management Director is a Director who is not an
officer of the Company or of any entity in a consolidated group
with the Company. An Independent Director is a
Non-Management Director who the Board of Directors has
affirmatively determined has no material relationships with the
Company or any of its consolidated subsidiaries and is
independent within the meaning of the New York Stock Exchange
Corporate Governance Standards. An Independent Director for
Audit Committee purposes meets additional requirements of
Rule 10A-3
under the Exchange Act. For more information on the Boards
determinations of Director independence, see Director
Independence on page 79.
The Companys Board of Directors is currently divided into
three classes. One class is elected each year to hold office for
a term of three years. Of the 13 current Directors, five are
Class I Directors with terms expiring at the 2012 Annual
Meeting, four are Class II Directors with terms expiring at
the 2013 Annual Meeting, and four are Class III Directors
with terms expiring at the 2011 Annual Meeting.
Board Leadership Structure. After
careful consideration, in 2006, the Board of Directors
determined that the best leadership structure for MetLife is a
Chairman of the Board who also is the Companys Chief
Executive Officer and a separate empowered Lead Director. The
Board believes that its experience with this structure over the
course of the last four years has confirmed that it made the
right decision. Experience has shown that the Chairman of the
Board and Chief Executive Officer has partnered effectively with
the Lead Director.
The Companys Chief Executive Officer is responsible for
the
day-to-day
operations of the Company and setting its strategic business
direction. The performance of his responsibilities as Chairman
of the Board is informed by his in-depth knowledge of the
business, its opportunities and challenges and the capabilities
and talents of the Companys senior leadership team.
Establishing the complementary roles of Lead Director and
11
Chairman of the Board and Chief Executive Officer has brought
assurance to MetLife Directors that they will be provided with
the information about the Companys businesses and
operations, have the access to senior management of MetLife and
have robust and appropriate corporate governance processes and
procedures that they need in order to effectively oversee the
management of the Company and to perform their roles and
responsibilities as Directors of a global provider of insurance
products and services.
Ms. Cheryl W. Grisé, the Companys Lead Director,
was appointed as Lead Director by the Companys Independent
Directors, as provided by the Companys Corporate
Governance Guidelines. The Guidelines establish an empowered
independent Lead Director whose responsibilities include:
|
|
|
presiding at executive sessions of the Non-Management Directors
(which are held at each regularly scheduled Board meeting);
|
|
|
conferring with the Chairman of the Board and Chief Executive
Officer about Board meeting schedules, agendas and information
to be provided to the Directors;
|
|
|
conferring with the Chairman of the Board and Chief Executive
Officer on issues of corporate importance that may involve
action by the Board;
|
|
|
participating in the Compensation Committees annual
performance evaluation of the Chairman of the Board and Chief
Executive Officer; and
|
|
|
in the event of the incapacity of the Chairman and Chief
Executive Officer, directing the Secretary of the Company to
take all necessary and appropriate action to call a special
meeting of the Board as specified in the By-Laws to consider the
action to be taken under the circumstances.
|
The Board of Directors has five standing committees (described
on pages 14 through 18): Audit, Compensation, Executive,
Finance and Risk, and Governance and Corporate Responsibility.
Each of those Committees, other than the Executive Committee, is
chaired by an Independent Director. The Investment Committee of
Metropolitan Life Insurance Company, which, at the request of
MetLife, oversees the management and mitigation of risks
associated with the investment portfolios of MetLife and certain
of MetLifes subsidiaries, is also chaired by an
Independent Director.
Executive Sessions of Non-Management
Directors. At each regularly scheduled
meeting of the Board of Directors, the Non-Management Directors
of the Company (all of whom were also Independent Directors of
the Company during 2010) meet in executive session without
the presence of the Companys management. The Lead Director
presides at the executive sessions of the Non-Management
Directors.
Director Nomination Process. Under the
Companys Corporate Governance Guidelines, the following
specific, minimum qualifications must be met by any candidate
whom the Governance and Corporate Responsibility Committee would
recommend for election to the Board of Directors:
|
|
|
Financial Literacy. Such person should be
financially literate, as such qualification is
interpreted by the Companys Board of Directors in its
business judgment.
|
|
|
Leadership Experience. Such person should
possess significant leadership experience, such as experience in
business, finance, accounting, law, education or government, and
shall possess qualities reflecting a proven record of
accomplishment and an ability to work with others.
|
|
|
Commitment to the Companys Values. Such
person shall be committed to promoting the financial success of
the Company and preserving and enhancing the Companys
reputation as a leader in American business and shall be in
agreement with the values of the Company as embodied in its
codes of conduct.
|
|
|
Absence of Conflicting Commitments. Such
person should not have commitments that would conflict with the
time commitments of a Director of the Company.
|
|
|
Reputation and Integrity. Such person shall be
of high repute and recognized integrity, and shall not have been
convicted in a criminal proceeding or be named a subject of a
pending criminal proceeding (excluding traffic violations and
other minor offenses). Such person shall not have been found in
a civil proceeding to have violated any federal or state
securities or commodities law, and shall not be subject to any
court or regulatory order or decree limiting his or her business
activity,
|
12
|
|
|
including in connection with the purchase or sale of any
security or commodity.
|
|
|
Other Factors. Such person shall have other
characteristics considered appropriate for membership on the
Board of Directors, including significant experience and
accomplishments, an understanding of marketing and finance,
sound business judgment, and an appropriate educational
background.
|
In recommending candidates for election as Directors, the
Governance and Corporate Responsibility Committee will take into
consideration the need for the Board to have a majority of
Directors that meet the independence requirements of the New
York Stock Exchange Corporate Governance Standards, the ability
of candidates to devote the time necessary for service on the
MetLife Board, their ability to enhance the perspective and
experience of the Board as a whole, and such other criteria as
shall be established from time to time by the Board of Directors.
Potential candidates for nomination as Directors are identified
by the Governance and Corporate Responsibility Committee and the
Board of Directors through a variety of means, including search
firms, Board members, Executive Officers and shareholders.
Potential candidates for nomination as Director provide
information about their qualifications and participate in
interviews conducted by individual Board members. Candidates are
evaluated based on the information supplied by the candidates
and information obtained from other sources.
The Governance and Corporate Responsibility Committee will
consider shareholder recommendations of candidates for
nomination as Director. To be timely, a shareholder
recommendation must be submitted to the Governance and Corporate
Responsibility Committee, MetLife, Inc., 1095 Avenue of the
Americas, New York, NY 10036, Attention: Corporate Secretary,
not later than 120 calendar days prior to the first anniversary
of the previous years annual meeting. Recommendations for
nominations of candidates for election at the 2012 Annual
Meeting must be received by the Corporate Secretary no later
than December 28, 2011.
The Governance Committee makes no distinctions in evaluating
nominees based on whether or not a nominee is recommended by a
shareholder. Shareholders recommending a nominee must satisfy
the notification, timeliness, consent and
information requirements set forth in the Companys By-Laws
concerning Director nominations by shareholders.
The shareholders recommendation must set forth all the
information regarding the person recommended that is required to
be disclosed in solicitations of proxies for election of
Directors pursuant to Section 14 of the Exchange Act and
related regulations, and must include the recommended
nominees written consent to being named in the Proxy
Statement as a nominee and to serving as a Director if elected.
The recommendation must also be accompanied by a completed
disclosure questionnaire on a form posted on the Companys
website. In addition, the shareholders recommendation must
include (i) the name and address of, and class and number
of shares of the Companys securities owned beneficially
and of record by, the recommending shareholder and any other
person on whose behalf the shareholder is acting or with whom
the shareholder is acting in concert; (ii) a description of
all arrangements or understandings between any shareholder and
the person being recommended and any other persons (naming them)
pursuant to which the nominations are to be made by the
shareholder; (iii) satisfactory evidence that each
shareholder is a beneficial owner, or a representation that the
shareholder is a holder of record, of the Companys stock
entitled to vote at the meeting, and a representation that the
shareholder intends to appear in person or by a qualified
representative at the meeting to propose the nomination; and
(iv) if the recommending shareholder intends to solicit
proxies, a statement to that effect.
Board Meetings and Director Attendance in
2010. In 2010, there were 12 regular and
special meetings of the Board of Directors. All of the current
Directors attended more than 75% of the aggregate number of
meetings of the Board of Directors and the Committees on which
they served during 2010, with the exception of General John M.
Keane who attended 73% of such meetings.
Oversight of Risk
by the Board of Directors.
The Board of Directors has allocated responsibilities for
overseeing risks associated with the Companys business
among the Board as a whole and the
13
Committees of the Board. In performing its risk oversight
functions, the Board of Directors:
|
|
|
oversees managements development and execution of
appropriate business strategies to mitigate the risk that such
strategies will fail to generate long-term value for the Company
and its shareholders or that such strategies will motivate
management to take excessive risks; and
|
|
|
oversees the development and implementation of processes and
procedures to mitigate the risk of failing to assure the orderly
succession of the Chief Executive Officer and the senior
executives of the Company.
|
The Board of Directors believes that the continuing development
of the Companys managerial leadership is critically
important to the Companys success. The Board periodically
reviews the skills, experience, and development plans of the
Companys senior leaders who may ultimately be candidates
for senior executive positions. The Board meets regularly with
senior leaders in the context of Board business, giving the
Board an opportunity to assess the qualifications of these
persons. In addition, the Board plans for executive succession
to ensure that the Company will have managerial talent available
to replace current executives when that becomes necessary.
In addition, as a financial holding company, MetLife is subject
to the umbrella jurisdiction of the Federal Reserve
Bank of New York (FRBNY). In this role, the FRBNY
evaluates the risk management control processes of MetLife and
its key business lines and monitors MetLifes risk profile
and financial performance. The MetLife Board of Directors
receives an annual report from the FRBNY regarding the
FRBNYs detailed risk management assessment of the Company,
including an assessment of Board and senior management
oversight, risk policies, procedures and limits, risk monitoring
and management information systems and internal controls.
Risk oversight functions performed by Board Committees are
included in the discussions of Committee roles and
responsibilities set forth in the next section under Board
Committees.
Board
Committees.
MetLifes Board of Directors has designated five standing
Board Committees. These Committees perform essential functions
on behalf of the
Board. The Committee Chairs review and approve agendas for all
meetings of their respective Committees. The responsibilities of
each of these Committees are summarized below. Only Independent
Directors may be members of the Audit, Compensation, Finance and
Risk, and Governance and Corporate Responsibility Committees.
Metropolitan Life Insurance Company also has designated Board
Committees, including an Investment Committee. Each Committee of
the Board of Directors has a Charter that defines the
Committees purposes and responsibilities. The Charters for
the Audit, Compensation and Governance and Corporate
Responsibility Committees incorporate the requirements of the
SEC and the New York Stock Exchange to the extent applicable,
and current, printable versions of these Charters are available
on MetLifes website at
www.metlife.com/corporategovernance by selecting Board
of Directors and then the appropriate link under the heading
Board Committee Information.
The Audit
Committee
The Audit Committee, which consists entirely of Independent
Directors,
|
|
|
is directly responsible for the appointment, compensation,
retention and oversight of the work of the Companys
independent auditor;
|
|
|
assists the Board in fulfilling its responsibility to oversee
the Companys accounting and financial reporting processes,
the adequacy of the Companys internal control over
financial reporting and the integrity of its financial
statements;
|
|
|
pre-approves all audit and non-audit services to be provided by
the independent auditor, reviews reports concerning significant
legal and regulatory matters, discusses the Companys
guidelines and policies with respect to the process by which the
Company undertakes risk management and risk assessment, and
reviews the performance of the Companys internal audit
function;
|
|
|
discusses with management, the Companys General Auditor
and the independent auditor, the Companys filings on
Forms 10-K
and 10-Q and
the financial information in those filings;
|
|
|
discusses with management the Companys practices regarding
earnings press releases and the provision of financial
information and
|
14
|
|
|
earnings guidance to analysts and rating agencies;
|
|
|
prepares an annual report to the shareholders for presentation
in the Companys proxy statement; and
|
|
|
has the authority to obtain advice and assistance from, and to
receive appropriate funding from the Company for the retention
of, outside counsel and other advisors as the Audit Committee
deems necessary to carry out its duties.
|
The Audit Committee also oversees managements development
and implementation of policies and procedures related to the
following matters and the management and mitigation of the
associated risks:
|
|
|
the preparation of the Companys financial statements and
disclosures;
|
|
|
the Companys critical accounting policies and estimates;
|
|
|
establishing and maintaining effective internal control over
financial reporting;
|
|
|
the appointment and performance of the internal auditor;
|
|
|
the Companys compliance with legal and regulatory
requirements; and
|
|
|
the effectiveness of the Companys disclosure controls and
procedures.
|
The Audit Committee met nine times during 2010. A more detailed
description of the role and responsibilities of the Audit
Committee is set forth in the Audit Committee Charter.
Financial Literacy and Audit Committee Financial
Expert. The Board of Directors has determined
that the members of the Audit Committee, all of whom are
Independent Directors and meet the additional independence
requirements of
Rule 10A-3
under the Exchange Act, are financially literate, as such
qualification is interpreted by the Board of Directors. The
Board of Directors has also determined that the following
members of the Audit Committee would qualify as audit
committee financial experts, as such term is defined by
the SEC: Kenton J. Sicchitano, the Chair of the Committee,
Cheryl W. Grisé, John M. Keane and Catherine R. Kinney.
The
Compensation Committee
Role of the Compensation Committee in Corporate
Governance. The Compensation Committee, which
consists entirely of Independent Directors,
|
|
|
assists the Board in fulfilling its responsibility to oversee
the compensation and benefits of the Companys executives
and other employees of the MetLife enterprise;
|
|
|
approves the goals and objectives relevant to the Chief
Executive Officers total compensation, evaluates the Chief
Executive Officers performance in light of such goals and
objectives, and endorses, for approval by the Independent
Directors, the Chief Executive Officers total compensation
level based on such evaluation;
|
|
|
reviews and recommends approval by the Board of Directors of the
total compensation of each person who is an executive
officer of the Company under the Exchange Act and related
regulations or an officer of the Company under
Section 16 of the Exchange Act and related regulations, as
well as the Companys Chief Risk Officer, including their
base salaries, annual incentive compensation and long-term
equity-based incentive compensation;
|
|
|
has sole authority to retain, terminate and approve the fees and
other retention terms of any compensation consultants retained
to assist the Committee in evaluating executive compensation;
|
|
|
retains, terminates and approves the fees and other retention
terms of any other advisor it retains to assist the
Committee; and
|
|
|
reviews and discusses with management the Compensation
Discussion and Analysis to be included in the proxy statement
(and incorporated by reference in the Annual Report on
Form 10-K),
and, based on this review and discussion, (i) recommends to
the Board of Directors whether the Compensation Discussion and
Analysis should be included in the proxy statement (and
incorporated by reference in the Annual Report on
Form 10-K),
and (ii) issues the Compensation Committee Report for
inclusion in the proxy statement (the 2011 Compensation
Committee Report also appears on page 27 of this Amendment).
|
The Compensation Committee also oversees the management and
mitigation of risks associated with (i) the development and
administration of the Companys compensation and benefit
15
programs, and (ii) assuring that the Companys
incentive plans do not encourage or reward excessive risk taking.
A more detailed description of the role and responsibilities of
the Compensation Committee is set forth in the Compensation
Committee Charter. Under its Charter, the Compensation Committee
may delegate to a subcommittee or to the Chief Executive Officer
or other officers of the Company any portion of the
Committees duties and responsibilities, if the Committee
believes such delegation is in the best interests of the Company
and the delegation is not prohibited by law, regulation or the
New York Stock Exchange Corporate Governance Standards.
Managements delegated authority does not include granting
salary increases or incentive compensation to any Executive
Officer, officer subject to the reporting requirements under
Section 16 of the Exchange Act, or to the Companys
Chief Risk Officer.
The Companys processes for consideration and determination
of executive compensation, and the central role of the Committee
in those processes, are further described in the Compensation
Discussion and Analysis, beginning on page 28.
Executive Compensation Consultant. The
Committee believes that its compensation consultant must be able
to provide candid, direct, independent and objective advice to
the Committee.
In February 2010, the Committees prior consultant, Hewitt
Associates (Hewitt), spun off a portion of its executive
compensation practice to form Meridian Compensation Partners,
LLC (Meridian). To assist the Committee in carrying out
its responsibilities, and to provide continuity, the
Compensation Committee retained Meridian as its executive
compensation consultant. Meridian has provided the Committee
with competitive market compensation data and overall market
trends about executive compensation, has advised the Committee
about the overall design and implementation of MetLifes
executive compensation programs, including decisions made under
the programs, and has advised the Committee about regulatory,
governance and accounting developments that may affect the
Companys executive compensation programs.
In order to promote the objectivity, independence, and candor of
the compensation consultants advice:
|
|
|
Meridian has reported directly to the Committee about executive
compensation matters;
|
|
|
Meridian has met with the Committee in executive sessions that
were not attended by any of the Companys Executive
Officers;
|
|
|
Meridian has had direct access to the Chair and members of the
Committee between meetings; and
|
|
|
the Committee has not directed Meridian to perform its services
in any particular manner or under any particular method.
|
Prior to February 2010, the Committee had retained Hewitt as its
executive compensation consultant. Hewitt performed
substantially the same role in the same manner as has Meridian.
The fees paid to Hewitt for providing these consulting services
in January 2010 were $29,387.
With the knowledge and concurrence of the Committee, management
had previously retained a separate and distinct unit of Hewitt
to provide recordkeeping and call center services for the
Companys retirement programs, as well as benefits
analyses, communications, mergers and acquisition consulting,
and other general human resources consulting. The bulk of these
services are provided under a written contract between the
Company and Hewitt. In light of this contract, the Committee did
not adopt a formal resolution approving the provision of these
services by Hewitt in 2010. The aggregate fees for Hewitts
services to the Company and its affiliates (other than those for
consulting services to the Compensation Committee) for 2010 were
$11,313,937.
The Committee and Hewitt took extensive steps to ensure that
Hewitt provided candid, direct, independent and objective advice
to the Committee that is not influenced by any other
relationship that the consultant might have with the Company, as
fully detailed in the Companys 2010 Proxy Statement. As a
result, the Committee believes that it received independent and
objective executive compensation advice from Hewitt.
To help ensure that the Committee continues to receive
independent and objective advice in the future, the
Companys Corporate Governance Guidelines provide that,
effective in 2011, any consultant retained to advise the
Compensation Committee on executive compensation matters
16
should not be retained to provide any other services to the
Company.
For information about the key factors that the Compensation
Committee considers in determining the compensation of the
members of the Executive Group, as well as the role of the Chief
Executive Officer and the Executive Vice President of Human
Resources in setting such compensation, see Compensation
Discussion and Analysis beginning on page 28. Also
see the Compensation Discussion and Analysis for information
about compensation paid to the persons listed in the Summary
Compensation Table (Named Executive Officers) on
page 44.
The Compensation Committee met eight times during 2010.
The Executive
Committee
The Executive Committee may exercise the powers and authority of
the Board of Directors during intervals between meetings of the
Board of Directors. The Executive Committee did not meet during
2010.
The Finance
and Risk Committee
The Finance and Risk Committee, which consists entirely of
Independent Directors,
|
|
|
assists the Board in overseeing the Companys financial
policies and strategies, capital structure and dividend
policies, assessment and management of material risks;
|
|
|
reviews the Companys key financial and business metrics;
|
|
|
reviews the Companys policies, practices and procedures
regarding risk assessment, management, and mitigation;
|
|
|
reviews and receives reports from the Chief Risk Officer and
other members of management of the steps taken to measure,
monitor and manage risk exposures in the enterprise (in
consultation with independent advisors or other Board Committees
where necessary or desirable);
|
|
|
reviews benchmarks for risks exposures in the enterprise and
managements performance against these benchmarks;
|
|
|
reviews reports on selected risk topics as the Committee or
management deems appropriate from time to time;
|
|
|
|
approves or recommends for Board consideration financial matters
such as the issuance or repurchase of the Companys
securities, payment of dividends on the Companys
securities, acquisitions or dispositions of businesses, and
funding of the Companys subsidiaries;
|
|
|
reviews reports on MetLife Banks capitalization
management, results and operations; and
|
|
|
oversees the appointment, retention and performance of the
Companys Chief Risk Officer and reviews the performance of
the Chief Risk Officer with the Compensation Committee.
|
The Finance and Risk Committee also oversees the Companys
policies and procedures to manage and mitigate risks related to
|
|
|
maintaining adequate liquidity;
|
|
|
maintaining appropriate credit ratings;
|
|
|
undertaking and executing corporate transactions; and
|
|
|
pricing the Companys products and services.
|
The Finance and Risk Committee met eight times during 2010.
The Governance
and Corporate Responsibility Committee
In January 2011, the Board created the Governance and Corporate
Responsibility Committee by combining the duties of the
Corporate Responsibility and Compliance Committee with those of
the Governance Committee.
The Governance and Corporate Responsibility Committee, which
consists entirely of Independent Directors,
|
|
|
assists the Board by identifying individuals qualified to become
members of the Board, consistent with the criteria established
by the Board;
|
|
|
assesses, and advises the Board with respect to, the experience,
qualifications, attributes or skills of each Director that the
Board should consider in concluding whether the person should
serve as a Director;
|
|
|
develops and recommends corporate governance guidelines to the
Board;
|
17
|
|
|
recommends to the Board policies and procedures regarding
shareholder nomination of Director candidates;
|
|
|
recommends to the Board policies and procedures regarding
communication with Non-Management Directors;
|
|
|
reviews, approves or ratifies, in accordance with applicable
policies and procedures established by the Company, related
person transactions involving Directors, Director nominees and
the Chief Executive Officer or any of their immediate family
members, as well as any transactions referred to the Committee
by the Chief Executive Officer;
|
|
|
performs other duties and responsibilities, including
recommending the appointment of Directors to serve as the Chairs
and members of the Committees of the Board, overseeing the
Boards self-evaluation process, reviewing the compensation
and benefits of the Non-Management Directors, and recommending
modifications of such compensation and benefits as may be
appropriate;
|
|
|
reviews the Companys goals and strategies for its
contributions in support of health, education, civic and
cultural activities and initiatives and other similar purposes;
|
|
|
receives period reports on the strategies and initiatives of the
MetLife Foundation;
|
|
|
reviews the Companys social investment program in which
loans and other investments are made to support affordable
housing, community, business and economic development, and
health care services for low and moderate income communities;
|
|
|
reviews the Companys activities and initiatives related to
diversity and receives periodic reports from the Companys
Chief Diversity Officer regarding the Companys diversity
activities and initiatives;
|
|
|
reviews the Companys activities and initiatives related to
sustainability and environmental issues;
|
|
|
reviews the Companys goals and strategies concerning
legislative and regulatory initiatives that impact the interests
of the Company;
|
|
|
reviews the Companys sales practices for consistency with
appropriate industry standards;
|
|
|
|
reviews the ethics and compliance programs of the Company and
its subsidiaries; and
|
|
|
reviews and approves the Companys annual compliance plan.
|
The Governance and Corporate Responsibility Committee also
oversees the management and mitigation of risks related to
failure to comply with required or appropriate corporate
governance standards.
A more detailed description of the role and responsibilities of
the Governance and Corporate Responsibility Committee is set
forth in the Governance and Corporate Responsibility Committee
Charter.
During 2010, prior to the reorganization of the Governance and
the Corporate Responsibility and Compliance Committees to form
the Governance and Corporate Responsibility Committee, the
Governance Committee met six times and the Corporate
Responsibility and Compliance Committee met three times.
The Investment
Committee of Metropolitan Life Insurance Company
The Investment Committee of Metropolitan Life Insurance Company
|
|
|
oversees the investment activities of Metropolitan Life
Insurance Company and certain of its subsidiaries;
|
|
|
at the request of MetLife, also oversees the management of
investment assets of MetLife and certain of MetLifes
subsidiaries and, in connection therewith, reviews reports from
the investment officers on the investment activities and
performance of the investment portfolio of such companies and
submits reports about such activities and performance to MetLife;
|
|
|
authorizes designated investment officers, within specified
limits and guidelines, to make and sell investments for
Metropolitan Life Insurance Companys general account and
separate accounts consistent with applicable laws and
regulations and applicable standards of care;
|
|
|
reviews reports from the investment officers regarding the
conformity of investment activities with the Committees
general
|
18
|
|
|
authorizations, applicable laws and regulations and applicable
standards of care; and
|
|
|
reviews and approves Metropolitan Life Insurance Companys
derivatives use plans and reviews reports from the investment
officers on derivative transaction activity; reviews and
approves Metropolitan Life Insurance Companys high return
program plan and reviews reports from the investment officers on
high return program activity; reviews reports from the
investment officers on the investment activities and performance
of investment advisors that are engaged to manage certain
investments of Metropolitan Life Insurance Company; reviews
reports from the investment officers on the non-performing
assets in Metropolitan Life Insurance Companys investment
portfolio; and reviews Metropolitan Life Insurance
Companys investment plans and receives periodic updates of
performance compared to projections in the investment plans.
|
At the request of MetLife, the Investment Committee also
oversees the management and mitigation of risks associated with
the investment portfolios of MetLife and certain of
MetLifes subsidiaries, including
|
|
|
credit risk;
|
|
|
interest rate risk;
|
|
|
portfolio allocation and diversification risk;
|
|
|
derivatives risk;
|
|
|
counterparty risk;
|
|
|
duration mismatch risk; and
|
|
|
compliance with insurance laws and regulations that govern
insurance company investments.
|
The Investment Committee met six times during 2010.
19
MEMBERSHIP ON
BOARD COMMITTEES
The following table lists the Directors who currently serve on
the Committees described above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Governance
|
|
|
(Metropolitan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finance and
|
|
|
and Corporate
|
|
|
Life Insurance
|
|
|
|
|
|
Audit
|
|
|
Compensation
|
|
|
Executive
|
|
|
Risk
|
|
|
Responsibility
|
|
|
Company)
|
|
|
Henrikson
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Burwell
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Castro-Wright
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grisé
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
Chair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hubbard
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
Chair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Keane
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kelly
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
Chair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kilts
|
|
|
|
|
|
|
|
|
Chair
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kinney
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Satcher
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sicchitano
|
|
|
|
Chair
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wang
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
ü
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
Section 16(a) Beneficial
Ownership Reporting Compliance
Section 16(a) of the Exchange Act requires the
Companys Directors, certain officers of the Company, and
beneficial owners of more than 10% of the Companys common
stock to file with the SEC initial reports of ownership and
reports of changes in ownership of common stock and other equity
securities of the Company. Based solely upon a review of these
filings furnished to the Company during 2010 or written
representations that no Form 5 was required, the Company
believes that all filings required to be made by reporting
persons were timely made in accordance with the requirements of
the Exchange Act, except that Mr. Alfred F.
Kelly, Jr., a Director, did not timely report three
acquisitions totaling 1,610 shares of Series B
Preferred Stock during 2010. These acquisitions were reported on
March 1, 2011.
21
Code of Ethics
The Company has adopted the MetLife Financial Management Code of
Professional Conduct (the Financial Management Code), a
code of ethics as defined under the rules of the
SEC, that applies to the Companys Chief Executive Officer,
Chief Financial Officer, Chief Accounting Officer and all
professionals in finance and finance-related departments. In
addition, the Company has adopted the Directors Code of
Business Conduct and Ethics (the Directors Code)
which applies to all members of the Companys Board of
Directors, including the Chief Executive Officer, and the
Employee Code of Business Conduct and Ethics (together with the
Financial Management Code and the Directors Code,
collectively, the Ethics Codes), which applies to all
employees of the Company, including the Companys Chief
Executive Officer, Chief Financial Officer and Chief Accounting
Officer. The Ethics Codes are
available on the Companys website at http://www.metlife.com/about/corporate-profile/corporate-
governance/corporate-conduct/index.html. The Company intends
to satisfy its disclosure obligations under Item 5.05 of
Form 8-K
by posting information about amendments to, or waivers from a
provision of, the Ethics Codes that apply to the Companys
Chief Executive Officer, Chief Financial Officer and Chief
Accounting Officer on the Companys website at the address
given above.
22
|
|
Item 11.
|
Executive
Compensation
|
Compensation Committee
Interlocks and Insider Participation
No member of the Compensation Committee has ever been an officer
or employee of MetLife or any of its subsidiaries. During 2010,
no Executive Officer of MetLife served as a Director or member
of the compensation committee (or other committee serving an
equivalent function) of any other entity, one of whose executive
officers is or has been a Director of MetLife or a member of
MetLifes Compensation Committee.
23
Compensation of Non-Management
Directors
2010 DIRECTOR
COMPENSATION TABLE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees Earned or
|
|
Stock
|
|
Option
|
|
All Other
|
|
|
|
|
Paid in Cash
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Total
|
Name(1)
|
|
($)(2)
|
|
($)(3)
|
|
($)(4)
|
|
($)(5)
|
|
($)
|
|
Sylvia M. Burwell
|
|
$
|
112,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
1,584
|
|
|
$
|
226,584
|
|
Eduardo Castro-Wright
|
|
$
|
112,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
6,574
|
|
|
$
|
231,574
|
|
Burton A. Dole, Jr. (retired)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
|
|
$
|
1,316
|
|
|
$
|
1,316
|
|
Cheryl W. Grisé
|
|
$
|
168,750
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
6,584
|
|
|
$
|
287,834
|
|
R. Glenn Hubbard
|
|
$
|
137,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
6,584
|
|
|
$
|
256,584
|
|
John M. Keane
|
|
$
|
112,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
1,584
|
|
|
$
|
226,584
|
|
Alfred F. Kelly, Jr.
|
|
$
|
143,750
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
6,584
|
|
|
$
|
262,834
|
|
James M. Kilts
|
|
$
|
137,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
6,584
|
|
|
$
|
256,584
|
|
Catherine R. Kinney
|
|
$
|
112,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
6,584
|
|
|
$
|
231,584
|
|
Hugh B. Price
|
|
$
|
137,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
15,411
|
|
|
$
|
265,411
|
|
David Satcher
|
|
$
|
112,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
6,584
|
|
|
$
|
231,584
|
|
Kenton J. Sicchitano
|
|
$
|
137,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
4,084
|
|
|
$
|
254,084
|
|
William C. Steere, Jr. (retired)
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
|
|
|
$
|
14,113
|
|
|
$
|
14,113
|
|
Lulu C. Wang
|
|
$
|
112,500
|
|
|
$
|
112,500
|
|
|
|
|
|
|
$
|
1,584
|
|
|
$
|
226,584
|
|
|
|
|
(1) |
|
C. Robert Henrikson was compensated in 2010 in his capacity as
an Executive Officer of the Company, but received no
compensation in his capacity as a member of the Board of
Directors. For information about Mr. Henriksons
compensation in 2010, see the Summary Compensation Table on
page 44 and the accompanying narrative disclosure. In
accordance with the Boards retirement policy, Messrs. Dole
and Steere retired from the Board effective at the time of the
2010 Annual Meeting of Shareholders. Pursuant to the
Companys Board compensation practices, on April 28,
2009, Messrs. Dole and Steere received payment of their annual
retainer fees for the period through the 2010 Annual Meeting of
Shareholders. |
|
(2) |
|
The amounts reported in this column represent the cash component
of the annual retainer paid to the Non-Management Directors in
2010, as well as additional fees paid for service as a Committee
Chair or Lead Director. The amount reported for
Ms. Grisé includes a prorated additional fee paid for
her service as the Lead Director from the time of her initial
appointment to the position on February 1, 2010 to the time
of the 2011 Annual Meeting. The amount reported for
Mr. Kelly includes a prorated fee paid for his service as a
Committee Chair from the time of his initial appointment to the
Board on February 1, 2010 to the time of the 2011 Annual
Meeting. For additional information, see Directors
Retainer Fees on page 26. |
|
(3) |
|
The MetLife, Inc. 2005 Non-Management Director Stock
Compensation Plan (2005 Directors Stock Plan), which
was approved by the Companys shareholders in 2004,
authorizes the Company to issue shares of common stock in
payment of Director retainer fees. On April 27, 2010, each
Non-Management Director was granted 2,540 shares of the
Companys common stock, which represents the stock
component of the annual retainer paid to the Non-Management
Directors in 2010. The dollar amounts reported in this column
represent the grant date fair value of such stock awards as
computed for financial statement reporting purposes in
accordance with Financial Accounting Standards Board Accounting
Standards Codification Topic 718 (FAS 718). The
grant date fair value represents the number of shares awarded
multiplied by the closing price of the Companys common
stock on the date of grant. The closing price of the
Companys common stock on the New York Stock Exchange was
$44.30 on April 27, 2010. Stock awards granted to the
Non-Management Directors as part of their annual retainer vest
and become payable immediately upon their grant. As a result, no
stock awards were outstanding for any of the Non-Management
Directors as of December 31, 2010. |
24
|
|
|
|
|
For information about the security ownership of the
Non-Management Directors as of February 14, 2011, see
Security Ownership of Directors and Executive
Officers beginning on page 70. For additional
information about the Directors annual retainer, see
Directors Retainer Fees on page 26. |
|
(4) |
|
Prior to 2004, Non-Management Directors received stock option
awards as part of their annual retainer. These awards were
issued pursuant to the MetLife, Inc. 2000 Directors Stock
Plan (2000 Directors Stock Plan), which was in
effect until April 15, 2005 when it was replaced by the
2005 Directors Stock Plan. The following table shows the
aggregate number of stock option awards outstanding for each
Non-Management Director as of December 31, 2010. These
awards vested and became exercisable but had not been exercised
as of December 31, 2010. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
Number of
|
|
|
Option Awards
|
|
|
|
Option Awards
|
|
|
|
Option Awards
|
Name
|
|
Outstanding
|
|
Name
|
|
Outstanding
|
|
Name
|
|
Outstanding
|
|
Burwell
|
|
|
553
|
|
|
Keane
|
|
|
1,210
|
|
|
Price
|
|
|
6,836
|
|
Castro-Wright
|
|
|
0
|
|
|
Kelly
|
|
|
0
|
|
|
Satcher
|
|
|
0
|
|
Grisé
|
|
|
178
|
|
|
Kilts
|
|
|
0
|
|
|
Sicchitano
|
|
|
1,536
|
|
Hubbard
|
|
|
0
|
|
|
Kinney
|
|
|
0
|
|
|
Wang
|
|
|
0
|
|
|
|
|
(5) |
|
The amount reported in this column includes the life insurance
premiums paid by Metropolitan Life Insurance Company in 2010 for
individual life insurance coverage for Mr. Price: $7,667;
and Mr. Steere: $11,369, as well as a $1,429 proportionate
share of a $20,000 service fee paid to administer the policies
for each of Mr. Price and Mr. Steere. The amounts reported in
this column also include life insurance premiums of $1,584 paid
by Metropolitan Life Insurance Company in 2010 for group life
insurance coverage for each of Ms. Burwell,
Mr. Castro-Wright, Ms. Grisé, Mr. Hubbard,
Mr. Keane, Mr. Kelly, Mr. Kilts, Ms. Kinney,
Dr. Satcher, Mr. Sicchitano, and Ms. Wang. See
Directors Benefit Programs on page 26 for
additional information. |
|
|
|
Under the Metropolitan Life Insurance Company charitable gift
program for Non-Management Directors, Non-Management Directors
elected as Directors of Metropolitan Life Insurance Company
prior to October 1, 1999 may recommend one or more
charitable or educational institutions to receive, in the
aggregate, a $1 million contribution from Metropolitan Life
Insurance Company in the name of that Director following the
Directors death. The amount reported in this column for
each of Mr. Dole, Mr. Price and Mr. Steere includes $1,316,
representing each of their proportionate shares of a $25,000
service fee paid by Metropolitan Life Insurance Company in 2010
to administer the program. The premiums for the insurance
policies under the program were paid in full prior to 2010. |
|
|
|
This column also includes charitable contributions made by the
MetLife Foundation to colleges and universities under the
matching gift program for employees and Non-Management
Directors. In 2010, the matching gifts made by the MetLife
Foundation on behalf of Non-Management Directors were as
follows: Castro-Wright: $4,990; Grisé, Hubbard, Kelly,
Kilts, Kinney, Price, and Satcher: $5,000 each; Sicchitano:
$2,500. |
|
|
|
The Company paid for personal expenses of certain Non-Management
Directors in connection with Company business conferences or
other events attended by such Directors in 2010. For each
Non-Management
Director for whom such expenses were paid, the aggregate amount
paid by the Company in 2010 was less than $10,000. |
25
The following discussion will assist in understanding the
information reported in the 2010 Director Compensation
Table:
Directors Retainer Fees. The
Company pays each Non-Management Director an annual retainer in
the amount of $225,000, 50% of which is paid in shares of the
Companys common stock and 50% of which is paid in cash. In
addition, the Company pays an annual cash retainer fee of
$25,000 to each Non-Management Director who serves as Chair of a
Board Committee, the Companys Lead Director, and the
Non-Management Director who serves as Chair of the Metropolitan
Life Insurance Company Investment Committee.
Annual retainer fees are paid in advance at the time of the
Companys Annual Meeting. A Non-Management Director who
serves for only a portion of the year is paid a prorated
retainer fee in advance at the time of commencement of service
to reflect the period of such service.
Director Fee Deferrals. A
Non-Management Director may defer the receipt of all or part of
his or her fees payable in cash or shares (and any imputed
dividends on those shares) until a later date or until after he
or she ceases to serve as a Director. From 2000 to 2004, such
deferrals could be made under the terms of the
2000 Directors Stock Plan (share awards) or the MetLife
Deferred Compensation Plan for Outside Directors (cash awards).
Since 2005, any such deferrals are made under the terms of the
MetLife Non-Management Director Deferred Compensation Plan,
which is intended to comply with Internal Revenue Code
Section 409A.
Directors Benefit
Programs. Non-Management Directors who joined
the Board on or after January 1, 2003 receive $200,000 of
group life insurance. Non-Management Directors who joined the
Board prior to January 1, 2003 are eligible to continue to
receive $200,000 of individual life insurance coverage under
policies then in existence, for which MetLife would pay the
Directors a cash amount sufficient to cover the cost of
premiums. MetLife provides each Non-Management Director with
business travel accident insurance coverage for travel on
MetLife business.
Stock Ownership
Guidelines for Non-Management Directors
The Board of Directors has established stock ownership
guidelines for Non-Management Directors. Each is expected to own
MetLife common stock-based holdings equal in value to at least
three times the cash component of the MetLife Non-Management
Directors annual retainer. Each Non-Management Director is
expected to achieve this level of ownership by December 31 of
the year in which the third anniversary of his or her election
to the Board occurs. The share ownership of each Non-Management
Director met these guidelines as of December 31, 2010.
Directors
Retirement Policy
The retirement policy adopted by the Board of Directors provides
that no Director may stand for election as a member of
MetLifes Board after he or she reaches the age of 72, and
that a Director may continue to serve until the Annual Meeting
coincident with or immediately following his or her
72nd birthday. No Director who is also an officer of
MetLife may serve as a Director after he or she retires as an
officer of MetLife or Metropolitan Life Insurance Company. In
addition, each Director must offer to resign from the Board upon
a change or discontinuance of his or her principal occupation or
business responsibilities. The Directors retirement policy
is set forth in the Companys Corporate Governance
Guidelines.
Director
Indemnity Plan
The Companys By-Laws provide for the Company to indemnify,
and advance expenses to, a person who is threatened with
litigation or made a party to a legal proceeding because of the
persons service as a Director of the Company. In addition,
the Companys Director Indemnity Plan affirms that a
Directors rights to this indemnification and expense
advancement are contract rights. The indemnity plan also
provides for expenses to be advanced to former Directors on the
same basis as they are advanced to current Directors. Any
amendment or repeal of the rights provided under the indemnity
plan would be prospective only and would not affect a
Directors rights with respect to events that have already
occurred.
26
Compensation Committee
Report
This report is furnished by the Compensation Committee of
MetLifes Board of Directors. The Compensation Committee
has reviewed and discussed with management the Compensation
Discussion and Analysis that is set forth on pages 28
through 43 of this Amendment and, based on such review and
discussion, the Compensation Committee has recommended to the
Board of Directors that such Compensation Discussion and
Analysis be included in the Companys Proxy Statement and
incorporated by reference in the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2010.
No portion of this Compensation Committee Report shall be deemed
to be incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Securities Exchange
Act of 1934, as amended, through any general statement
incorporating by reference in its entirety any document in which
this Report appears or will appear, including but not limited to
the Companys Proxy Statement, except to the extent that
the Company specifically incorporates this report or a portion
of it by reference. In addition, this report shall not be deemed
to be soliciting material or to be filed
under either the Securities Act of 1933, as amended, or the
Exchange Act.
Respectfully,
James M. Kilts, Chair
Eduardo Castro-Wright
Cheryl W. Grisé
Alfred F. Kelly, Jr.
Hugh B. Price
Kenton J. Sicchitano
27
Compensation Discussion and
Analysis
This Compensation Discussion and Analysis describes the
objectives and policies underlying MetLifes executive
compensation program. It also describes key factors that the
Compensation Committee considered in determining the
compensation of the members of the Executive Group. The
Executive Group includes the Named Executive Officers as well as
the other Executive Officers of the Company. References to the
Companys executive compensation programs and
policies refer to those that apply to the Executive Group.
Shareholders will have the opportunity, at the 2011 Annual
Meeting, to vote to endorse or not endorse the compensation paid
to the Companys Named Executive Officers, as disclosed
pursuant to the compensation disclosure rules of the Securities
and Exchange Commission, including this Compensation Discussion
and Analysis and the compensation tables and narrative
discussion. The Compensation Committee and the Board of
Directors believe that this Compensation Discussion and Analysis
and the compensation tables and narrative discussion that follow
support their recommendation to approve that shareholder
advisory resolution.
Executive Summary
and Overview
2010 Business Results. Throughout 2010,
MetLife continued to focus on its global objectives, creating
long-term shareholder value and growing its businesses, while
taking prudent (not excessive) risks. Maintaining focus was
essential to MetLifes success given the uncertain global
economy and impending comprehensive changes to the regulatory
framework.
MetLifes business results for 2010 included the following:
|
|
|
premiums, fees and other revenues of $35.8 billion, up 5%
from 2009;
|
|
|
Operating Earnings of $3,892 million, or $4.38 per
share, up from $2,365 million, or $2.87 per share, in 2009;
|
|
|
|
Return on Equity of 10.2%, up from 6.7% in 2009; and
|
|
|
cumulative pre-tax annualized savings of $700 million
through its Operational Excellence initiative, compared to its
objective of $600 million.
|
For more information on these financial measures, see
Shared Financial Performance Goals on page 37.
At the same time, MetLife completed the largest acquisition in
its history by buying American Life Insurance Company and
Delaware American Life Insurance Company (together,
Alico). The acquisition transformed MetLife into a global
competitor which expects to generate 30% of projected 2011
premiums, fees, and other revenues, and 40% of projected 2011
Operating Earnings, from outside the United States. The
acquisition advanced MetLifes presence in markets where
the Company was established (such as western Europe and Japan),
and established MetLife positions in important emerging growth
markets (such as eastern Europe, parts of Latin America, and the
Middle East).
2010 Compensation Highlights. MetLife
maintained its commitment to its pay for performance philosophy,
and continued to emphasize variable performance-based
compensation over fixed or guaranteed pay. For 2010, variable
compensation to Executive Group members was over seven times
fixed compensation, and stock-based incentive compensation for
2010 performance to Executive Group members was over one and
one-half times cash incentive compensation.
Given this mix of pay, Executive Group members interests
are aligned with those of shareholders. Much of their
compensation depends on increases in the price of MetLife, Inc.
common stock (Shares) that benefit shareholders. Further,
the Companys Share ownership guidelines align
executives interests with those of shareholders and
reinforce the focus on long-term shareholder value. The Named
Executive Officers have maintained significant Share ownership.
28
The Companys long-term performance, including changes to
the price of Shares, has a significant impact on the Named
Executive Officers compensation. For example, the
performance factor for the 2007-2009 Performance Shares (paid
out in 2010) was slightly below target, based on the
Companys three-calendar-year performance relative to
competition, and the price of Shares was considerably lower than
on the date the Performance Shares were granted due to a
tumultuous stock market. As a result, the payment value on
vesting of the awards was 53% of the target value of the awards
on the grant date. At the same time, the Companys total
shareholder return for 2010 was over 24%, which compares
favorably to the increase in the Chief Executive Officers
compensation as reported in the Total column of the
Summary Compensation Table (approximately 20%).
Changes made in 2009 continued to have an impact in 2010. The
cap on final average pay for purposes of auxiliary pension
benefits contributed to an absolute decrease in the present
value of the Chief Executive Officers accumulated pension
benefits for 2010. In addition, for four of the five Named
Executive Officers, the amount of perquisites and personal
benefits provided by the Company dropped from 2009, reflecting
the continuing Company practice of scrutinizing the items it
provides to ensure that they remain limited and reasonable.
Further, the reduction in the severance pay and related benefits
potentially payable to a terminated executed after a
change-in-control, which became effective in 2010, resulted in a
64% decrease in the amount of such potential payments to the
Chief Executive Officer and a 56% decrease in the amount of such
potential payments for the other Named Executive Officers
combined.
Risk Assessment. The Companys
Chief Risk Officer has concluded that risks arising from the
compensation policies and practices for employees
of the Company and its affiliates are not reasonably likely to
have a material adverse effect on the Company as a whole, in
light of the features of those policies and practices and the
controls in place to limit and manage risk. The Chief Risk
Officer discussed aspects of his analysis with the Compensation
Committee.
Compensation
Philosophy and Objectives
MetLifes executive compensation program is designed to:
|
|
|
provide competitive Total Compensation opportunities that will
attract, retain and motivate high-performing executives;
|
|
|
align the Companys compensation plans with its short- and
long-term business strategies;
|
|
|
align the financial interests of the Companys executives
with those of its shareholders through stock-based incentives
and stock ownership requirements; and
|
|
|
reinforce the Companys pay for performance culture by
making a significant portion of Total Compensation variable, and
differentiating awards based on Company, business unit and
individual performance.
|
MetLifes program aligns with Company strategies and has a
number of features that contribute to prudent decision making
and avoid providing executives with an incentive to take
excessive risks. One important feature is the use of Operating
Earnings as a metric in incentive programs. Operating Earnings
excludes investment gains and losses, which removes incentives
to take excessive risk in MetLifes investment portfolio.
In addition, the Company uses three-year performance periods and
vesting for long-term incentive compensation, so that time
horizons for compensation reflect the extended time horizons for
the results of many business decisions.
29
Overview of
Compensation Program
MetLife uses a competitive total compensation structure that
consists of base salary, annual incentive awards and stock-based
long-term incentive award opportunities. For purposes of this
discussion and MetLifes compensation program, Total
Compensation for an Executive Group member means the total
of those three elements. The Independent Directors approve the
Total Compensation for the Chief Executive Officer and the other
Executive Group members.
The Compensation Committee recommends Total Compensation amounts
for each Executive Group member for approval by the Independent
Directors. When determining an Executive Group members
Total Compensation, the Committee considers the three elements
of Total Compensation together. As a result, decisions on the
award or payment amount of one element impact the decisions on
the amount of other elements.
Each Executive Group members Total Compensation reflects
the Compensation Committees assessment of Company,
business unit, and the executives performance as well as
competitive market data based on peer compensation comparisons.
However, the Compensation Committee does not structure
particular elements of compensation to relate to separate
individual goals or performance.
The Compensation Committee also reviews other compensation and
benefit programs, such as retirement benefits and potential
payments that would be made if an Executive Group members
employment were to end. Benefits such as retirement and medical
programs do not impact Total Compensation decisions since they
apply to substantially all employees. As a result, decisions
about those benefits do not vary based on decisions about an
Executive Group members base salary or annual or
stock-based awards.
Generally, the forms of compensation and benefits provided to
the Executive Group members are similar to those provided to
other officer-level employees. None of the Executive Group
members is a party to any agreement with the Company that
governs the executives employment.
The Compensation Committees independent executive
compensation consultant, Meridian, assisted the Committee in its
design and review of the Companys compensation program.
For more information on the role of Meridian regarding the
Companys executive compensation program, see Board
Committees The Compensation Committee
beginning on page 15.
30
VARIABLE VS.
FIXED COMPENSATION
A substantial portion of the Executive Group members Total
Compensation for 2010 performance was variable and dependent
upon the attainment of performance objectives or the value of
Shares.
STOCK-BASED
INCENTIVES VS. ANNUAL CASH INCENTIVES
To align executive and shareholder interests, in determining
Total Compensation for 2010 performance, the Compensation
Committee allocated a greater portion of the Executive Group
members variable compensation to stock-based incentives
than it allocated to annual cash incentives:
For purposes of the above calculations, Performance Shares were
valued using a Share price, based on recently-prevailing Share
prices at the time of grant, that was also used for compensation
planning purposes. Each Stock Option was valued at one-third of
that price. See Stock-Based Long-Term Incentive
Awards beginning on page 40. All of the long-term
incentive compensation awarded to the Executive Group members
consisted of Stock Options that vest over three years, or at the
end of three years, and awards normally payable in the form of
Shares that cannot be acquired by the executive for at least
three years.
Peer Compensation
Comparisons
The Compensation Committee periodically reviews the
competitiveness of MetLifes Total Compensation structure
using data reflecting a comparator group of companies in the
insurance and broader financial services industries with which
MetLife competes for executive talent (Comparator Group).
Likewise, the Compensation Committee reviews the composition of
the Comparator Group from time to time to assure that it remains
an appropriate comparison for the Company. The Compensation
Committee reviewed and modified the Comparator Group in 2010 and
made a minor change. The
Committee added PNC Financial Services Group, Inc. a large
company with a broad financial services range of business and
removed Suntrust Banks, Inc., a smaller regional bank.
The current Comparator Group consists of the 24 financial
services companies listed under Comparator Group
below. Companies were chosen for the Comparator Group in light
of their size relative to MetLife and the extent of their global
presence, or their similarity to MetLife in the importance of
investment and risk management to their business, or both.
MetLife was between the 50th and 75th percentile of
the Comparator Group as a whole in each of assets (as of
year-end
31
2009), revenue (for 2009), and market capitalization (as of
April, 2010).
In 2010, the Compensation Committee also reviewed the
Companys approach to determining competitive Total
Compensation. In view of the increasingly global nature of the
Companys business as a consequence of its acquisition of
Alico, and the greater proportion of the Companys earnings
derived outside the United States, the Compensation Committee
concluded that a broader focus on financial services competitors
as a group better reflected the challenges the Executive Group
faced and the expectations it had for the performance of the
business. To that end, the Compensation Committee has determined
that an Executive Group members Total Compensation is
competitive if it falls between the 50th and
75th percentile of the companies in the Comparator Group
for the executives position, based on total compensation
data from recent periods (the Competitive Range). (Prior
to this change, the Compensation Committee had compared
Executive Group members Total Compensation opportunities
to the 50th percentile of the entire Comparator Group
and the 75th percentile of the insurance companies in the
Comparator Group.) The Compensation Committee does not compare
compensation on a separate
element-by-element
basis, but rather focuses on Total Compensation.
The Competitive Range for an Executive Group members Total
Compensation is one element of the Compensation Committees
determination of Total Compensation for the executive. For 2010
performance, Mr. Wheelers, Mr. Toppetas,
and Mr. Kandarians Total Compensation fell within the
upper third of the Competitive Range for their respective
positions and Mr. Mullaneys Total Compensation fell
within the approximate middle third of the Competitive Range for
his position. Mr. Henriksons Total Compensation was
slightly above the Competitive Range for his position. The
Compensation Committee considered the Companys 2010
results, Mr. Henriksons own performance, and the
impact of recent turmoil in the financial services sector on the
Competitive Range for Chief Executive Officers in determining
that Mr. Henriksons compensation should be above that
range.
COMPARATOR
GROUP
|
|
|
AEGON N.V.
Aflac Incorporated
The Allstate Corporation
American Express Company
AXA Financial, Inc.
Bank of America Corporation
Citigroup Inc.
The Hartford Financial Services Group, Inc.
HSBC Holdings plc
ING Groep N.V.
JPMorgan Chase & Co.
Lincoln National Corporation
|
|
Manulife Financial Corporation
Massachusetts Mutual Life Insurance Company
Morgan Stanley
Nationwide Financial Services, Inc.
New York Life Insurance Company
PNC Financial Services Group Inc.
The Principal Financial Group, Inc.
Prudential Financial, Inc.
Sun Life Financial Inc.
The Travelers Companies, Inc.
U.S. Bancorp
Wells Fargo & Company
|
32
Setting Total
Compensation
Chief Executive Officer
Compensation. At the beginning of 2010, the
Chief Executive Officer and the Compensation Committee
established goals and objectives that were designed to drive
Company performance. For a description of these goals, see
Annual Incentive Awards beginning on page 35.
In early 2011, the Compensation Committee recommended to the
Independent Directors the Total Compensation for the Chief
Executive Officer, including annual and stock-based awards for
2010. The Committees Total Compensation recommendations
for 2010 reflected its assessment of Mr. Henriksons
performance relative to his established goals and objectives in
his role as Chief Executive Officer, and took into account
Mr. Henriksons performance relative to additional
business challenges and opportunities that arose during the
year. The Committee also considered competitive market data
provided by Meridian. Meridians report included a
comparison and analysis of Mr. Henriksons
compensation to chief executive officer compensation at
Comparator Group companies. The comparison included historical
information on Comparator Group companies size (measured
by revenue, market capitalization and assets) and performance
(measured by
3-year and
1-year
growth in Operating Earnings, book value, operating return on
equity, and total shareholder return) compared to MetLife. The
application of these practices and processes for 2010 resulted
in relatively higher compensation being awarded to
Mr. Henrikson than to other Executive Group members due to
Mr. Henriksons broader responsibilities and higher
levels of accountability as the most senior executive in the
Company, as well as competitive market data.
Compensation of Other Executive Group
Members. At the beginning of 2010, the Chief
Executive Officer and each Executive Group member agreed on the
respective executives goals. In early 2011, the Chief
Executive Officer provided to the Compensation Committee an
assessment of the other Executive Group members
performance during 2010 relative to their goals and the
additional business challenges and opportunities that arose
during the year. He also recommended to the Committee Total
Compensation amounts for each Executive Group member taking into
account performance during the year as well as available
competitive data and compensation opportunities for each
position. The Committee reviewed these recommendations and
endorsed the components of each Executive Group members
Total Compensation to the Board of Directors.
The Executive Vice President, Human Resources of the Company
provided the Compensation Committee with advice and
recommendations on the form and overall level of executive
compensation, and provided guidance and information to the Chief
Executive Officer to assist him in making recommendations to the
Compensation Committee of Total Compensation amounts for each
Executive Group member, other than herself. She also provided
guidance to the Committee on the Committees general
administration of the programs and plans in which Executive
Group members, as well as other employees, participate.
Other than the Chief Executive Officer and the Executive Vice
President, Human Resources, no Executive Group member played a
role in determining the compensation of any of the other
Executive Group members. Neither the Chief Executive Officer nor
the Executive Vice President, Human Resources took part in the
Boards consideration of his or her own compensation.
33
Components of
Compensation and Benefits
The primary components of the Companys executive
compensation and benefits program play various strategic roles:
|
|
|
|
|
|
|
|
|
|
Description
|
|
|
Strategic Role
|
Total
Compensation
|
|
|
Base Salary: Fixed based on position, scope of
responsibilities, individual performance, and competitive data
|
|
|
Compensation for services during the year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annual Incentive Awards: Variable based on
performance relative to Company, business unit, and individual
goals and (when applicable) additional business challenges or
opportunities that arose during the year that were not reflected
in previously established goals for the year; the Compensation
Committee determines awards using its judgment of all of these
factors as a whole, and not by using a formula
|
|
|
Primary compensation vehicle for recognizing and differentiating
individual performance each year; designed to motivate Executive
Group members and other employees to achieve strong annual
business results that will contribute to the Companys
long-term success, without creating an incentive to take
excessive risk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-Based Long-Term Incentive Awards: Amount of
awards based on discretionary assessment of individual level of
responsibility, performance, relative contribution, and
potential for assuming increased responsibilities; ultimate
value of awards depends exclusively on increases in the price of
Shares (Stock Options), or on MetLifes performance
relative to its competition as well as the value of Shares
(Performance Shares); generally, 50% of Stock-Based Long-Term
Incentive Awards to Executive Group members are allocated to
Stock Options and 50% to Performance Shares, valued using a
compensation planning Share price (based on recently-prevailing
Share prices at the time of grant) for Performance Shares, and
one-third of that Share price for Stock Options
|
|
|
Ensures that Executive Group members have a significant
continuing stake in the long-term financial success of the
Company (see Stock Ownership on page 41);
aligns executives interests with those of shareholders;
encourages decisions and rewards performance that contribute to
the long-term growth of the Companys business and enhance
shareholder value; motivates Executive Group members to
outperform MetLifes competition in terms of key
performance measures over a three-year period; encourages
executives to remain with MetLife
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits
|
|
|
Retirement Program and Other
Benefits: Post-retirement income (pension) or the
opportunity to save a portion of current compensation for
retirement and other future needs (savings and investment
program and nonqualified deferred compensation)
|
|
|
Attracts and retains executives and other employees
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
|
|
|
|
Description
|
|
|
Strategic Role
|
Potential
Payments
|
|
|
Severance Pay and Related Benefits: Transition
assistance if employment ends due to job elimination or, in
limited circumstances, poor performance
|
|
|
Encourages focus on transition to other opportunities and allows
the Company to obtain a release of employment-related claims
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change-in-control Benefits: Replacement or vesting
of stock-based long-term incentive awards; severance and related
benefits also paid if the Executive Group members
employment is terminated without cause or the Executive Group
member resigns with good reason following a change-in-control
|
|
|
Retains Executive Group members through a change-in-control and
allows executives to act in the best interests of shareholders
in a change-in-control without distractions due to concerns over
personal circumstances; promotes the unbiased and disinterested
efforts of the Executive Group members to maximize shareholder
value during and after a change-in-control; keeps executives
whole in situations where Shares may no longer exist or awards
otherwise can not or will not be replaced
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The primary components of the Companys executive
compensation and benefits program are further discussed below.
Base
Salary
The base salaries earned by the Named Executive Officers in 2010
are reported in the Summary Compensation Table on page 44.
In February 2010 the Compensation Committee approved the
following base salary increases for the following Named
Executive Officers in light of their levels of responsibility,
their performance, and the competitive market:
|
|
|
|
|
|
|
|
|
Base Salary
|
|
Effective
|
Executive
|
|
Increase
|
|
Date
|
|
William J. Wheeler
|
|
$
|
25,000
|
|
|
December 1, 2010
|
William J. Toppeta
|
|
$
|
20,000
|
|
|
March 1, 2010
|
William J. Mullaney
|
|
$
|
25,000
|
|
|
August 1, 2010
|
Annual Incentive
Awards
The MetLife Annual Variable Incentive Plan (AVIP)
provides eligible employees, including the Executive Group
members, the opportunity to earn annual cash incentive awards.
AVIP is administered as a Cash-Based Awards program under the
MetLife, Inc. 2005 Stock and Incentive Compensation Plan
(Stock and Incentive Plan or 2005 Stock Plan). The
2010 AVIP Awards are reported in the Non-Equity Incentive
Plan Compensation column of the Summary Compensation Table
on page 44.
Section 162(m) of the United States Internal Revenue Code
(Section 162(m)) limits the deductibility of
compensation paid to four of the Companys most
highly-compensated executives, but exempts certain
performance-based compensation from those limits.
For 2010, the Compensation Committee established limits and
performance goals for purposes of qualifying the AVIP awards to
the Companys Executive Group members for this exemption.
See Non-Equity Incentive Plan Awards on page 50
for more information about the individual maximums set for 2010
AVIP awards.
Determining the Amount Available for
Awards. Each year, the Compensation Committee
approves the maximum amount available for AVIP awards to all
covered employees, including the Named Executive Officers, which
for 2010 included 23,000 employees. Early in 2010, the
Compensation Committee determined that the amount available for
2010 would be based primarily on the Companys Operating
Earnings and, to a lesser extent, its Return on Equity, compared
to the Companys 2010 Business Plan (the Business
Plan), subject to its exercise of discretion. The
methodology for determining this amount for 2010 was as follows:
35
|
|
|
|
|
($ in millions)
|
|
|
|
|
AVIP Operating Earnings Factor
|
|
|
|
|
Operating Earnings
|
|
$
|
3,817
|
(1)
|
Less Excess or Shortfall of Variable Investment Income (solely
to the extent more than 10% higher or lower than the business
plan target)
|
|
$
|
(393
|
)
|
|
|
|
|
|
Result
|
|
$
|
3,424
|
|
Business Plan Operating Earnings
|
|
$
|
3,415
|
|
Operating Earnings less Excess or Shortfall of Variable
Investment Income as a percentage of Business Plan Operating
Earnings equals AVIP Operating Earnings Factor (may not exceed
150%)
|
|
|
100.0
|
%(2)
|
|
|
|
|
|
AVIP Return on Equity Factor
|
|
|
|
|
Return on Equity
|
|
|
10.7
|
%(1)
|
Less Business Plan Return on Equity
|
|
|
(9.7
|
)%
|
|
|
|
|
|
Result
|
|
|
1.0
|
%
|
AVIP Return on Equity Modifier (for each 0.1% by which the
Return on Equity exceeds the Business Plan, 0.3% is added (may
not exceed 15%)
|
|
|
3.0
|
%
|
|
|
|
|
|
Calculation of Total Amount Available for AVIP Awards
|
|
|
|
|
Annual Operating Earnings Factor plus Annual Operating Return on
Equity Modifier equals AVIP Performance Factor
|
|
|
103.0
|
%
|
Total target-performance planning amount of all employees
AVIP awards (the AVIP Planning Target)
|
|
$
|
331
|
|
Total amount available for all AVIP awards equals AVIP
Performance Factor times AVIP Planning Target
|
|
$
|
341
|
|
|
|
|
(1) |
|
Excludes the impact of the Alico acquisition. |
|
(2) |
|
Rounded to the nearest whole percent. |
For more information on Operating Earnings and Return on Equity,
see Shared Financial Performance Goals on
page 37. For this purpose, Variable Investment
Income means after-tax variable investment income
available to common shareholders.
This formula avoids providing employees with an incentive to
take excessive risk in several ways. Operating Earnings does not
include investment gains or losses. In addition, the impact of
after-tax variable investment income is limited to no more than
a 10% variation from the Business Plan. As a result, the formula
does not provide an incentive to take excessive risk in the
Companys investment portfolio. Nor is the formula an
unlimited function of revenues; rather, the formula caps the
amount that can be generated for AVIP awards, and is a function
of financial
measures that account for the Companys costs and
liabilities.
Performance Goals. The Executive Group
members performance goals consisted of shared financial
performance goals and individual performance goals, all of them
aligned with the Companys performance objectives. The
Compensation Committee considered the Companys financial
results, and each Named Executive Officers
accomplishments, in determining the Named Executive
Officers 2010 AVIP Awards.
36
Shared Financial Performance Goals. The
Executive Group members key shared financial performance
goals for 2010 included Operating Earnings, Earnings Per Share,
Return on Equity, and Book Value Per Share, as set forth in the
Business Plan. Under the leadership of Mr. Henrikson and
the Executive Group, the Company achieved the results in 2010
compared below to its 2010 Business Plan and its results for
2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
|
|
|
2010
|
|
Business Plan
|
|
2009
|
|
Operating Earnings ($ millions)
|
|
$
|
3,892
|
|
|
$
|
3,415
|
|
|
$
|
2,365
|
|
Earnings Per Share
|
|
$
|
4.38
|
|
|
$
|
4.12
|
|
|
$
|
2.87
|
|
Return on Equity
|
|
|
10.2
|
%
|
|
|
9.7
|
%
|
|
|
6.7
|
%
|
Book Value Per Share
|
|
$
|
43.23
|
|
|
$
|
44.04
|
|
|
$
|
41.69
|
|
These performance measures are not calculated based on
accounting principles generally accepted in the United States of
America (GAAP). They should be read in conjunction with
the Appendix regarding non-GAAP financial measures beginning on
p. 66, which includes reconciliations to the most directly
comparable GAAP measures, which are income (loss) from
continuing operations, net of income tax (for Operating
Earnings), net income (loss) available to common
shareholders per diluted common share (for Earnings Per
Share), return on the Companys common equity (for
Return on Equity), and book value per actual common share
(for Book Value Per Share).
Individual Performance Goals. In addition to
their shared financial performance goals for 2010, each Named
Executive Officer had individual performance goals.
Key individual goals for Mr. Henrikson included:
|
|
|
promoting long-term shareholder value, particularly through
strategic international growth;
|
|
|
refining and implementing strategic growth and expense reduction
initiatives;
|
|
|
maintaining and enhancing effective risk management;
|
|
|
developing leadership to assure executive succession consistent
with sustained excellence; and
|
|
|
driving strategic communications and building relationships to
increase associate engagement and bolster MetLifes thought
leadership.
|
Under Mr. Henriksons leadership, MetLife undertook a
strategic assessment in 2010 which determined that international
growth would be key to creating long-term shareholder value. As
a result of MetLifes completion of the acquisition of
Alico, 2011 Operating Earnings from International are expected
to be more than double the goal, set before MetLife began to
pursue the acquisition, of generating 20% of MetLifes
Operating Earnings from international operations by 2012.
MetLife also established an Enterprise Strategy Management Group
to translate strategic decisions into concrete actions. The
Companys
cumulative pre-tax annualized savings of $700 million in
2010 exceeded its Operational Excellence goal of
$600 million.
The Company strengthened its risk management infrastructure
through the continued development of its Enterprise Risk
Management organization, led by the Chief Risk Officer. Both
regulators and credit rating agencies recognized MetLifes
demonstrated success and effectiveness in avoiding losses
incurred by some competitors.
Mr. Henriksons ongoing focus on executive leadership
development and succession planning has prepared MetLife for
continued future success. In addition to preparing for CEO
succession when he reaches his mandatory retirement date,
Mr. Henrikson replaced the retiring General Counsel with an
internal candidate and conducted a comprehensive assessment of
the top fifty executives in senior management for the Board of
Directors, emphasizing their readiness to take on greater
leadership or the developmental opportunities they need to be
prepared for greater responsibilities. Under
Mr. Henriksons leadership, the Company has also put
action plans into place to improve talent management and create
the conditions necessary to empower associates.
Mr. Henrikson employed strategic communications with
associates to promote common objectives and shared values. He
also successfully communicated to external stakeholders about
many issues that affect MetLifes business, enhancing
MetLifes position in thought leadership.
Mr. Henrikson served on the Presidents Export
Council, which
37
enabled him to reinforce with government leaders the importance
of free trade in financial services. Mr. Henrikson also
served as the Chairman of the American Council of Life Insurers
which, along with his role as Chief Executive Officer of
MetLife, provided an opportunity to bring his vast experience in
the insurance industry and leadership of MetLife to bear on
regulatory and legislative issues and initiatives such as
financial services reform.
Mr. Wheelers key individual goals included:
|
|
|
leadership of the Alico acquisition and the financing necessary
to pay for the acquisition;
|
|
|
continued development and financial performance of MetLife Bank;
|
|
|
maintenance of appropriate capital levels;
|
|
|
leadership of Operational Excellence initiatives;
|
|
|
continued strengthening of risk management;
|
|
|
active management of initiatives to optimize capital usage and
return on equity expansion;
|
|
|
active engagement in public accounting developments; and
|
|
|
enhanced career development for associates in the Financial
Management Group.
|
Mr. Wheeler successfully led the Alico acquisition and
obtained financing designed to optimize the enterprise capital
structure, maintain credit ratings, and limit common stock
dilution. In addition, under Mr. Wheelers leadership,
MetLife Banks financial performance exceeded its goals of
$1.112 billion in revenue, $177 million in Operating
Earnings and 19% Return on Equity, but did not meet its goal of
a 74% efficiency ratio. The Company also maintained satisfactory
credit ratings and satisfactory risk-based capital levels for
its domestic insurance companies, and strengthened overall risk
management through reserve financing and rollout of an enhanced
capital model and enhanced risk management processes. The
Financial Management Group business unit fell just short of its
pre-tax savings (before one-time costs) goal of
$50 million. At the same time, Mr. Wheeler led the
Companys active engagement in key accounting initiatives
such as presentations to the International Accounting Standards
Board (IASB) and IASB and Financial Accounting Standards
Board (FASB) staff on convergence and participated in the
FASB
emerging issue task force consideration of deferred acquisition
costs. Finally, Mr. Wheeler enhanced the career development
of Financial Management Group associates through preparing his
direct reports for advancement to additional responsibilities
and successful integration of the Alico financial staff.
Mr. Toppetas key individual goals included:
|
|
|
the financial performance of the International business unit;
|
|
|
closing day Alico integration deliverables; and
|
|
|
design and implementation of new management structures for the
combined International business unit.
|
Under Mr. Toppetas leadership, the International
business unit (excluding Alico) met or exceeded its financial
plan goals for earnings ($590 million) and return on equity
(12.9%), and substantially met its goal for premiums, fees, and
other revenues ($5 billion), but did not meet its goal for
sales ($6.2 billion). International business grew in sales,
premiums, fees, and other revenues, earnings, and return on
equity over 2009. The Company accomplished the closing day Alico
integration deliverables, making the closing a transparent event
to customers, distributors, and associates. Mr. Toppeta
also led the successful implementation of a new operating model
and organization structure to ensure seamless continuity of
operations and to achieve 2010 goals while preserving the
pre-acquisition core strengths of both MetLife and Alico
international operations. Mr. Toppeta established an
International leadership team, balancing the talent, skill, and
expertise of each prior organization, and implemented governance
processes (including delegations of authority) to clarify roles
and decision-making authority, with checks and balances for
appropriate risk management. Finally, Mr. Toppeta
established effective communication channels within the combined
organization, with analysts, with customers, and with regulators.
Mr. Mullaneys key individual goals included:
|
|
|
meeting the U.S. Business goals under the financial plan;
|
|
|
development and deployment of the U.S. Business strategy;
|
38
|
|
|
talent management and organizational effectiveness; and
|
|
|
rationalizing distribution across diverse channels.
|
Under Mr. Mullaneys leadership, U.S. Business
exceeded its financial plan goals for earnings
($2.9 billion), return on equity (12.4%), and expense
savings ($167.7 million), but did not meet its goal for
premiums, fees and other revenues ($30.0 billion).
Mr. Mullaney also led U.S. Business in rolling out its
new, customer-centric business strategy, with both short-term
deliverables and a long-term roadmap to achieve growth
objectives and an integrated communication plan for both sales
and non-sales associates. U.S. Business also conducted
development reviews for all officer-level associates and
succession planning for critical roles. Mr. Mullaney led
the effort to begin the transformation of distribution across
channels in U.S. Business by moving to lower-cost models
while increasing sales agent productivity, developing a stronger
value proposition to recruit and retain experienced sales
agents, and performing a comprehensive review of the
distribution system as a whole. This distribution system review
identified the most profitable and attractive segments, the role
of each channel in meeting future customer needs, and the
operating model needed to optimize all channels.
U.S. Business also supported Global Brand and Marketing
Services in creating the middle market direct marketing
initiative, a platform which is expected to make direct
marketing a more prominent part of future sales.
Mr. Kandarians key individual goals included:
|
|
|
effectively managing MetLifes investment portfolio to meet
MetLifes investment plan in
|
|
|
|
light of changing market conditions, producing net investment
income without taking excessive risk;
|
|
|
addressing the Companys asset-liability management needs;
|
|
|
integrating the Alico investment portfolio into the overall
enterprise portfolio;
|
|
|
leading the effort to refresh the Companys strategy to
meet future business challenges;
|
|
|
designing and implementing an Alico brand integration
strategy; and
|
|
|
establishing new initiatives in branding and marketing,
|
Under Mr. Kandarians leadership, MetLife exceeded its
investment plan goal of $16.45 billion in net investment
income, and had net realized after-tax losses that were less
than the plan goal of $1 billion. Mr. Kandarian also
maintained portfolio yields and lengthened the portfolios
duration as interest rates fell, repositioning the portfolio to
return to long-term targets. At the same time,
Mr. Kandarian successfully integrated Alicos
investment portfolio into that of MetLife. Mr. Kandarian
created and led the Enterprise Strategy Group to refresh
corporate strategy and determine the financial metrics and
priorities for that effort. The Companys Global Brand and
Marketing Services formulated and executed the Alico integration
brand strategy, launched a middle market initiative to acquire
new customers through direct marketing and deployed new
underwriting techniques to radically reduce the time from
application to sale, and increased brand visibility.
39
Stock-Based
Long-Term Incentive Awards
The Company awards Stock Options and Performance Shares and
determines the amount of such awards as part of its Total
Compensation program.
Stock Options. Stock Options are
granted at an exercise price equal to the closing price of
Shares on the date of grant. The ultimate value of Stock Options
depends exclusively on increases in the price of Shares.
One-third of each award of Stock Options vests on each of the
first three anniversaries of the date of grant.
Performance Shares. Performance Shares
are units that may become payable in Shares at the end of a
three-year performance period, depending on specified Company
performance relative to MetLifes competition over that
time. For this purpose, MetLifes competition is defined as
the Fortune
500®
companies included in the Standard & Poors
Insurance Index (Insurance Index Comparators). The
Insurance Index Comparators were chosen to measure
MetLifes relative performance because insurance is the
predominant portion of the Companys overall business mix.
The final number of Performance Shares paid is determined by the
Companys performance in total shareholder return and
change in annual net Operating Earnings per share (as defined by
the Company for each year) compared to the other Insurance Index
Comparators. The amount paid can be as low as zero and as high
as twice the number of Performance Shares granted. Beginning
with awards made in 2009, if the Company does not produce a
positive total shareholder return for the performance period,
the number of Shares to be paid out, if any, will be reduced by
25%. For additional information about the Performance Share
formula, see Equity Incentive Plan Awards on
page 50.
The Performance Shares for the
2007-2009
performance period became payable during 2010. Based on
MetLifes performance relative to the Insurance Index
Comparators for that period, the Company paid 94% of each vested
Performance Share award. For information about these payments,
see the table entitled, Option Exercises and Stock Vested
in 2010 on page 54.
In 2010, Standard & Poors added Berkshire
Hathaway Inc. (BHI) to its insurance index. The
Compensation Committee has excluded BHI from the Insurance Index
Comparators beginning with Performance Share awards for the
2011-2013
performance period. Given the size of BHI, and the diversity of
its business outside of insurance and financial services, the
Committee determined that excluding BHI from the Insurance Index
Comparators for future awards will maintain an appropriate peer
comparison. Without this prospective change, BHI would comprise
a disproportionate part of the Insurance Index Comparators,
representing over 40% of the total market capitalization of the
Insurance Index Comparators as of October 21, 2010.
Vesting, Tax, and
Accounting. Performance Shares and Stock
Options are normally forfeited if the executive leaves the
Company voluntarily before the end of the applicable performance
period or vesting period and is not Retirement Eligible or
Bridge Eligible. An employee is considered Retirement
Eligible when the employee meets any one of the age and
service combinations defined in the Metropolitan Life Retirement
Plan for the United States Employees (the Retirement
Plan) to begin payout of certain benefits immediately upon
separation from service. See Pension Program
beginning on page 41 for more information about the
Retirement Plan. Employees who are Bridge Eligible are
considered eligible for post-retirement medical benefits despite
not being Retirement Eligible.
The Company has designed Performance Shares and Stock Options to
meet the requirements for the performance-based
compensation exemption from Section 162(m) limits. As
designed, these awards also qualify as equity-classified
instruments whose fair value for determining compensation
expense under current accounting rules is fixed on the date of
grant. This allows the Company to provide stock-based incentive
opportunities while limiting the volatility of the related
accounting cost of such compensation. For information about the
specific grants of Stock Options and Performance Shares to the
Named Executive Officers in 2010, see the table entitled
Grants of Plan-Based Awards in 2010 on page 50.
Performance-Based
Compensation Recoupment Policy
The Companys performance-based compensation recoupment
policy applies to all officers and officer-equivalent employees
of the Company and
40
its affiliates and subsidiaries. The policy provides that the
Company (and its affiliates or subsidiaries) will seek the
recovery of performance-based compensation purportedly earned by
or paid to such an employee where the compensation was based on
Company financial results that were subsequently restated due to
the employees fraudulent or other wrongful conduct, and
the restated financial results would have resulted in lower or
no compensation. The policy reinforces the Companys intent
to seek recovery of performance-based compensation under such
circumstances.
Equity Award
Timing Practices
The Committee grants Stock Options and Performance Shares to the
Executive Group members at its regularly scheduled meeting in
February of each year. The amount of the grants are made with
consideration of the Total Compensation for each Executive Group
member, including AVIP awards and any base salary increases. The
exercise price of these Stock Options is the closing price of a
Share on the day the Stock Options are granted. The Company has
never granted, and has no plans to grant, any stock-based awards
to current or new employees in coordination with the release of
non-public information about the Company or any other company.
The Chief Executive Officer does not have any authority to grant
stock-based awards of any kind to any Executive Group members,
the Chief Accounting Officer, the Chief Risk Officer, or
Directors of the Company.
Stock
Ownership
To further promote alignment of managements interests with
shareholders, the Company has established minimum Share
ownership guidelines for officers at the Senior Vice President
level and above, including the Executive Group members. Each is
expected to own Shares in an amount that is equal to a
percentage or multiple of annual base salary rate depending on
position.
Employees may count toward these guidelines the value of Shares
they or their immediate family members own directly or in trust.
They may also count Shares held in the Companys savings
and investment program, Shares deferred under the Companys
nonqualified deferred compensation program and deferred cash
compensation or auxiliary benefits measured in Share value.
Each employee subject to the guidelines is expected to retain
the net Shares acquired through the exercise of Stock Options or
from long-term stock-based incentive plan award payments until
the employee meets the guidelines. The Companys policy
prohibits all employees, including the Executive Group members,
from engaging in short sales, hedging, and trading in put and
call options, with respect to the Companys securities.
The Share ownership of the active Named Executive Officers,
rounded to the nearest whole multiple of their respective annual
base salary rates, is reported below as of December 31,
2010:
|
|
|
|
|
|
|
|
|
Name
|
|
Ownership
|
|
Guideline
|
|
C. Robert Henrikson
|
|
|
13
|
|
|
|
7
|
|
William J. Wheeler
|
|
|
7
|
|
|
|
4
|
|
William J. Toppeta
|
|
|
9
|
|
|
|
4
|
|
William J. Mullaney
|
|
|
4
|
|
|
|
4
|
|
Steven A. Kandarian
|
|
|
2
|
|
|
|
4
|
|
Mr. Kandarian has retained all net Shares acquired through
stock-based compensation awards from the beginning of his
employment through the end of 2010. During 2010,
Mr. Kandarian increased his ownership by over 72%, on a
multiple of base salary rate basis.
Retirement and
Other Benefits
MetLife recognizes the importance of providing comprehensive,
cost-effective employee benefits to attract, retain and motivate
talented associates. The Company reviews its benefits program
from time to time and makes adjustments to the design of the
program to meet these objectives and to remain competitive with
other employers.
Pension Program. The Company sponsors a
pension program in which all eligible U.S. employees,
including the Executive Group members, participate after one
year of service. The program includes the Retirement Plan and
the MetLife Auxiliary Pension Plan (Auxiliary Pension
Plan), an unfunded nonqualified plan.
The program rewards employees for the length of their service
and, indirectly, for their job performance, because the amount
of benefits increases with the length of employees service
with the Company and the salary and annual incentive awards they
earn. Benefits under the Companys pension program are
determined under two separate benefit formulas. For any given
period of time, an employees benefit is
41
determined under one or the other formula. In no event do
benefits accrue for the same period under both formulas. The
Traditional Formula is based on length of service and
final average compensation. The Personal Retirement Account
Formula is based on monthly contributions for each employee
based on the employees compensation, plus interest.
The Auxiliary Pension Plan does not provide any pension benefits
for any Executive Group members, other than those that would
apply under the (qualified) Retirement Plan if U.S. tax
limits on accruals did not apply. The same final average
compensation formula is used for Traditional Formula pension
benefits in both plans, for benefits accrued in 2010 and later.
For additional information about pension benefits for the Named
Executive Officers, see the table entitled Pension
Benefits on page 55.
Savings and Investment Program. The
Company sponsors a savings and investment program for
U.S. employees in which each Executive Group member is
eligible to participate. The program includes the Savings and
Investment Plan for Employees of Metropolitan Life and
Participating Affiliates (Savings and Investment Plan), a
tax-qualified defined contribution plan under Internal Revenue
Code Section 401(k), and the Metropolitan Life Auxiliary
Savings and Investment Plan (Auxiliary Savings and Investment
Plan), an unfunded nonqualified deferred compensation plan.
Employee contributions to the Savings and Investment Plan may be
made on a before-tax 401(k), Roth 401(k) or after-tax basis. The
Company also provides a matching contribution to employees after
one year of service in order to encourage and reward such
savings. The Auxiliary Savings and Investment Plan provides
additional Company contributions to employees who elect to
contribute to the Savings and Investment Plan and who have
compensation beyond Internal Revenue Code limits. Company
contributions for the Named Executive Officers are included in
the All Other Compensation column of the Summary
Compensation Table on page 44. Because the Auxiliary
Savings and Investment Plan is a nonqualified deferred
compensation plan, the Companys contributions to the Named
Executive Officers accounts, and the Named Executive
Officers accumulated account balances and any payouts made
during 2010, are reported in the table
entitled Nonqualified Deferred Compensation on
page 58.
Nonqualified Deferred Compensation. The
Company sponsors a nonqualified deferred compensation program
for officer-level employees, including the Executive Group
members. Participants may choose from a range of simulated
investments, according to which the value of their deferrals may
go up or down. See the table entitled Nonqualified
Deferred Compensation on page 58 for amounts of
nonqualified deferred compensation reported for the Named
Executive Officers.
Employees choose in advance the amount they want to defer, the
date on which payment of their deferred compensation will begin
and whether they want to receive payment in a lump sum or in up
to 15 annual payments. If the employee becomes Retirement
Eligible or Bridge Eligible, the employees choice of form
and timing of payment are honored. Otherwise, the Company
generally pays out the employees deferred compensation in
a single lump sum after the end of the employees service.
The continued deferral of income taxation and pre-tax simulated
investment earnings through the employees chosen payment
dates encourage employees to remain with the Company.
Perquisites
The Company provides its Executive Group members with limited
perquisites.
The Company leases an aircraft for purposes of efficient
business travel by the Companys executives. While the
Chief Executive Officer may occasionally use the Companys
aircraft for personal travel, Company policy does not require
him to use the Companys aircraft for all personal and
business travel. To maximize the accessibility of Executive
Group members, the Company makes leased vehicles and drivers and
outside car services available to them for commuting and
personal use.
For recordkeeping and administrative convenience of the Company,
the Company also pays certain other costs, such as those for
travel and meals for family members accompanying Executive Group
members on business functions.
The incremental cost of perquisites provided to the Named
Executive Officers during 2010 is included in the All
Other Compensation column of the Summary Compensation
Table on page 44.
42
Severance Pay and
Related Benefits
If an Executive Group members employment with the Company
ends involuntarily due to job elimination or, in limited
circumstances, due to performance, he or she may be eligible for
the severance program available to substantially all salaried
employees. The program provides employees with severance pay,
outplacement services and other benefits. Employees terminated
for cause, as defined under the program, are not eligible.
The amount of severance pay reflects the employees salary
grade, base salary rate and length of service, with
longer-service employees receiving greater payments and benefits
than shorter-service employees given the same salary grade and
base salary. Employees who are not Retirement Eligible or Bridge
Eligible and who receive severance pay also receive a prorata
cash payment in consideration of their unvested Performance
Shares and Restricted Stock Units. The Company also may enter
into severance agreements that can differ from the general terms
of the program, where business circumstances warrant.
Change-in-Control
Arrangements
The Company has adopted arrangements that would impact the
Executive Group members compensation and benefits upon a
change-in-control
of MetLife. None of the Executive Group members is entitled to
any excise tax
gross-up
either on severance pay or on any other benefits payable in
connection with a
change-in-control
of the Company.
Executive Severance Plan. The Company
established the MetLife Executive Severance Plan (Executive
Severance Plan) in 2007 to replace individual
change-in-control
agreements. The Compensation Committee determined the terms of
the plan on an overall program basis in light of
its judgment of what is appropriate in order to maximize
shareholder value should a
change-in-control
occur. The terms apply in the same manner to each Executive
Group member. An Executive Group member who receives benefits
under the Executive Severance Plan would not be eligible to
receive severance pay under the Companys severance plan
that is available to substantially all salaried employees.
The Executive Severance Plan does not provide for any payments
or benefits based solely on a
change-in-control
of MetLife. Rather, as described beginning on page 64 under
Termination with Severance Pay
(Change-in-Control),
the executives employment must also terminate under
certain circumstances in order for the executive to receive
severance pay and related benefits.
Additional
Change-in-Control
Arrangements. The Companys Stock
Option, Performance Share, and Restricted Stock Unit agreements
also include
change-in-control
arrangements. Under these arrangements, MetLife or its successor
may substitute an alternative award of equivalent value and
vesting provisions no less favorable than the award being
replaced. Unless such substitution occurs, the awards vest
immediately upon a
change-in-control.
For additional information about
change-in-control
arrangements, including the Companys definition of
change-in-control
for these purposes, see Potential Payments Upon
Termination or
Change-in-Control
beginning on page 62. The Company determined the elements
of its definition of
change-in-control
in light of the impact that a change in Board membership, a sale
of substantially all assets, or the acquisition of a controlling
interest in the Company by a single shareholder or group of
shareholders would have on the Company.
43
Summary Compensation
Table
The amounts reported in the table below for 2010 include
elements in addition to compensation paid to the Named Executive
Officers in 2010. The table includes items such as salary and
cash incentive compensation that have been earned and paid (or
earned and deferred), as well as the grant date fair value of
Performance Shares and Stock Options granted in 2010. The
Performance Shares and Stock Options may never become payable or
may ultimately have a value that differs substantially from the
values reported in this table. The table also includes for 2010
changes in the value of pension benefits from prior year-end to
year-end 2010, which will become payable only after the Named
Executive Officer ends his or her employment. In addition, the
amounts in the Total column do not represent Total
Compensation as defined for purposes of the Companys
compensation structure and philosophy, and include elements that
do not relate to 2010 performance. For additional information,
see Compensation Discussion and Analysis beginning
on page 28. The items and amounts reported in the table
below for 2009 and 2008 bear a similar relationship to
performance and amounts paid or payable in those years.
Mr. Mullaney was not a Named Executive Officer in the
Companys 2008 Proxy Statement. Accordingly, only his
compensation with respect to 2010 and 2009 is reported.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonqualified
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Equity
|
|
Deferred
|
|
|
|
|
|
|
|
|
|
|
Stock
|
|
Option
|
|
Incentive Plan
|
|
Compensation
|
|
All Other
|
|
|
Name and Principal
|
|
|
|
Salary
|
|
Awards
|
|
Awards
|
|
Compensation
|
|
Earnings
|
|
Compensation
|
|
Total
|
Position
|
|
Year
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
($)
|
|
C. Robert Henrikson,
|
|
|
2010
|
|
|
$
|
1,000,000
|
|
|
$
|
3,933,280
|
|
|
$
|
4,088,000
|
|
|
$
|
4,500,000
|
|
|
$
|
0
|
(1)
|
|
$
|
346,574
|
|
|
$
|
13,867,854
|
|
Chairman of the Board,
|
|
|
2009
|
|
|
$
|
1,000,000
|
|
|
$
|
2,898,000
|
|
|
$
|
2,301,600
|
|
|
$
|
3,500,000
|
|
|
$
|
1,620,255
|
|
|
$
|
280,483
|
|
|
$
|
11,600,338
|
|
President and
|
|
|
2008
|
|
|
$
|
1,000,000
|
|
|
$
|
4,056,500
|
|
|
$
|
3,723,300
|
|
|
$
|
3,250,000
|
|
|
$
|
10,043,542
|
|
|
$
|
404,129
|
|
|
$
|
22,477,471
|
|
Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
William J. Wheeler,
|
|
|
2010
|
|
|
$
|
627,083
|
|
|
$
|
902,720
|
|
|
$
|
940,800
|
|
|
$
|
2,000,000
|
|
|
$
|
337,606
|
|
|
$
|
95,291
|
|
|
$
|
4,903,500
|
|
Executive Vice President
|
|
|
2009
|
|
|
$
|
608,333
|
|
|
$
|
1,987,200
|
|
|
$
|
1,645,800
|
|
|
$
|
1,300,000
|
|
|
$
|
277,488
|
|
|
$
|
102,156
|
|
|
$
|
5,920,977
|
|
and Chief Financial Officer
|
|
|
2008
|
|
|
$
|
568,750
|
|
|
$
|
898,255
|
|
|
$
|
824,445
|
|
|
$
|
1,200,000
|
|
|
$
|
216,945
|
|
|
$
|
109,647
|
|
|
$
|
3,818,042
|
|
William J. Toppeta,
|
|
|
2010
|
|
|
$
|
646,667
|
|
|
$
|
870,480
|
|
|
$
|
784,000
|
|
|
$
|
1,700,000
|
|
|
$
|
630,517
|
|
|
$
|
91,907
|
|
|
$
|
4,723,571
|
|
President, International
|
|
|
2009
|
|
|
$
|
630,000
|
|
|
$
|
621,000
|
|
|
$
|
493,200
|
|
|
$
|
900,000
|
|
|
$
|
1,051,447
|
|
|
$
|
86,671
|
|
|
$
|
3,782,318
|
|
|
|
|
2008
|
|
|
$
|
625,000
|
|
|
$
|
811,300
|
|
|
$
|
735,795
|
|
|
$
|
800,000
|
|
|
$
|
1,760,357
|
|
|
$
|
105,587
|
|
|
$
|
4,838,039
|
|
William J. Mullaney,
|
|
|
2010
|
|
|
$
|
610,417
|
|
|
$
|
870,480
|
|
|
$
|
896,000
|
|
|
$
|
1,500,000
|
|
|
$
|
738,081
|
|
|
$
|
76,576
|
|
|
$
|
4,691,554
|
|
President, U.S. Business
|
|
|
2009
|
|
|
$
|
562,500
|
|
|
$
|
621,000
|
|
|
$
|
411,000
|
|
|
$
|
1,000,000
|
|
|
$
|
875,838
|
|
|
$
|
76,651
|
|
|
$
|
3,546,989
|
|
Steven A. Kandarian,
|
|
|
2010
|
|
|
$
|
625,000
|
|
|
$
|
870,480
|
|
|
$
|
896,000
|
|
|
$
|
1,500,000
|
|
|
$
|
197,136
|
|
|
$
|
69,000
|
|
|
$
|
4,157,616
|
|
Executive Vice President
|
|
|
2009
|
|
|
$
|
583,333
|
|
|
$
|
1,987,200
|
|
|
$
|
1,519,200
|
|
|
$
|
1,100,000
|
|
|
$
|
173,487
|
|
|
$
|
77,100
|
|
|
$
|
5,440,320
|
|
and Chief Investment Officer
|
|
|
2008
|
|
|
$
|
531,250
|
|
|
$
|
840,275
|
|
|
$
|
771,255
|
|
|
$
|
1,000,000
|
|
|
$
|
213,112
|
|
|
$
|
93,297
|
|
|
$
|
3,449,189
|
|
|
|
|
(1) |
|
The present value of accumulated pension benefits for
Mr. Henrikson declined by $321,382 in 2010. See
Change in Pension Value and Nonqualified Deferred
Compensation Earnings in the narrative discussion below. |
44
Salary
The amount reported in the Salary column for 2010 represents the
amount of base salary earned by each Named Executive Officer in
2010.
For 2010, the relationship of each Named Executive
Officers base salary payments to the amount in the Total
column, rounded to the nearest whole number, is:
|
|
|
|
|
|
|
Base Salary Payments as a
|
Executive
|
|
Percentage of Total Column
|
|
C. Robert Henrikson
|
|
|
7
|
%
|
William J. Wheeler
|
|
|
13
|
%
|
William J. Toppeta
|
|
|
14
|
%
|
William J. Mullaney
|
|
|
13
|
%
|
Steven A. Kandarian
|
|
|
15
|
%
|
Stock
Awards
These awards were made pursuant to the Stock and Incentive Plan.
No monetary consideration was paid by a Named Executive Officer
for any Performance Shares. No dividends or dividend equivalents
are earned on Performance Shares. For a description of the
effect on the awards of a termination of employment or
change-in-control
of MetLife, see Potential Payments Upon Termination or
Change-in-Control
beginning on page 62.
2010 Awards. On February 23, 2010,
the Compensation Committee awarded each Named Executive Officer
Performance Shares, payable in Shares after the end of the
three-year performance period from January 1, 2010 to
December 31, 2012. Shares are payable to eligible award
recipients following the completion of the performance period.
In order for Performance Shares for the
2010-2012
performance period to be payable, the Company must generate
either (1) positive income from continuing operations
before provision for income tax, excluding net investment gains
(losses) (defined in accordance with Section 3(a) of
Article 7.04 of SEC
Regulation S-X)
either for the
third year of the performance period or for the performance
period as a whole, or (2) positive total shareholder return
(TSR) either for the third year of the performance period
or for the performance period as a whole.
If any of the above income or TSR goals are met, the number of
Shares payable at the end of the performance period is
calculated by multiplying the number of Performance Shares by a
performance factor (from 0% to 200%). The performance factor is
determined by reference to the Companys performance
relative to the Insurance Index Comparators. Such performance is
measured on the basis of TSR and change in annual net Operating
Earnings available to common shareholders per share
(Operating EPS).
The Companys Operating EPS is measured year over year for
each year of the performance period, as compared to the other
companies in the Insurance Index Comparators (other than
companies which adopt International Financial Reporting
Standards before the Company does). For each year, Operating EPS
will be defined in the Companys Quarterly Financial
Supplement for the fourth quarter of the prior year. The results
for each of the three years of the performance period are
averaged.
The Companys TSR is compared to the composite return of
the Insurance Index Comparators during the performance period.
TSR will be determined using the change (plus or minus) from the
initial closing price of a Share to the final closing price of a
Share, plus reinvested dividends, for the performance period,
divided by the initial closing price of a Share. For this
purpose, the initial closing price is the average of the closing
prices for the 20 trading days before the performance period,
and the final closing price is the average of the closing prices
for the 20 trading days prior to and including the final trading
day of the performance period.
45
The following are some significant performance percentiles and
their corresponding performance factors:
|
|
|
|
|
MetLife TSR minus Insurance Index
|
|
TSR
|
Comparators TSR equals:
|
|
Performance Factor
|
|
30% or above
|
|
|
100
|
%
|
0%
|
|
|
50
|
%
|
−25%
|
|
|
25
|
%
|
−26% or less
|
|
|
0
|
%
|
|
|
|
|
|
MetLife Rank as a Percentile of
|
|
Operating EPS
|
Insurance Index Comparators
|
|
Performance Factor
|
|
75th or Above
|
|
|
100
|
%
|
median
|
|
|
50
|
%
|
25th
|
|
|
25
|
%
|
below 25th
|
|
|
0
|
%
|
Each of the two performance elements (TSR and Operating EPS) is
weighted equally and added together to produce a total
performance factor. If, however, the Companys TSR for the
performance period is zero percent or less, the total
performance factor will be multiplied by 0.75 to produce the
total performance factor.
For a further discussion of the performance goals applicable to
the Performance Share awards in 2010, see Compensation
Discussion and Analysis beginning on page 28.
2009 and 2008 Awards. The method for
determining the performance factor for the Performance Share
awards made to the Named Executive Officers in 2009 and 2008
will depend on the Companys change in annual Operating EPS
and TSR during the three-year performance period, as defined for
each award. In order for Performance Shares awarded in 2009 to
be payable, the Company must generate positive net income
available to common shareholders for either the third year of
the performance period or for the performance period as a whole.
For a description of the material terms and conditions of the
2009 and 2008 awards, see the table entitled, Grants of
Plan-Based Awards in the applicable Company Proxy
Statement.
Method for Determining Amounts
Reported. The amounts reported in this column
were calculated by multiplying the number of Performance Shares
by a grant date fair value per share of $32.24 for 2010, $20.70
for 2009, and $57.95 for 2008. Those amounts represent the
aggregate grant date fair value of the Performance Shares
awarded in each year under FAS 718 consistent with the
estimate of
aggregate compensation cost to be recognized over the service
period. The amounts are based on target performance, which is a
total performance factor of 100%. This is the probable
outcome of the performance conditions to which Performance
Share awards are subject, determined under FAS 718. The
grant date fair values of the Performance Share awards assuming
the highest level of performance conditions would be double the
amounts reported in this column, as the same grant date fair
value per share would be used but the total performance factor
used would be 200%.
For a description of the assumptions made in determining the
expenses, see Notes 1 and 18 in the Notes to Consolidated
Financial Statements in the Companys Annual Report on
Form 10-K
for the applicable year. In determining these expenses, it was
assumed that each Named Executive Officer would satisfy any
service requirements for vesting or payment of the award. As a
result, while a discount for the possibility of forfeiture of
the award was applied to determine the expenses of these awards
as reported in the Companys Annual Reports on
Form 10-K,
no such discount was applied in determining the expenses
reported in this column. In each case, the grant date of the
awards was the date that the Compensation Committee approved the
awards.
The amounts reported in this column for 2008 differ from the
amounts reported in the Companys 2009 Proxy Statement. The
amounts reported in that Proxy Statement represented the
Companys accounting expense in 2008 for all outstanding
Stock awards. The method for determining the amounts reported in
this column in this Amendment reflects revised SEC rules
effective on the date of this Amendment.
Option
Awards
Each of these awards was made pursuant to the Stock and
Incentive Plan. No monetary consideration was paid by a Named
Executive Officer for the award of any Stock Option. For a
description of the effect on the awards of a termination of
employment or
change-in-control
of MetLife, see Potential Payments Upon Termination or
Change-in-Control
beginning on page 62.
2009, 2008, and 2007 Awards. On
February 23, 2010, the Compensation Committee awarded each
Named Executive Officer Stock Options at a per Share exercise
price equal to the closing price of a
46
Share on that date ($34.84). In the case of the Stock Options
awarded in 2009 and 2008, the exercise price was also equal to
the closing price of Shares on the grant date ($23.30 and
$60.51, respectively), which was the date that the Compensation
Committee acted to award the Stock Options.
The Stock Options will normally become exercisable at the rate
of one-third of each grant on each of the first three
anniversaries of that grant date, and expire on the day before
the tenth anniversary of that grant date (except for the special
grants of 130,000 Stock Options to Mr. Wheeler and 120,000
Stock Options to Mr. Kandarian made in 2009, which will
normally become exercisable on the third anniversary of their
grant date, and which were discussed in further detail in the
Companys 2010 Proxy Statement).
Method for Determining Amounts
Reported. The amounts reported in this column
were calculated by multiplying the number of Stock Options by a
grant date fair value per share of $11.20 for 2010, $8.22 for
2009 (except for the special grants to Mr. Wheeler and
Mr. Kandarian, which had a grant date fair value per share
of $8.55, and which were discussed in further detail in the
Companys 2010 Proxy Statement), and $17.73 for 2008. Those
amounts represent the aggregate grant date fair value of the
Stock Options awarded in each year under FAS 718,
consistent with the estimate of aggregate compensation cost to
be recognized over the service period.
For a description of the assumptions made in determining the
expenses, see Notes 1 and 18 in the Notes to Consolidated
Financial Statements in the Companys Annual Report on
Form 10-K
for the applicable year. In determining these expenses, it was
assumed that each Named Executive Officer would satisfy any
service requirements for vesting or payment of the award. As a
result, while a discount for the possibility of forfeiture of
the award was applied to determine the expenses of these awards
as reported in the Companys Annual Reports on
Form 10-K,
no such discount was applied in determining the expenses
reported in this column. In each case, the grant date of the
awards was the date that the Compensation Committee approved the
awards.
The amounts reported in this column for 2008 differ from the
amounts reported in the Companys 2009 and Proxy Statement.
The amounts reported in those Proxy Statements represented the
Companys accounting expense in 2008 for all
outstanding Stock Options. The method for determining the
amounts reported in this column in this Amendment reflects
revised SEC rules effective on the date of this Amendment.
Non-Equity
Incentive Plan Compensation
The amounts reported in the Non-Equity Incentive Plan
Compensation column for 2010 are the 2010 AVIP Awards made in
February 2011 by the Compensation Committee to each of the Named
Executive Officers, which are based on 2010 performance. The
awards are payable in cash by March 15, 2011. The factors
considered and analyzed by the Compensation Committee in
determining the awards are discussed in the Compensation
Discussion and Analysis. For a description of the maximum award
formula that applied to the awards for tax deductibility
purposes, see the table entitled Grants of Plan-Based
Awards in 2010 on page 50.
Change in Pension
Value and Nonqualified Deferred Compensation Earnings
The amounts reported in the Change in Pension Value and
Nonqualified Deferred Compensation Earnings column for 2010
represent the aggregate increase during 2010 in the present
value of accumulated pension benefits for each of the Named
Executive Officers, except for Mr. Henrikson. These
increases reflect additional service in 2010, any increase in
base salary compensation rate in 2010, and annual incentive
awards payable in March 2010 for services in 2009.
Mr. Henrikson and the other Named Executive Officers
participate in the same retirement program that applies to other
employees. For all employees in the Traditional Formula for
their entire career who reach full benefit status (as
Mr. Henrikson did in 2009), the program, when combined with
social security benefits, generally replaces 60% of final
average cash compensation upon retirement. For
Mr. Henrikson, the increases in 2009 and 2008 were the
result of the application of the same Traditional Formula rules
for determining benefits that apply to other eligible senior
officers.
In early 2009, at Mr. Henriksons recommendation, the
Auxiliary Pension Plan was amended to cap the final average
compensation of each participant, including each Executive Group
member, at $4.6 million. The purpose and effect of this
change on Mr. Henriksons benefit is to reduce
expected future pension accruals, thus limiting future increases
in his benefit.
47
The present value of accumulated pension benefits for
Mr. Henrikson declined by $321,382 in 2010. As of
January 1, 2010 Mr. Henrikson had passed the earliest
date he could retire with full pension benefits (age 62 with at
least 20 years of service). Since Mr. Henrikson did
not retire and begin receiving his benefits on that date, he
effectively lost the value of the benefit payments he would have
received in 2010 had he retired. Under the Traditional Formula,
the benefit accrual for 2010 service for employees, such as
Mr. Henrikson, who had at least 35 years of service,
was limited to 0.5% of final average compensation, or less than
one-third of the accrual for annual service during the first
35 years of service. In addition, as a result of the
amendment to the Auxiliary Pension Plan limiting final average
compensation to $4.6 million, Mr. Henriksons
final average compensation did not increase during 2010. As a
result, the value of the benefit payments foregone by
Mr. Henrikson
in 2010 far exceeds the value of the limited amount of his
additional accrual for 2010 service, and the impact of a change
to the discount rate used to calculate the present value of
qualified benefits.
For a description of pension benefits, including the formula for
determining benefits, see the table entitled Pension
Benefits on page 55.
The Named Executive Officers earnings on their
nonqualified deferred compensation in 2010 were not above-market
or preferential. As a result, earnings credited on their
nonqualified deferred compensation are not required to be, nor
are they, reflected in this column. For a description of the
Companys nonqualified deferred compensation plans and the
simulated investments used to determine earnings, see the table
entitled Nonqualified Deferred Compensation on
page 58.
All Other
Compensation
The amounts reported in this column for 2010 include all other
items of compensation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
Life
|
|
|
|
|
|
|
Savings and
|
|
Insurance
|
|
|
|
|
|
|
Investment
|
|
Above
|
|
Perquisites and
|
|
|
|
|
Program
|
|
Standard
|
|
Other Personal
|
|
|
Executive
|
|
Contributions
|
|
Formula
|
|
Benefits
|
|
Total
|
|
C. Robert Henrikson
|
|
$
|
180,000
|
|
|
$
|
0
|
|
|
$
|
166,574
|
|
|
$
|
346,574
|
|
William J. Wheeler
|
|
$
|
77,083
|
|
|
$
|
2,751
|
|
|
$
|
15,457
|
|
|
$
|
95,291
|
|
William J. Toppeta
|
|
$
|
61,867
|
|
|
$
|
0
|
|
|
$
|
30,040
|
|
|
$
|
91,907
|
|
William J. Mullaney
|
|
$
|
64,417
|
|
|
$
|
0
|
|
|
$
|
12,159
|
|
|
$
|
76,576
|
|
Steven A. Kandarian
|
|
$
|
69,000
|
|
|
$
|
0
|
|
|
|
|
(1)
|
|
$
|
69,000
|
|
|
|
|
(1) |
|
For Mr. Kandarian, the aggregate amount of perquisites and
other personal benefits provided to him by the Company in 2010
was less than $10,000. |
Company Savings and Investment Program
Contributions. The Company makes matching
contributions to the Savings and Investment Plan, which is a
tax-qualified 401(k) plan. In 2010, it made $9,800 in matching
contributions for each Named Executive Officer. It also makes
contributions to the Auxiliary Savings and Investment Plan due
to Internal Revenue Code limits on the amount of compensation
that is eligible for contributions to the Savings and Investment
Plan. The amount of Company contributions for each Named
Executive Officer, other than those made to the Savings and
Investment Plan, is also reflected in the Registrant
Contributions in Last FY column of the Nonqualified
Deferred Compensation table on page 58.
Life Insurance Coverage Above Standard
Formula. In 2003, the Company discontinued
its split-dollar life insurance programs in which a small group
of senior officers and some other employees and agents
participated. Former participants in those programs were given
the opportunity to continue to receive group life insurance
coverage at the levels that were provided under the program. The
amounts shown in the table above reflect the additional cost to
the Company in 2010 to provide group life insurance coverage at
those former levels over and above the cost for the standard
group life coverage.
Perquisites and Other Personal
Benefits. The Companys aggregate
incremental cost to provide perquisites or other personal
benefits to each Named Executive Officer in 2010 (other than for
Mr. Kandarian) is included in the All Other
48
Compensation column for 2010. Goods or services provided
to the Named Executive Officers are perquisites or personal
benefits only if they confer a personal benefit on the
executive. However, goods or services that are directly and
integrally related to the executives job duties, or are
offered generally to all employees, or for which the executive
fully reimbursed the Company are not perquisites or personal
benefits. Each type of perquisite or other personal benefit is
discussed below.
Personal Car Service. These amounts include
the cost paid by the Company for car service provided by vendors
for personal travel. Where the Company used its own vehicles,
the cost of tolls, fuel, and driver overtime compensation is
included.
Personal Aircraft Use. These amounts include
the variable costs for personal use of aircraft that were
charged to the Company by the vendor that operates the
Companys leased aircraft for trip-related crew hotels and
meals, landing and ground handling fees, hangar and parking
costs,
in-flight catering and telephone usage, and similar items. Fuel
costs were calculated based on average fuel cost per flight hour
for each hour of personal use. Because the aircraft is leased
primarily for business use, fixed costs such as lease payments
are not included in these amounts. The incremental cost of
personal aircraft use by Mr. Henrikson during 2010 was
$141,810. As of early 2009, the Company no longer required the
Chief Executive Officer to use the Companys aircraft for
all personal and business travel.
Personal Conference, Travel and Other. These
amounts include the costs incurred by the Company for personal
items for the Named Executive Officer at a Company business
conference or meeting and for personal guests of the Named
Executive Officer at such events. Costs paid for a
Company-sponsored holiday event and to a vendor to make personal
travel reservations for the Named Executive Officers or their
family members are also included.
49
Grants of Plan-Based Awards in
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated
|
|
|
|
|
|
|
|
All Other
|
|
|
|
Grant
|
|
|
|
|
Possible
|
|
|
|
|
|
|
|
Option
|
|
|
|
Date
|
|
|
|
|
Payouts Under
|
|
|
|
|
|
|
|
Awards:
|
|
Exercise
|
|
Fair
|
|
|
|
|
Non-Equity
|
|
|
|
|
|
|
|
Number of
|
|
or Base
|
|
Value
|
|
|
|
|
Incentive Plan
|
|
Estimated Future Payouts Under
|
|
Securities
|
|
Price of
|
|
of Stock
|
|
|
|
|
Awards
|
|
Equity Incentive Plan Awards
|
|
Underlying
|
|
Option
|
|
and
|
|
|
|
|
Maximum
|
|
Threshold
|
|
Target
|
|
Maximum
|
|
Options
|
|
Awards
|
|
Option
|
Name
|
|
Grant Date
|
|
($)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
(#)
|
|
($/Sh)
|
|
Awards
|
|
C. Robert Henrikson
|
|
February 23, 2010
|
|
$
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
22,875
|
|
|
|
122,000
|
|
|
|
244,000
|
|
|
|
|
|
|
|
|
|
|
$
|
3,933,280
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
365,000
|
|
|
$
|
34.84
|
|
|
$
|
4,088,000
|
|
William J. Wheeler
|
|
February 23, 2010
|
|
$
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
5,250
|
|
|
|
28,000
|
|
|
|
56,000
|
|
|
|
|
|
|
|
|
|
|
$
|
902,720
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
84,000
|
|
|
$
|
34.84
|
|
|
$
|
940,800
|
|
William J. Toppeta
|
|
February 23, 2010
|
|
$
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
5,063
|
|
|
|
27,000
|
|
|
|
54,000
|
|
|
|
|
|
|
|
|
|
|
$
|
870,480
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70,000
|
|
|
$
|
34.84
|
|
|
$
|
784,000
|
|
William J. Mullaney
|
|
February 23, 2010
|
|
$
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
5,063
|
|
|
|
27,000
|
|
|
|
54,000
|
|
|
|
|
|
|
|
|
|
|
$
|
870,480
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80,000
|
|
|
$
|
34.84
|
|
|
$
|
896,000
|
|
Steven A. Kandarian
|
|
February 23, 2010
|
|
$
|
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
5,063
|
|
|
|
27,000
|
|
|
|
54,000
|
|
|
|
|
|
|
|
|
|
|
$
|
870,000
|
|
|
|
February 23, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
80,000
|
|
|
$
|
34.84
|
|
|
$
|
896,000
|
|
Non-Equity
Incentive Plan Awards
In February, 2010, the Compensation Committee made each Named
Executive Officer eligible for an AVIP award for 2010
performance of up to $10 million, if the Company attained
either of two performance goals in 2010. Those goals were
(1) positive income from continuing operations before
provision for income tax, excluding net investment gains
(losses) (defined in accordance with Section 3(a) of
Article 7.04 of SEC
Regulation S-X),
or (2) positive TSR. These goals were established for the
purpose of exempting AVIP awards to four of the Companys
most highly-compensated executives for 2010 from the limits on
tax deductibility under Section 162(m). This limit is
labeled maximum in this table. No amounts were
established as minimum or target awards.
The factors and analysis of results considered by the
Compensation Committee in determining the 2010 AVIP awards are
discussed in the Compensation Discussion and Analysis.
Equity Incentive
Plan Awards
For a description of the material terms and conditions of these
awards, see the Summary Compensation
Table on page 44. If the Companys TSR and Operating
EPS performance results in a total performance factor of 25%,
and the Companys TSR for the performance period is zero
percent or less, the total performance factor will be 18.75% and
each Named Executive Officer would receive the number of
Performance Shares reflected in the Threshold column of this
table for that officer. If the Companys performance
results in a total performance factor of 100%, the Named
Executive Officer would receive the number of Performance Shares
reflected in the Target column of the table. If the
Companys performance results in a total performance factor
of 200%, the Named Executive Officer would receive the number of
Performance Shares reflected in the Maximum column of the table.
All Other Option
Awards
For a description of the material terms and conditions of these
awards, see the Summary Compensation Table on page 44.
Grant Date Fair
Value of Stock and Option Awards
For a description of the method used to determine the amounts
reported in this column, see the Summary Compensation Table on
page 44.
50
Outstanding Equity Awards at
2010 Fiscal Year-End
This table presents information about outstanding Stock Options
that were granted to the Named Executive Officers from 2001
through 2010. The Stock Options were outstanding because they
had not been exercised or forfeited as of December 31,
2010. This table also presents information about outstanding
Performance Shares granted to the Named Executive Officers. The
Performance Shares were outstanding because they had not vested
or become payable as of December 31, 2010 (except for the
Performance Shares for the performance period of January 1,
2008 to December 31, 2010, which vested on
December 31, 2010, but for which the amounts payable are
not yet known). The Stock Options and Performance Shares
reported in this table include awards granted in 2010, which are
also reported in the Summary Compensation Table on page 44
and the table entitled Grants of Plan-Based Awards in
2010 on page 50.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Market or
|
|
|
Option Awards(1)
|
|
Unearned
|
|
Payout Value
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
Shares,
|
|
of Unearned
|
|
|
Securities
|
|
Securities
|
|
|
|
|
|
Units or
|
|
Shares, Units
|
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
Other
|
|
or Other
|
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
Rights That
|
|
Rights That
|
|
|
Options
|
|
Options
|
|
Exercise
|
|
Option
|
|
Have Not
|
|
Have Not
|
|
|
(#)
|
|
(#)
|
|
Price
|
|
Expiration
|
|
Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
($)
|
|
Date
|
|
(#)(2)(3)
|
|
($)(4)
|
|
C. Robert Henrikson
|
|
|
140,000
|
|
|
|
0
|
|
|
$
|
30.35
|
|
|
February 18, 2012
|
|
|
664,000
|
|
|
$
|
29,508,160
|
|
|
|
|
115,000
|
|
|
|
0
|
|
|
$
|
26.00
|
|
|
February 17, 2013
|
|
|
|
|
|
|
|
|
|
|
|
90,000
|
|
|
|
0
|
|
|
$
|
35.26
|
|
|
February 16, 2014
|
|
|
|
|
|
|
|
|
|
|
|
90,000
|
|
|
|
0
|
|
|
$
|
38.47
|
|
|
April 14, 2015
|
|
|
|
|
|
|
|
|
|
|
|
110,000
|
|
|
|
0
|
|
|
$
|
50.12
|
|
|
February 27, 2016
|
|
|
|
|
|
|
|
|
|
|
|
210,000
|
|
|
|
0
|
|
|
$
|
62.80
|
|
|
February 26, 2017
|
|
|
|
|
|
|
|
|
|
|
|
140,000
|
|
|
|
70,000
|
|
|
$
|
60.51
|
|
|
February 25, 2018
|
|
|
|
|
|
|
|
|
|
|
|
93,334
|
|
|
|
186,666
|
|
|
$
|
23.30
|
|
|
February 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
365,000
|
|
|
$
|
34.84
|
|
|
February 23, 2020
|
|
|
|
|
|
|
|
|
William J. Wheeler
|
|
|
38,200
|
|
|
|
0
|
|
|
$
|
30.35
|
|
|
February 18, 2012
|
|
|
279,000
|
|
|
$
|
12,398,760
|
|
|
|
|
28,500
|
|
|
|
0
|
|
|
$
|
26.00
|
|
|
February 17, 2013
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
0
|
|
|
$
|
35.26
|
|
|
February 16, 2014
|
|
|
|
|
|
|
|
|
|
|
|
35,000
|
|
|
|
0
|
|
|
$
|
38.47
|
|
|
April 14, 2015
|
|
|
|
|
|
|
|
|
|
|
|
45,000
|
|
|
|
0
|
|
|
$
|
50.12
|
|
|
February 27, 2016
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
0
|
|
|
$
|
62.80
|
|
|
February 26, 2017
|
|
|
|
|
|
|
|
|
|
|
|
31,000
|
|
|
|
15,500
|
|
|
$
|
60.51
|
|
|
February 25, 2018
|
|
|
|
|
|
|
|
|
|
|
|
21,667
|
|
|
|
43,333
|
|
|
$
|
23.30
|
|
|
February 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
130,000
|
|
|
$
|
23.30
|
|
|
February 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
84,000
|
|
|
$
|
34.84
|
|
|
February 23, 2020
|
|
|
|
|
|
|
|
|
William J. Toppeta
|
|
|
10,325
|
|
|
|
0
|
|
|
$
|
29.95
|
|
|
April 8, 2011
|
|
|
142,000
|
|
|
$
|
6,310,480
|
|
|
|
|
95,330
|
|
|
|
0
|
|
|
$
|
30.35
|
|
|
February 18, 2012
|
|
|
|
|
|
|
|
|
|
|
|
80,000
|
|
|
|
0
|
|
|
$
|
26.00
|
|
|
February 17, 2013
|
|
|
|
|
|
|
|
|
|
|
|
65,000
|
|
|
|
0
|
|
|
$
|
35.26
|
|
|
February 16, 2014
|
|
|
|
|
|
|
|
|
|
|
|
55,000
|
|
|
|
0
|
|
|
$
|
38.47
|
|
|
April 14, 2015
|
|
|
|
|
|
|
|
|
|
|
|
55,000
|
|
|
|
0
|
|
|
$
|
50.12
|
|
|
February 27, 2016
|
|
|
|
|
|
|
|
|
|
|
|
40,000
|
|
|
|
0
|
|
|
$
|
62.80
|
|
|
February 26, 2017
|
|
|
|
|
|
|
|
|
|
|
|
27,666
|
|
|
|
13,834
|
|
|
$
|
60.51
|
|
|
February 25, 2018
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
40,000
|
|
|
$
|
23.30
|
|
|
February 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
70,000
|
|
|
$
|
34.84
|
|
|
February 23, 2020
|
|
|
|
|
|
|
|
|
51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Awards
|
|
|
|
|
|
|
|
|
|
|
Equity
|
|
Equity
|
|
|
|
|
|
|
|
|
|
|
Incentive
|
|
Incentive
|
|
|
|
|
|
|
|
|
|
|
Plan
|
|
Plan
|
|
|
|
|
|
|
|
|
|
|
Awards:
|
|
Awards:
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Market or
|
|
|
Option Awards(1)
|
|
Unearned
|
|
Payout Value
|
|
|
Number of
|
|
Number of
|
|
|
|
|
|
Shares,
|
|
of Unearned
|
|
|
Securities
|
|
Securities
|
|
|
|
|
|
Units or
|
|
Shares, Units
|
|
|
Underlying
|
|
Underlying
|
|
|
|
|
|
Other
|
|
or Other
|
|
|
Unexercised
|
|
Unexercised
|
|
Option
|
|
|
|
Rights That
|
|
Rights That
|
|
|
Options
|
|
Options
|
|
Exercise
|
|
Option
|
|
Have Not
|
|
Have Not
|
|
|
(#)
|
|
(#)
|
|
Price
|
|
Expiration
|
|
Vested
|
|
Vested
|
Name
|
|
Exercisable
|
|
Unexercisable
|
|
($)
|
|
Date
|
|
(#)(2)(3)
|
|
($)(4)
|
|
William J. Mullaney
|
|
|
11,425
|
|
|
|
0
|
|
|
$
|
30.35
|
|
|
February 18, 2012
|
|
|
138,000
|
|
|
$
|
6,132,720
|
|
|
|
|
16,000
|
|
|
|
0
|
|
|
$
|
26.00
|
|
|
February 17, 2013
|
|
|
|
|
|
|
|
|
|
|
|
14,000
|
|
|
|
0
|
|
|
$
|
35.26
|
|
|
February 16, 2014
|
|
|
|
|
|
|
|
|
|
|
|
19,000
|
|
|
|
0
|
|
|
$
|
38.47
|
|
|
April 14, 2015
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
0
|
|
|
$
|
50.12
|
|
|
February 27, 2016
|
|
|
|
|
|
|
|
|
|
|
|
30,000
|
|
|
|
0
|
|
|
$
|
62.80
|
|
|
February 26, 2017
|
|
|
|
|
|
|
|
|
|
|
|
24,000
|
|
|
|
12,000
|
|
|
$
|
60.51
|
|
|
February 25, 2018
|
|
|
|
|
|
|
|
|
|
|
|
16,667
|
|
|
|
33,333
|
|
|
$
|
23.30
|
|
|
February 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
80,000
|
|
|
$
|
34.84
|
|
|
February 23, 2020
|
|
|
|
|
|
|
|
|
Steven A. Kandarian
|
|
|
35,000
|
|
|
|
0
|
|
|
$
|
50.12
|
|
|
February 27, 2016
|
|
|
275,000
|
|
|
$
|
12,221,000
|
|
|
|
|
45,000
|
|
|
|
0
|
|
|
$
|
62.80
|
|
|
February 26, 2017
|
|
|
|
|
|
|
|
|
|
|
|
29,000
|
|
|
|
14,500
|
|
|
$
|
60.51
|
|
|
February 25, 2018
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
40,000
|
|
|
$
|
23.30
|
|
|
February 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
120,000
|
|
|
$
|
23.30
|
|
|
February 23, 2019
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
80,000
|
|
|
$
|
34.84
|
|
|
February 23, 2020
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
For Mr. Wheeler, 65,000 of the Stock Options with an
exercise price of $23.30, and for Mr. Kandarian, 60,000 of
the Stock Options with an exercise price of $23.30 become
exercisable on the third anniversary of their grant date of
February 24, 2009. All of the other Stock Options for each
Named Executive Officer became exercisable (or will do so) at a
rate of one-third of each annual grant on each of the first
three anniversaries of the grant date. All of the options have
an expiration date that is the day before the tenth anniversary
of the grant date. |
|
(2) |
|
None of the Performance Shares reflected in this column have
been paid. If they are paid, the amount that is paid may be
different than the amounts reflected in this table. The number
of Performance Shares in this column was determined by
multiplying the aggregate Performance Shares awarded to each
Named Executive Officer for the performance periods of
January 1, 2008 to December 31, 2010, January 1,
2009 to December 31, 2011, and January 1, 2010 to
December 31, 2012 by a hypothetical performance factor of
200%. This hypothetical performance factor is the maximum
performance factor that could be applied to the awards. The
maximum performance factor has been used because it was not
possible to determine the Companys performance in 2010 in
comparison to the performance of other Insurance Index
Comparators at the time this Amendment was filed. Under the
terms of the awards, the number of Shares that will be paid, if
any, will be determined based upon a three-year performance
period. See the Summary Compensation Table on page 44 for a
description of the terms of the Performance Share awards. |
|
(3) |
|
None of the Performance Shares reflected in this column has
vested, with the exception of the Performance Shares for the
performance period of January 1, 2008 to December 31,
2010. The actual amount of Performance Shares payable for
2008-2010
period is not yet known, and will be determined by the
Companys performance in comparison to the performance of
the Insurance Index Comparators over the three-year performance
period and be payable in the second quarter of 2011. The amount
that is payable may be different than the amounts reflected in
this table. The hypothetical number of Performance Shares
attributable to that performance period reflected in this column
for each Named Executive Officer, determined by the methodology
described above in note 2 to this table, is: |
52
|
|
|
|
|
|
|
Maximum 2008-2010
|
|
|
Performance Share Payout
|
Executive
|
|
(# of Shares)
|
|
C. Robert Henrikson
|
|
|
140,000
|
|
William J. Wheeler
|
|
|
31,000
|
|
William J. Toppeta
|
|
|
28,000
|
|
William J. Mullaney
|
|
|
24,000
|
|
Steven A. Kandarian
|
|
|
29,000
|
|
|
|
|
(4) |
|
The hypothetical amount reflected in this column for each Named
Executive Officer is equal to the number of Performance Shares
reflected in the column entitled Equity Incentive Plan
Awards: Number of Unearned Shares, Units or Other Rights That
Have Not Vested multiplied by the closing price of a Share
on December 31, 2010, the last business day of that year. |
53
Option Exercises and Stock
Vested in 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Awards(1)
|
|
Stock Awards(2)(3)
|
|
|
Number of Shares
|
|
Value Realized
|
|
Number of Shares
|
|
Value Realized
|
|
|
Acquired on Exercise
|
|
on Exercise
|
|
Acquired on Vesting
|
|
on Vesting
|
Name
|
|
(#)
|
|
(#)
|
|
(#)
|
|
($)
|
|
C. Robert Henrikson
|
|
|
0
|
|
|
$
|
0
|
|
|
|
65,800
|
|
|
$
|
2,326,030
|
|
William J. Wheeler
|
|
|
19,175
|
|
|
$
|
208,151
|
|
|
|
15,510
|
|
|
$
|
548,279
|
|
William J. Toppeta
|
|
|
34,670
|
|
|
$
|
410,342
|
|
|
|
14,100
|
|
|
$
|
498,435
|
|
William J. Mullaney
|
|
|
20,125
|
|
|
$
|
254,366
|
|
|
|
9,400
|
|
|
$
|
332,290
|
|
Steven A. Kandarian
|
|
|
0
|
|
|
$
|
0
|
|
|
|
14,100
|
|
|
$
|
498,435
|
|
|
|
|
(1) |
|
The amounts for value realized on exercise of Stock Options
represent the aggregate value realized upon the exercise of
vested Stock Options. The value realized upon the exercise of
each such Stock Option is the difference between the market
value of Shares when the Stock Option was exercised and the
exercise price of the Stock Option. Each of the Named Executive
Officers exercised his Stock Options pursuant to a plan he
established under
Rule 10b5-1
of the Securities Exchange Act of 1934, as amended. |
|
(2) |
|
These amounts reflect payouts of Performance Shares for the
performance period of January 1, 2007 to December 31,
2009. The number of Shares payable was calculated by multiplying
the number of Performance Shares by the performance factor that
pertained to the awards, which was 94%. This factor was
determined by comparing the Companys performance with that
of other Insurance Index Comparators, as measured by
(i) change in annual Operating EPS from the year before the
beginning of the performance period to the final year of the
performance period, and (ii) total shareholder return
during the performance period. For this purpose, Operating EPS
was determined using net income, excluding: (1) after-tax
net investment gains and losses, (2) after-tax adjustments
related to net investment gains and losses, (3) after-tax
discontinued operations other than discontinued real estate, and
(4) preferred stock dividends, in each case determined
according to GAAP, divided by the weighted average number of
shares outstanding, determined on a diluted basis under GAAP.
The Companys change in annual Operating EPS was in the
47th percentile of the other Insurance Index Comparators,
resulting in a change in annual Operating EPS performance factor
of 47%. Total shareholder return was determined using the change
(plus or minus) from the initial closing price of a Share to the
final closing price of a Share, plus reinvested dividends, for
the performance period, divided by the initial closing price of
a share. For this purpose, the initial closing price was the
average of the closing prices for the 20 trading days before the
performance period, and the final closing price was the average
of the closing prices for the 20 trading days prior to and
including the final trading day of the performance period. The
Companys total shareholder return was in the
47th percentile of the other Insurance Index Comparators,
resulting in a change in annual Operating EPS performance factor
of 47%. The value realized on vesting was determined using the
closing price of Shares on the vesting date, December 31,
2009. Each of the Named Executive Officers had the opportunity
to defer any or all Shares payable. Mr. Mullaney deferred
receipt of 75% of the Shares payable to him. |
|
(3) |
|
The Performance Shares for the performance period of
January 1, 2008 to December 31, 2010 for each of the
Named Executive Officers have vested, but the actual amount of
Performance Shares payable is not yet known and is not reflected
in this table. See the table entitled Outstanding Equity
Awards at 2010 Fiscal Year-End on page 51 for more
information about these Performance Shares. The amount of
Performance Shares payable for the performance period of
January 1, 2008 to December 31, 2010 will be reflected
in the table entitled Option Exercises and Stock Vested in
2011 in the Companys 2012 Proxy Statement. |
54
Pension Benefits
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Years
|
|
Present Value of
|
|
|
|
|
Credited Service
|
|
Accumulated Benefit
|
Name
|
|
Plan Name
|
|
(#)
|
|
($)
|
|
C. Robert Henrikson
|
|
Retirement Plan
|
|
|
38
|
.501
|
|
|
$
|
1,569,577
|
|
|
|
Auxiliary Pension Plan
|
|
|
38
|
.501
|
|
|
$
|
33,113,203
|
|
William J. Wheeler
|
|
Retirement Plan
|
|
|
13
|
.250
|
|
|
$
|
256,321
|
|
|
|
Auxiliary Pension Plan
|
|
|
13
|
.250
|
|
|
$
|
1,414,385
|
|
William J. Toppeta
|
|
Retirement Plan
|
|
|
37
|
.407
|
|
|
$
|
1,593,267
|
|
|
|
Auxiliary Pension Plan
|
|
|
37
|
.407
|
|
|
$
|
11,351,382
|
|
William J. Mullaney
|
|
Retirement Plan
|
|
|
28
|
.668
|
|
|
$
|
694,982
|
|
|
|
Auxiliary Pension Plan
|
|
|
28
|
.668
|
|
|
$
|
3,281,454
|
|
Steven A. Kandarian
|
|
Retirement Plan
|
|
|
5
|
.750
|
|
|
$
|
102,054
|
|
|
|
Auxiliary Pension Plan
|
|
|
5
|
.750
|
|
|
$
|
684,652
|
|
The Named Executive Officers participate in the Retirement Plan
and the Auxiliary Pension Plan.
Eligible employees qualify for pension benefits after one year
of service and become vested in their benefits after three years
of service.
Pension benefits are paid under two separate plans, primarily
due to tax requirements. The Retirement Plan is a tax-qualified
defined benefit pension plan that provides benefits for eligible
employees on the United States payroll. The Internal Revenue
Code imposes limitations on eligible compensation and on the
amounts that can be paid under the Retirement Plan. The purpose
of the Auxiliary Pension Plan is to provide benefits which
eligible employees would have received under the Retirement Plan
if these limitations were not imposed. Benefits under the
Auxiliary Pension Plan are calculated in substantially the same
manner as they are under the Retirement Plan. The Auxiliary
Pension Plan is unfunded, and benefits under that plan are
general promises of payment not secured by any rights to Company
property.
An employees benefit is calculated under either one or a
combination of two different formulas, only one of which applies
to any given period of service. The Traditional Formula is based
on length of service and final average compensation. The
Personal Retirement Account Formula is based on amounts
contributed or credited for each participant based on the
participants compensation, plus interest. The Traditional
Formula is used to calculate benefits for each eligible
employees service before 2002. Employees hired before 2002
who remained employed throughout 2002 accrued benefits for
2002 under the Traditional Formula. These employees were given
the opportunity to continue accruing their pension benefits
under the Traditional Formula for service in 2003 and later or
to begin accruing benefits for 2003 and later under the Personal
Retirement Account Formula. All employees hired (or rehired) on
or after January 1, 2002 accrue benefits for 2002 and later
under the Personal Retirement Account Formula.
The annual benefit under the Traditional Formula is determined
by multiplying the employees years of service (up to
35) by the sum of (a) 1.1% of the employees
final average compensation up to the average Social Security
wage base over the past 35 years, and (b) 1.7% of the
employees final average compensation in excess of the
average Social Security wage base over the past 35 years.
Employees who served more than 35 years also receive 0.5%
of final average compensation multiplied by years and months of
service in excess of 35 years. An employees final
average compensation is calculated by looking back at the
10-year
period prior to retirement or termination of employment and
determining the consecutive five-year period during which the
employees eligible compensation (including base salary and
eligible annual incentive awards) produces the highest average
annual compensation. When determining Traditional Formula
benefits under the Auxiliary Pension Plan for the Named
Executive Officers (and other senior officers) for service
through December 31, 2009, final average compensation is
calculated by looking back at the
10-year
period prior to retirement or termination of employment and
determining (a) the consecutive five-year period that would
produce
55
the highest average base salary, and (b) the average of the
highest five AVIP awards, regardless of whether in consecutive
years, determined using a projected AVIP award (equal to the
highest of the last three AVIP awards paid while the Named
Executive Officer was in active service) on a prorated basis for
any partial final year of employment. The sum of the highest
average annual base salary and the average eligible annual
incentive award is the Named Executive Officers final
average compensation.
Beginning January 1, 2010, the same final average
compensation formula that applies to qualified Traditional
Formula benefits for all eligible employees applies to
Traditional Formula benefits for senior officers under the
Auxiliary Pension Plan: by looking back at the
10-year
period prior to retirement or termination of employment and
determining the consecutive five-year period during which the
employees eligible compensation (including base salary and
eligible annual incentive awards) produces the highest average
annual compensation. Benefits accrued through 2009 will not be
affected by this change.
Under the Personal Retirement Account Formula, an employee is
credited each month with an amount equal to 5% of eligible
compensation up to the Social Security wage base (for 2010,
$106,800), plus 10% of eligible compensation in excess of that
wage base. In addition, amounts credited to each employee earn
interest at the U.S. governments
30-year
treasury securities rate. Mr. Henriksons,
Mr. Toppetas, and Mr. Mullaneys benefit
will be determined exclusively under the Traditional Formula.
Mr. Wheelers benefit will be determined using the
Traditional Formula for benefits for service prior to 2003, and
the Personal Retirement Account Formula for benefits for service
in 2003 and later. Mr. Kandarians benefit will be
determined exclusively under the Personal Retirement Account
Formula.
For pension benefit purposes, the 2009 annual incentive awards,
which were paid outside of AVIP, are considered on the same
basis as AVIP awards.
Whether an employees pension benefit is determined under
the Traditional Formula or the Personal Retirement Account
Formula, the employee may choose to receive the benefit as a
joint and survivor annuity, life annuity, life annuity
with term certain, contingent survivor annuity, or
first-to-die
annuity. The Traditional Formula benefit may not be paid to
employees before they become Retirement Eligible. Employees may
choose a lump sum payout of their vested benefits under the
Personal Retirement Account Formula at termination of their
employment or later. The Named Executive Officers could also
have selected, no later than December 31, 2008 and subject
to the approval of the Compensation Committee or its designee,
the timing and form of the Traditional Formula benefit payment
under the Auxiliary Pension Plan, including a lump sum payment.
The actuarial value of all forms of payment is substantially
equivalent.
The present value of a Named Executive Officers
accumulated pension benefits is reported in the table above
using certain assumptions. In the case of Mr. Henrikson,
Mr. Wheeler, Mr. Toppeta, and Mr. Mullaney, the
assumptions used in the determination of present value as of
December 31, 2010 include assumed retirement for each Named
Executive Officer at the earliest date the executive could
retire with full pension benefits. This was the earlier of the
date the executive reached at least age 62 with at least
20 years of service, or the normal retirement date
(age 65). Otherwise, the assumptions used were the same as
those used for financial reporting under GAAP. For a discussion
of the assumptions made regarding this valuation, see
Note 17 of the Notes to Consolidated Financial Statements
included in the Companys 2010 Annual Report on
Form 10-K.
In the case of Mr. Kandarian, the present value of his
benefit as of December 31, 2010 is equal to his Personal
Retirement Account balance. Mr. Kandarian was vested in his
benefit as of that date, and vested Personal Retirement Account
balances may be paid in full upon termination of employment at
any time.
In early 2009, at Mr. Henriksons recommendation, the
Auxiliary Pension Plan was amended to cap the final average
compensation of each participant, including each Executive Group
member, at $4.6 million. The purpose and effect of this
change on Mr. Henriksons benefit is to reduce
expected future pension accruals, thus limiting future increases
in his benefit. Any increases in pension value beyond 2009
primarily reflect Mr. Henriksons additional service,
and will not reflect any increases in his final average
compensation.
56
Amounts that were vested in the Auxiliary Pension Plan after
2004 are subject to the requirements of Internal Revenue Code
Section 409A (Section 409A). Each Named
Executive Officer had the opportunity to choose his or her form
of payment (including a lump sum) through 2008 (so long as the
officer did not begin receiving payments in the year of his or
her election), which was within the time period permitted for
such elections under Section 409A. Payments of amounts that
are subject to the requirements of Section 409A to the top
50 highest paid officers in the Company that are due upon
separation from service are delayed for six months following
their separation, as required by Section 409A.
Traditional Formula participants qualify for normal retirement
at age 65 with at least one year of service. An employee is
eligible for early retirement beginning at age 55 with
15 years of service. Each year of age over
age 571/2
reduces the number of years of service required to qualify for
early retirement, until normal retirement at age 65 and at
least one year of service. Mr. Henrikson and
Mr. Toppeta were each eligible for early retirement
benefits in 2009. Early retirement payments for Traditional
Formula participants are reduced from normal retirement benefits
by an early retirement factor that depends on the
employees age at the time payments begin and years of
service at the end of employment. If an employee has
20 years of service or more and is Retirement Eligible, the
factors range from 72% at age 55 to 100% at age 62. If
an employee does not have 20 years of service at the end of
employment, the factors range from 54.8% at age 55 to 100%
at age 65.
Personal Retirement Account participants qualify to be paid
their full vested benefit when their employment ends. Because
Personal Retirement Account benefits are based on total amounts
credited for the employee and not final average compensation,
those benefits are not reduced for any early retirement.
57
Nonqualified Deferred
Compensation
The Companys nonqualified deferred compensation program
offers savings opportunities to the Named Executive Officers, as
well as hundreds of other eligible employees. The program
consists of a plan for amounts that are subject to the
requirements of Section 409A (the MetLife Leadership
Deferred Compensation Plan, or Leadership Plan) and a
plan for amounts that were vested by December 31, 2004 and
are not subject to the requirements of Section 409A (the
MetLife Deferred Compensation Plan for Officers, or Officers
Plan). Under this program, employees may elect to defer
receipt of their base salary and incentive compensation. Income
taxation on such compensation is delayed until the employee
receives payment. Employees also receive Company contributions
under the Auxiliary Savings and Investment Plan.
The following table includes the amount of their own
compensation that each Named Executive Officer deferred under
the Leadership Plan in 2010 and the amount the Company credited
to the Named Executive Officers Leadership Plan and
Auxiliary Savings and Investment Plan accounts in 2010, as well
as aggregate earnings in 2010 on all deferred compensation, any
distributions made in 2010, and the aggregate deferred
compensation balance at the end of 2010. The aggregate balance
includes any deferrals and earnings on deferrals in all years of
employment, not limited to 2010. In the table below, the
Auxiliary Savings and Investment Plan is referred to as the
Auxiliary Plan.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Executive
|
|
Registrant
|
|
Aggregate
|
|
Aggregate
|
|
Aggregate
|
|
|
|
|
Contributions
|
|
Contributions
|
|
Earnings
|
|
Withdrawals/
|
|
Balance at
|
|
|
|
|
in Last FY
|
|
in Last FY
|
|
in Last FY
|
|
Distributions
|
|
Last FYE
|
Name
|
|
Plan Name
|
|
($)(1)
|
|
($)(2)
|
|
($)(3)
|
|
($)(4)
|
|
($)(5)
|
|
C. Robert Henrikson
|
|
Leadership Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
1,798,260
|
|
|
$
|
0
|
|
|
$
|
8,257,490
|
|
|
|
Officers Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
718,341
|
|
|
$
|
0
|
|
|
$
|
3,674,491
|
|
|
|
Auxiliary Plan
|
|
$
|
0
|
|
|
$
|
170,200
|
|
|
$
|
71,015
|
|
|
$
|
0
|
|
|
$
|
1,769,719
|
|
William J. Wheeler
|
|
Leadership Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
765,258
|
|
|
$
|
0
|
|
|
$
|
3,514,015
|
|
|
|
Officers Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
5,606
|
|
|
$
|
214,214
|
|
|
$
|
0
|
|
|
|
Auxiliary Plan
|
|
$
|
0
|
|
|
$
|
67,283
|
|
|
$
|
18,967
|
|
|
$
|
0
|
|
|
$
|
481,890
|
|
William J. Toppeta
|
|
Leadership Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
529,994
|
|
|
$
|
0
|
|
|
$
|
2,433,698
|
|
|
|
Officers Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
480,960
|
|
|
$
|
0
|
|
|
$
|
2,304,263
|
|
|
|
Auxiliary Plan
|
|
$
|
0
|
|
|
$
|
52,067
|
|
|
$
|
48,185
|
|
|
$
|
0
|
|
|
$
|
900,829
|
|
William J. Mullaney
|
|
Leadership Plan
|
|
$
|
319,859
|
|
|
$
|
0
|
|
|
$
|
360,714
|
|
|
$
|
0
|
|
|
$
|
1,980,755
|
|
|
|
Officers Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
88,276
|
|
|
$
|
0
|
|
|
$
|
405,357
|
|
|
|
Auxiliary Plan
|
|
$
|
0
|
|
|
$
|
54,617
|
|
|
$
|
14,018
|
|
|
$
|
0
|
|
|
$
|
359,203
|
|
Steven A. Kandarian
|
|
Leadership Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
139,669
|
|
|
$
|
0
|
|
|
$
|
641,353
|
|
|
|
Officers Plan
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
$
|
0
|
|
|
|
Auxiliary Plan
|
|
$
|
0
|
|
|
$
|
52,900
|
|
|
$
|
11,081
|
|
|
$
|
0
|
|
|
$
|
288,948
|
|
|
|
|
(1) |
|
The amount in this column for Mr. Mullaney reflects payout
of Performance Shares for the performance period of
January 1, 2007 to December 31, 2009.
Mr. Mullaney deferred receipt of 75% of the Shares payable
to him. The full payout amount is included in the table entitled
Option Exercises and Stock Vested in 2010 on
page 54. The amount reported in this column does not appear
in the Summary Compensation Table for 2010. No employee
contributions are made under the Auxiliary Plan. |
|
(2) |
|
Amounts in this column are reported as components of the Company
savings and investment program contributions for 2010 in the
All Other Compensation column of the Summary
Compensation Table on page 44. |
|
(3) |
|
None of the amounts in this column are reported for 2010 in the
Summary Compensation Table. See the text pertaining to the
Change in Pension Value and Nonqualified Deferred Compensation
Earnings column of that table on page 44. |
|
(4) |
|
In 2010, Mr. Wheeler received a payout of Shares he had
previously deferred. The Shares were paid on the date
Mr. Wheeler chose when he initially elected to defer the
Shares. |
|
(5) |
|
A portion of the amounts reported in this column is attributable
to Company savings and investment program contributions in the
All Other Compensation column of the Summary
Compensation Tables in |
58
|
|
|
|
|
the Companys Proxy Statements for 2010, 2009, 2008, and
2007. The amounts originally credited under the Auxiliary Plan
are shown below: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
2009
|
|
2008
|
|
2007
|
Executive
|
|
Proxy Statement
|
|
Proxy Statement
|
|
Proxy Statement
|
|
Proxy Statement
|
|
C. Robert Henrikson
|
|
$
|
160,200
|
|
|
$
|
230,800
|
|
|
$
|
191,000
|
|
|
$
|
144,200
|
|
William J. Wheeler
|
|
$
|
62,533
|
|
|
$
|
85,550
|
|
|
$
|
79,500
|
|
|
$
|
63,533
|
|
William J. Toppeta
|
|
$
|
47,400
|
|
|
$
|
63,800
|
|
|
$
|
59,000
|
|
|
$
|
64,533
|
|
William J. Mullaney
|
|
$
|
44,700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Steven A. Kandarian
|
|
$
|
53,533
|
|
|
$
|
72,050
|
|
|
$
|
|
|
|
|
|
|
Deferred
Compensation Program
Under the Companys deferred compensation program, Named
Executive Officers may elect to defer receipt of up to 75% of
their base salary, all of their AVIP awards, and any payouts for
Performance Share awards. These deferrals are voluntary
contributions of the Named Executive Officers own earnings.
In addition, to the extent a Named Executive Officer deferred
base salary payments in 2010 and had elected to participate in
the Savings and Investment Plan, the Company made a
4% matching contribution to the Leadership Plan rather than
making that contribution to the Savings and Investment Plan.
AVIP awards are also generally eligible for the same such
matching, but the executives annual incentive compensation
paid in 2010 was not paid under AVIP.
Payments that would have been made in Shares, but are deferred,
remain payable in Shares. This includes deferred payments from
Performance Shares, Restricted Stock Units, and the Share
payments under the Long Term Performance Compensation Plan
formerly maintained by the Company. Cash Awards under the Long
Term Performance Compensation Plan that were irrevocably
deferred in the form of Shares are also payable in Shares. All
other deferred compensation is payable in cash.
Named Executive Officers may elect to receive compensation they
have deferred at a specified date before, upon or after
retirement. In addition, Named Executive Officers may elect to
receive payments in a single lump sum or in up to
15 annual installments. However, despite a Named Executive
Officers election, payment is generally made in full in a
single lump sum should the executive terminate employment with
the Company before becoming Retirement Eligible or Bridge
Eligible. Payments to the top 50 highest paid officers that are
due upon separation from service are delayed for six months
following their separation, in compliance with Section 409A.
The terms of the Officers Plan and the Leadership Plan are
substantially similar, except that under the Officers Plan
participants may choose to receive amounts not subject to
Section 409A at any time with a 10% reduction, and that
payments under the Leadership Plan to the top 50 highest paid
officers in the Company that are due upon separation from
service are delayed for six months following their separation.
The Company offers a range of simulated investments under the
deferred compensation program. Named Executive Officers may
generally choose the simulated investments for their deferred
cash compensation at the time they elect to defer compensation,
and may change the simulated investment selections for their
existing account balances up to six times each calendar year.
The table below reflects the simulated investment returns for
2010 on each of the alternatives offered under the program. The
MetLife Deferred Shares Fund is available exclusively for
deferred Shares. The MetLife Common Stock Fund is available for
deferred cash compensation. Each of these two funds reflects
changes in value of Shares plus the value of imputed reinvested
dividends.
59
|
|
|
|
|
Simulated Investment
|
|
2010 Return
|
|
Auxiliary Fixed Income Fund
|
|
|
4.30
|
%
|
Lord Abbett Bond Debenture Fund
|
|
|
13.18
|
%
|
Oakmark
Fund®
|
|
|
12.18
|
%
|
Small Cap Equity Fund
|
|
|
27.99
|
%
|
Oakmark International Fund
|
|
|
16.22
|
%
|
Standard & Poors
500®
Index
|
|
|
15.06
|
%
|
Russell
2000®
Index
|
|
|
26.85
|
%
|
MSCI
EAFE®
Index
|
|
|
7.75
|
%
|
Barclays Capital U.S. Aggregate Bond Index
|
|
|
6.54
|
%
|
BofA Merrill Lynch US High Yield Master II Index
|
|
|
15.19
|
%
|
MSCI Emerging
Markets
Indexsm
|
|
|
18.88
|
%
|
MetLife Deferred Shares Fund
|
|
|
27.84
|
%
|
MetLife Common Stock Fund
|
|
|
27.84
|
%
|
Each simulated investment was available for the entirety of 2010.
Auxiliary Savings
and Investment Plan
Named Executive Officers and other eligible employees who
elected to contribute a portion of their eligible compensation
under the tax-qualified Savings and Investment Plan in 2010
received a matching contribution of their eligible compensation
in that plan in 2010:
|
|
|
|
|
Employee Contribution
|
|
Matching Contribution
|
(as a percentage of eligible
|
|
(as a percentage of eligible
|
compensation)
|
|
compensation)
|
|
3%
|
|
|
3
|
%
|
4%
|
|
|
3
|
.5%
|
5% or more
|
|
|
4
|
%
|
The employees eligible compensation under the Savings and
Investment Plan includes base salary and eligible annual
incentive awards.
The U.S. Internal Revenue Code limits compensation that is
eligible for employer matching contributions under the Savings
and Investment Plan. In 2010, the Company could not make
matching contributions based on compensation over $245,000.
Named Executive Officers and other eligible employees who
elected to participate in the Savings and Investment Plan during
2010 were credited with 4% of their eligible compensation beyond
that limit. This Company contribution is credited to an account
established for the employee under
the nonqualified Auxiliary Savings and Investment Plan.
Employees can elect to receive their Auxiliary Savings and
Investment Plan balances in a lump sum or in up to 15 annual
installments, in either case beginning one year after
termination of employment. Employees can also elect to delay
their payment, or the beginning of their annual payments, up to
ten years after termination of employment.
Amounts in the Auxiliary Savings and Investment Plan are subject
to the requirements of Section 409A. Participants were able
to elect the time and form of their payments through 2008, which
was within the time period permitted for such elections under
Section 409A. Participants may change the time and form of
their payments after 2008, but the election must be made during
employment, is not effective until twelve months after it is
made, and must delay the start of benefit payments by at least
five years. Payments to the top 50 highest paid officers that
are due upon separation from service are delayed for six months
following their separation, in compliance with Section 409A.
Employees may choose from a range of simulated investments for
their Auxiliary Savings and Investment Plan accounts. These
simulated investments were identical to the core funds offered
under the Savings and Investment Plan in 2010, except that the
rate set for the fixed income fund available under the Auxiliary
Savings and Investment Plan cannot exceed 120% of the applicable
federal long term rate under U.S. Internal Revenue Code
Section 1274(d) at the time that rate is set. Employees may
change the simulated investments for new Company contributions
to their Auxiliary Savings and Investment Plan accounts at any
time.
Employees could change the simulated investments for their
existing Auxiliary Savings and Investment Plan accounts up to
four times a month in 2010. Beginning in 2010, employees could
not allocate more than 10% of their existing Auxiliary Savings
and Investment Plan account balances to the MetLife Company
Stock Fund (except for any account balance already in the
MetLife Company Stock Fund as of January 1, 2010), and
could not allocate more than 10% of future contribution to that
fund. Fees are charged to employees for moving existing balances
out of certain
60
international simulated investments prior to the expiration of
pre-established holding periods.
The table below reflects the simulated investment returns for
2010 on each of the alternatives offered under the Auxiliary
Savings and Investment Plan.
|
|
|
|
|
Simulated Investment
|
|
2010 Return
|
|
Auxiliary Fixed Income Fund
|
|
|
4.30
|
%
|
Bond Index Fund
|
|
|
6.12
|
%
|
Large Cap Equity Index Fund
|
|
|
15.00
|
%
|
Large Cap Value Equity Fund
|
|
|
15.39
|
%
|
Large Cap Growth Index Fund
|
|
|
16.60
|
%
|
Mid Cap Equity Index Fund
|
|
|
26.42
|
%
|
Small Cap Equity Fund
|
|
|
27.99
|
%
|
International Equity Fund
|
|
|
10.56
|
%
|
MetLife Company Stock Fund
|
|
|
27.61
|
%
|
The MetLife Company Stock Fund includes a limited proportion of
simulated investments in instruments other than Shares.
Each simulated investment was available for the entirety of 2010.
61
Potential Payments Upon
Termination or
Change-in-Control
The table and accompanying text below reflect estimated
additional payments or benefits that would have been earned or
accrued, or that would have vested or been paid out earlier than
normal, had any Named Executive Officer been terminated from
employment or had a
change-in-control
of the Company occurred on the last business day of 2010 (the
Trigger Date). The table reflects hypothetical payments
and benefits. None of the payments or benefits has actually been
made. It does not include payments or benefits under
arrangements available on the same basis generally to all
salaried employees. The Named Executive Officers pension
benefits and nonqualified deferred compensation are described in
the tables entitled Pension Benefits and
Nonqualified Deferred Compensation, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Change-in-Control
|
|
Change-in-Control
|
|
|
|
|
Involuntary
|
|
|
|
Payments Solely on
|
|
|
|
|
Voluntary
|
|
Termination With
|
|
|
|
Account of
|
|
Termination With
|
|
|
Resignation
|
|
Severance Pay
|
|
Death
|
|
Change-in-Control
|
|
Severance Pay
|
|
C. Robert Henrikson
|
|
$
|
0
|
|
|
$
|
1,018,501
|
|
|
$
|
19,093,399
|
|
|
$
|
19,093,399
|
|
|
$
|
5,759,953
|
|
William J. Wheeler
|
|
$
|
0
|
|
|
$
|
2,347,400
|
|
|
$
|
9,981,220
|
|
|
$
|
9,981,220
|
|
|
$
|
2,344,564
|
|
William J. Toppeta
|
|
$
|
0
|
|
|
$
|
668,500
|
|
|
$
|
4,050,680
|
|
|
$
|
4,050,680
|
|
|
$
|
3,275,531
|
|
William J. Mullaney
|
|
$
|
0
|
|
|
$
|
643,500
|
|
|
$
|
4,005,740
|
|
|
$
|
4,005,740
|
|
|
$
|
3,209,541
|
|
Steven A. Kandarian
|
|
$
|
0
|
|
|
$
|
2,219,935
|
|
|
$
|
9,616,520
|
|
|
$
|
9,616,520
|
|
|
$
|
3,746,205
|
|
Voluntary Resignation (No
Change-in-Control)
None of the Named Executive Officers has an employment agreement
or other arrangement that calls for any severance pay in
connection with a voluntary resignation from employment prior to
a
change-in-control.
Nor in such a case would any additional payments or benefits
have been earned or accrued, or have vested or been paid out
earlier than normal, in favor of any Named Executive Officer.
A Named Executive Officer who had resigned but was Retirement
Eligible as of the Trigger Date would have continued to receive
the benefit of the executives existing stock-based awards,
unless the executive had been involuntarily terminated for
cause. For this purpose, cause is defined as
engaging in a serious infraction of Company policy, theft of
Company property or services or other dishonest conduct, conduct
otherwise injurious to the interests of the Company, or
demonstrated unacceptable lateness or absenteeism. Each of the
executives Performance Shares would have been paid after
the conclusion of the performance period as if the executive had
remained employed and all of the executives unexercised
Stock Options would have continued to vest and remain
exercisable for the remainder of their full ten-year term. The
executive would also have been eligible for an annual award for
2010, at the discretion of the Compensation Committee. These
terms apply to all employees of the Company who meet the age and
service qualifications to become Retirement Eligible and have
received such awards. See the table entitled Outstanding
Equity Awards at 2010 Fiscal Year-End on page 51 for
details on the Performance Shares and Stock Options. Of the
Named Executive Officers, Mr. Henrikson and Mr. Toppeta
were Retirement Eligible as of the Trigger Date.
Any Named Executive Officer who had resigned but was not
Retirement Eligible as of the Trigger Date would have received
the
2008-2010
Performance Shares that vested on December 31, 2010, and
would have had 30 days from the Trigger Date to exercise
any Stock Options that had vested as of the Trigger Date. The
Named Executive Officer would have forfeited all other
outstanding stock-based compensation awards.
62
Involuntary Termination With Severance Pay (No
Change-in-Control)
None of the Named Executive Officers has an employment agreement
or other arrangement that calls for any severance pay in
connection with a termination of employment for cause. If the
Named Executive Officer had been terminated for cause, the
executives unvested Performance Shares and all of the
executives Stock Options would have been forfeited and the
executive would have received no annual award for 2009
performance. For the definition of cause for this purpose, see
above under Voluntary Resignation (No
Change-in-
Control).
Had a Named Executive Officers employment been terminated
due to job elimination without a
change-in-control
having occurred, the executive would have been eligible for
severance pay under a severance program for all officer-level
employees. The severance pay would have been equal to
28 weeks base salary plus one week for every year of
service, up to 52 weeks base salary. In order to receive
any severance pay, the executive would have had to enter into a
separation agreement that would have included a release of
employment-related claims against the Company (a Separation
Agreement). Each executive would also have been entitled to
outplacement services. The cost of these payments and services
is reflected in the table above.
If the Named Executive Officers termination had been due
to performance, the amount of severance pay and the length of
the Severance Period would have each been one-half of what it
would have been in the case of job elimination.
Mr. Mullaney would have been Bridge Eligible had he been
involuntarily terminated with severance pay on the Trigger Date.
As a result, Mr. Mullaney would have received the benefit of all
stock-based awards made in 2005 or later on the same basis as
those executives who were Retirement Eligible. In order to be
Bridge Eligible, Mr. Mullaney would have had to enter into a
Separation Agreement.
Any Named Executive Officer who was neither Retirement Eligible
nor Bridge Eligible as of the Trigger Date would have received
the
2008-2010
Performance Shares, which vested at the end of the performance
period on December 31, 2010, and would have had
30 days from the Trigger Date to exercise any Stock Options
that had vested as of the
Trigger Date. The Named Executive Officer would have been
offered prorata payments in consideration of any
2009-2011
and
2010-2012
Performance Shares.
The amount of payment for
2009-2011
Performance Shares would have been determined using the amount
of time that had passed in the performance period through the
date of the termination of employment, the number of Performance
Shares granted, and the closing price of a Share on the date the
Performance Shares were granted. The estimated cost of these
payments for each Named Executive Officer who was not Retirement
Eligible or Bridge Eligible on the Trigger Date is reflected in
the table above.
For
2010-2012
Performance Shares the amount of payment would have been
determined using the amount of time that had passed in the
performance period through the date of the termination of
employment and the number of Performance Shares granted.
However, the lesser of the performance factor ultimately
determined for that three-year performance period (0-200%) or
target performance (100%) would have been used. In addition, the
lesser of the closing price of Company common stock on the date
of grant and the closing price of Company common stock on the
date the Compensation Committee determined that performance
factor would have been used. Such payments would not have been
made until after the end of the applicable performance period.
The estimated cost of these payments for each Named Executive
Officer who was not Retirement Eligible or Bridge Eligible on
the Trigger Date is reflected in the table above, using the
closing price of Company common stock on the date of grant and a
hypothetical 100% performance factor.
Death (No
Change-in-Control)
In the unlikely event that a Named Executive Officer had died on
the Trigger Date, that executives stock-based awards would
have vested and become payable immediately. The Company would
have paid the executives unvested Performance Shares using
100% of Performance Shares granted (Target Performance).
All of the executives Stock Options would have become
immediately exercisable. These terms apply to all employees of
the Company who have been made such awards. The payment on
stock-based awards
63
reflected in the table above was calculated using the closing
price of Shares on the Trigger Date (the Trigger Date Closing
Price).
Payments Solely on Account of a
Change-in-Control
The Companys definition of
change-in-control
is: any person acquires beneficial ownership of 25% or more of
MetLifes voting securities (for this purpose, persons
include any group under
Rule 13d-5(b)
under the Exchange Act, not including MetLife, any affiliate of
MetLife, any Company employee benefit plan, or the MetLife
Policyholder Trust); a change in the majority of the membership
of MetLifes Board of Directors (other than any director
nominated or elected by other directors) occurs within any
24-month
period; or a completed transaction after which the previous
shareholders of MetLife do not own the majority of the voting
shares in the resulting company, or do not own the majority of
the voting shares in each company that holds more than 25% of
the assets of MetLife prior to the transaction.
Had a
change-in-control
occurred on the Trigger Date, the Company could have chosen to
substitute an award with at least the same value and at least
equivalent material terms that complies with Section 409A
(an Alternative Award), rather than accelerate or pay out
the existing award. Otherwise, the Company would have paid out
the executives unvested Performance Shares in cash using
Target Performance and the
change-in-control
price of Shares. Payment would have been made within thirty days
after the
change-in-control,
except that if the event did not qualify as a
change-in-control
as defined in Section 409A, then payment would have been
made following the end of the three-year performance period
originally applicable to the Performance Shares. In addition, if
no Alternative Award had been made, each executives
unvested Stock Options would have become immediately
exercisable, and the Compensation Committee could have chosen to
cancel each option in exchange for a cash payment equal to the
difference between the exercise price of the Stock Option and
the
change-in-control
price.
The estimated cost of these payments and benefits (assuming no
Alternative Award) is reflected in the table above. The payment
related to unvested Stock Options and unvested Performance
Shares was calculated using the Trigger Date Closing Price.
Termination with Severance Pay
(Change-in-Control)
In addition to being eligible to receive the payments described
above under Payments Solely on Account of a
Change-in-Control, each of the Named Executive Officers is
eligible to participate in the Executive Severance Plan. Under
this plan, had a
change-in-control
occurred on the Trigger Date, and the Named Executive
Officers terms and conditions of employment during the
three-year period beginning with the Trigger Date (Employment
Period) not satisfied specified standards, the Named
Executive Officer could have terminated employment and received
severance pay and related benefits. These standards include:
|
|
|
base pay no lower than the level paid before the
change-in-control;
|
|
|
annual bonus opportunities at least as high as other Company
executives;
|
|
|
participation in all long-term incentive compensation programs
for key executives at a level at least as high as for other
executives of the Company of comparable rank;
|
|
|
aggregate annual bonus and long-term compensation awards at
least equal to the aggregate value of such awards for any of
three years prior to the
change-in-control;
|
|
|
a prorata annual bonus for any fiscal year that extends beyond
the end of the three-year period at least equal to the same
prorata portion of any of the three annual bonuses awarded prior
to the
change-in-control;
|
|
|
participation in all Company pension, deferred compensation,
savings, and other benefit plans at the same level as or better
than those made available to other similarly-situated officers;
|
|
|
vacation, indemnification, fringe benefits, and reimbursement of
expenses on the same basis as other similarly-situated
officers; and
|
|
|
a work location at the same office as the executive had
immediately prior to the
change-in-control,
or within 50 miles of that location.
|
In addition, if the Company had involuntarily terminated the
Named Executive Officers employment without cause during
the Employment Period, the executive would have
64
received severance pay and related benefits. For these purposes,
cause is defined as the executives conviction or plea of
nolo contendere to a felony, dishonesty or gross
misconduct which results or is intended to result in material
damage to the Companys business or reputation, or
repeated, material, willful and deliberate violations by the
executive of the executives obligations.
Had a Named Executive Officer qualified for severance pay as of
the Trigger Date, the amount would have been two times the sum
of the executives annual salary rate plus the average of
the executives annual incentive awards for the three
fiscal years prior to the
change-in-control.
If the executive would have received a greater net after-tax
benefit by reducing the amount of severance pay below the
change-in-control
excise tax threshold, the severance pay would have been reduced
to an amount low enough to avoid that excise tax. The
executives related benefits would have included up to
three years continuation of existing medical, dental, and
long-term disability plan benefits. The estimated
cost of these payments and benefits is reflected in the table
above, using the Trigger Date Closing Price and the actuarial
present value of continuation of benefits using the same
assumptions that are used by the Company for financial reporting
purposes under GAAP.
Effective June 14, 2010 the amount of severance pay that
could be paid under the plan changed from three times to two
times the sum of the executives annual salary rate plus
the average of the executives annual incentive awards for
the three fiscal years prior to the
change-in-control.
Also effective in June 2010, no additional service credit for
pension benefits would have been awarded in connection with
qualifying for severance pay.
If severance pay and related benefits had become due because the
executive voluntarily terminated employment, payment would have
been delayed for six months in order to comply with
Section 409A.
65
Appendix
Non-GAAP Financial Measures
Operating earnings is defined as operating revenues less
operating expenses, net of income tax. Operating earnings
available to common shareholders is defined as operating
earnings less preferred stock dividends, and operating earnings
available to common shareholders per diluted common share is
calculated by dividing operating earnings available to common
shareholders by the number of weighted average diluted common
shares outstanding for the period indicated.
Operating revenues is defined as GAAP revenues (i) less net
investment gains (losses) and net derivative gains (losses),
(ii) less amortization of unearned revenue related to net
investment gains (losses) and net derivative gains (losses),
(iii) plus scheduled periodic settlement payments on
derivatives that are hedges of investments but do not qualify
for hedge accounting treatment, (iv) plus income from
discontinued real estate operations, (v) less net
investment income related to contractholder-directed unit-linked
investments, and (vi) plus, for operating joint ventures
reported under the equity method of accounting, the
aforementioned adjustments, those identified in the definition
of operating expenses and changes in fair value of hedges of
operating joint venture liabilities, all net of income tax.
Operating expenses is defined as GAAP expenses (i) less
changes in policyholder benefits associated with asset value
fluctuations related to experience-rated contractholder
liabilities and certain inflation-indexed liabilities,
(ii) less costs related to business combinations and
noncontrolling interests, (iii) less amortization of
deferred policy acquisition costs and value of business acquired
and changes in the policyholder dividend obligation related to
net investment gains (losses) and net derivative gains (losses),
(iv) less interest credited to policyholder account
balances related to contractholder-directed unit-linked
investments, and (v) plus scheduled periodic settlement
payments on derivatives that are hedges of policyholder account
balances but do not qualify for hedge accounting treatment.
In addition, operating revenues and operating expenses do not
reflect the consolidation of certain securitization entities
that are variable interest entities as required under GAAP.
Return on Equity refers to operating return on common equity,
which is calculated by dividing operating earnings available to
common shareholders by average MetLife, Inc. common equity for
the period indicated, excluding accumulated other comprehensive
income.
Book Value Per Share refers to book value per actual common
share excluding accumulated other comprehensive income (loss),
which is determined by dividing GAAP equity less accumulated
other comprehensive income (loss) by the number of actual common
shares outstanding.
66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
2009
|
|
|
(In millions, except Share and per Share data)
|
|
Reconciliation of Operating Earnings to Net Income(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to MetLife, Inc.s common
shareholders
|
|
$
|
2,668
|
|
|
$
|
3.00
|
|
|
$
|
(2,368
|
)
|
|
$
|
(2.89
|
)
|
Adjustments from net income (loss) available to MetLife,
Inc.s common shareholders to operating earnings available
to common shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: Net investment gains (losses)
|
|
|
(392
|
)
|
|
|
(0.44
|
)
|
|
|
(2,906
|
)
|
|
|
(3.53
|
)
|
Less: Net derivative gains (losses)
|
|
|
(265
|
)
|
|
|
(0.30
|
)
|
|
|
(4,866
|
)
|
|
|
(5.91
|
)
|
Less: Other adjustments to continuing operations
|
|
|
(981
|
)
|
|
|
(1.10
|
)
|
|
|
283
|
|
|
|
0.33
|
|
Less: Provision for income tax (expense) benefit related to
adjustments above
|
|
|
401
|
|
|
|
0.45
|
|
|
|
2,683
|
|
|
|
3.26
|
|
Less: Income (loss) from discontinued operations, net of income
tax
|
|
|
9
|
|
|
|
0.01
|
|
|
|
41
|
|
|
|
0.05
|
|
Net income (loss) attributable to noncontrolling interests
|
|
|
(4
|
)
|
|
|
|
|
|
|
(32
|
)
|
|
|
(0.04
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating earnings available to common shareholders
|
|
$
|
3,892
|
|
|
$
|
4.38
|
|
|
$
|
2,365
|
|
|
$
|
2.87
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock outstanding basic
|
|
|
|
|
|
|
882.5
|
|
|
|
|
|
|
|
818.5
|
|
Exercise or issuance of stock-based awards
|
|
|
|
|
|
|
7.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common stock outstanding diluted
|
|
|
|
|
|
|
889.6
|
|
|
|
|
|
|
|
818.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actual common stock outstanding
|
|
|
|
|
|
|
1,054.4
|
|
|
|
|
|
|
|
818.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Premiums, Fees & Other Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums, Fees & Other Revenues, as presented
|
|
$
|
35,758
|
|
|
|
|
|
|
$
|
34,019
|
|
|
|
|
|
Adjustments related to universal life and investment-type
product policy fees
|
|
|
1
|
|
|
|
|
|
|
|
(27
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums, Fees & Other Revenues
|
|
$
|
35,759
|
|
|
|
|
|
|
$
|
33,992
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Calculation of Return on MetLife, Inc.s Common
Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MetLife, Inc.s common equity
|
|
$
|
46,582
|
|
|
|
|
|
|
$
|
31,078
|
|
|
|
|
|
Less: Accumulated other comprehensive income (loss)
|
|
|
1,000
|
|
|
|
|
|
|
|
(3,058
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted common equity
|
|
|
45,582
|
|
|
|
|
|
|
|
34,136
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average adjusted common equity
|
|
|
38,308
|
|
|
|
|
|
|
|
35,040
|
|
|
|
|
|
Return on MetLife, Inc.s common equity
|
|
|
7.0
|
%
|
|
|
|
|
|
|
(6.8
|
)%
|
|
|
|
|
Operating return on MetLife, Inc.s common equity
|
|
|
10.2
|
%
|
|
|
|
|
|
|
6.7
|
%
|
|
|
|
|
|
|
|
(1) |
|
For the year ended December 31, 2009, 4.2 million
shares, related to the assumed exercise or issuance of
stock-based awards, have been excluded from the weighted average
common shares outstanding diluted, as these assumed
shares are anti-dilutive to net income (loss) available to
MetLife, Inc.s common shareholders per common
share diluted. These shares were included in the
calculation of operating earnings available to common
shareholders per common share diluted. |
67
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
Equity Compensation Plan
Information at December 31, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
Remaining Available for
|
|
|
|
|
|
|
Future Issuance Under
|
|
|
Number of Securities to
|
|
Weighted-average
|
|
Equity Compensation
|
|
|
be Issued upon Exercise
|
|
Exercise Price of
|
|
Plans (Excluding
|
|
|
of Outstanding Options,
|
|
Outstanding Options,
|
|
Securities Reflected
|
|
|
Warrants and Rights (2)
|
|
Warrants and Rights (3)
|
|
in Column (a))
(4)
|
Plan Category
|
|
(a)
|
|
(b)
|
|
(c)
|
|
Equity compensation plans approved by security holders (1)
|
|
|
44,703,216
|
|
|
|
$38.47
|
|
|
|
42,285,559
|
|
Equity compensation plans not approved by security holders
|
|
|
None
|
|
|
|
|
|
|
|
None
|
|
Total
|
|
|
44,703,216
|
|
|
|
$38.47
|
|
|
|
42,285,559
|
|
|
|
|
(1) |
|
Includes the MetLife, Inc. 2000 Stock Incentive Plan (the
2000 Stock Plan) and the 2000 Directors Stock Plan,
each of which was approved by Metropolitan Life Insurance
Company (MLIC), the sole shareholder of the Company at
the time of approval. The policyholders of MLIC entitled to vote
on its plan of reorganization (the Plan of
Reorganization) approved the Plan of Reorganization, which
included both the 2000 Stock Plan and the 2000 Directors
Stock Plan. The policyholders entitled to so vote received a
summary description of each plan, including the applicable
limits on the number of Shares available for issuance under each
plan. Also includes the 2005 Stock Plan and the
2005 Directors Stock Plan, which were approved by Company
security holders. |
|
(2) |
|
As of December 31, 2010, awards of Stock Options remained
outstanding under the 2000 Stock Plan and 2000 Directors
Stock Plan, and awards of Stock Options, Performance Shares, and
Restricted Stock Units (each as defined in the 2005 Stock Plan)
remained outstanding under the 2005 Stock Plan. In addition, as
of December 31, 2010, a number of Shares that had vested
and become payable from any awards under any plan, but had been
deferred, remained deferred and unpaid (Deferred Shares).
Under the award agreements that apply to the Performance Share
awards made under the 2005 Stock Plan as of December 31,
2010, Shares are payable to eligible award recipients following
the conclusion of the performance period. The number of shares
payable is determined by multiplying the number of performance
shares by a performance factor (from 0% to 200%) based on the
performance of the Company with respect to: (i) change in
annual net operating earnings per share; and
(ii) proportionate total shareholder return, as defined, as
a percentile of the performance of other companies in the
Fortune
500®
companies in the Standard & Poors Insurance
Index, with such exceptions as the Company Compensation
Committee has determined, with regard to the performance period.
With respect to Performance Share awards made in 2010, no
Performance Shares will be payable unless the Company generates
positive net income for either the third year of the performance
period or for the performance period as a whole. In addition,
with respect to Performance Share awards made in 2009 and 2010,
the performance factor will be multiplied by 0.75 if the
Companys total shareholder return with regard to the
performance period is zero percent or less. Under the award
agreements that apply to the Restricted Stock Unit awards made
under the 2005 Stock Plan as of December 31, 2010, Shares
equal to the number of Restricted Stock Units awarded are
normally payable to eligible award recipients on the third or
later anniversary of the date the Restricted Stock Units were
granted. |
|
(3) |
|
Column (b) reflects the weighted average exercise price of
all Stock Options under any plan that, as of December 31,
2010, had been granted but not forfeited, expired, or exercised.
Performance Shares, Restricted Stock Units, and Deferred Shares
are not included in determining the weighted average in column
(b) because they have no exercise price. |
68
|
|
|
(4) |
|
The aggregate number of Shares available for issuance under the
2005 Stock Plan is 68,000,000. In addition,
6,099,881 Shares that were available but had not been
utilized under the 2000 Stock Plan became available for issuance
under the 2005 Stock Plan at the time the 2005 Stock Plan became
effective. At December 31, 2010, 6,957,603 additional
Shares recovered due to forfeiture or expiration of awards under
the 2000 Stock Plan, or that, under the Plan of Reorganization,
would otherwise have reduced the number of Shares available for
issuance under the 2000 Stock Plan, from the time the 2005 Stock
Plan became effective to December 31, 2010, were also
available for issuance under the 2005 Stock Plan. The aggregate
number of Shares available for issuance under the
2005 Directors Stock Plan is 2,000,000. Each Share issued
under the 2005 Stock Plan in connection with awards other than
Stock Options or Stock Appreciation Rights (including Shares
payable on account of Performance Shares, Restricted Stock
Units, and Stock-Based Awards) reduces the number of Shares
remaining for issuance under the 2005 Stock Plan by
1.179 Shares. Each Share issued under the 2005 Stock Plan
in connection with a Stock Option or Stock Appreciation Right
reduces the number of Shares remaining for issuance under the
2005 Stock Plan by 1.0. As of December 31, 2010, all
Stock-Based awards made under the 2005 Directors Stock Plan
have been immediately vested. Share awards to Directors under
the 2000 Directors Stock Plan were made under a separate
Share award authorization under that plan, and have not reduced
the number of Shares remaining available for issuance under any
plan as of December 31, 2010. Under the 2005 Stock Plan,
awards may be in the form of Stock Options, Stock Appreciation
Rights, Restricted Stock or Restricted Stock Units, Performance
Shares or Performance Share Units, Cash-Based Awards, and
Stock-Based Awards (each as defined in the 2005 Stock Plan).
Under the 2005 Directors Stock Plan, awards granted may be
in the form of non-qualified Stock Options, Stock Appreciation
Rights, Restricted Stock or Restricted Stock Units, or Stock-
Based Awards (each as defined in the 2005 Directors Stock
Plan). Under both the 2005 Stock Plan and the
2005 Directors Stock Plan, in the event of a corporate
event or transaction (including, but not limited to, a change in
the Shares or the capitalization of the Company) such as a
merger, consolidation, reorganization, recapitalization,
separation, stock dividend, extraordinary dividend, stock split,
reverse stock split, split up, spin-off, or other distribution
of stock or property of the Company, combination of securities,
exchange of securities, dividend in kind, or other like change
in capital structure or distribution (other than normal cash
dividends) to shareholders of the Company, or any similar
corporate event or transaction, the appropriate committee of the
Board of Directors of the Company (each, a
Committee), in order to prevent dilution or
enlargement of participants rights under the applicable
plan, shall in its sole discretion substitute or adjust, as
applicable, the number and kind of Shares that may be issued
under that plan and shall adjust the number and kind of Shares
subject to outstanding awards. Any Shares related to awards
under either plan which: (i) terminate by expiration,
forfeiture, cancellation, or otherwise without the issuance of
Shares; (ii) are settled in cash either in lieu of Shares
or otherwise; or (iii) are exchanged with the appropriate
Committees permission for awards not involving Shares, are
available again for grant under the applicable plan. If the
option price of any Stock Option granted under either plan or
the tax withholding requirements with respect to any award
granted under either plan are satisfied by tendering Shares to
the Company (by either actual delivery or by attestation), or if
a Stock Appreciation Right is exercised, only the number of
Shares issued, net of the Shares tendered, if any, will be
deemed delivered for purposes of determining the maximum number
of Shares available for issuance under that plan. The maximum
number of Shares available for issuance under either plan shall
not be reduced to reflect any dividends or dividend equivalents
that are reinvested into additional Shares or credited as
additional Restricted Stock, Restricted Stock Units, or
Stock-Based Awards. |
69
Security Ownership of Directors
and Executive Officers
The table below shows the number of equity securities of MetLife
beneficially owned by each of the Directors and Named Executive
Officers of MetLife and all the Directors and Executive
Officers, as a group. Other than as disclosed in note (6)
below, the information reported in this table is given as of
February 14, 2011.
Securities beneficially owned include shares held in each
Directors or Executive Officers name, shares held by
a broker for the benefit of the Director or Executive Officer,
shares which the Director or Executive Officer could acquire
within 60 days (as described in notes (3) and
(4) below), shares held indirectly in the Savings and
Investment Plan and other shares for which the Director or
Executive Officer may directly or indirectly have or share
voting power or investment power (including the power to direct
the disposition of the shares). Other than as disclosed below,
none of the Directors or Executive Officers of the Company
beneficially owned Floating Rate Non-Cumulative Preferred Stock,
Series A, of the Company or 6.50% Non-Cumulative Preferred
Stock, Series B, of the Company (Series B Preferred
Stock) or Convertible Preferred Stock of the Company as of
February 14, 2011.
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Amount and
|
|
|
|
|
Nature of
|
|
|
|
|
Beneficial
|
|
|
|
|
Ownership
|
|
Percent of
|
Name
|
|
(1)(2)(3)(4)
|
|
Class
|
|
C. Robert Henrikson
|
|
|
1,367,827
|
|
|
|
*
|
|
Sylvia M. Burwell
|
|
|
12,288
|
|
|
|
*
|
|
Eduardo Castro-Wright
|
|
|
14,041
|
|
|
|
*
|
|
Cheryl W. Grisé
|
|
|
9,808
|
|
|
|
*
|
|
R. Glenn Hubbard
|
|
|
18,682
|
|
|
|
*
|
|
John M. Keane
|
|
|
20,055
|
|
|
|
*
|
|
Alfred F. Kelly, Jr.(5)
|
|
|
9,879
|
|
|
|
*
|
|
James M. Kilts(5)
|
|
|
5,107
|
|
|
|
*
|
|
Catherine R. Kinney
|
|
|
13,188
|
|
|
|
*
|
|
Hugh B. Price
|
|
|
15,300
|
|
|
|
*
|
|
David Satcher
|
|
|
3,298
|
|
|
|
*
|
|
Kenton J. Sicchitano
|
|
|
22,912
|
|
|
|
*
|
|
Lulu C. Wang
|
|
|
8,836
|
|
|
|
*
|
|
Steven A. Kandarian
|
|
|
202,461
|
|
|
|
*
|
|
William J. Mullaney
|
|
|
212,917
|
|
|
|
*
|
|
William J. Toppeta
|
|
|
556,977
|
|
|
|
*
|
|
William J. Wheeler
|
|
|
372,701
|
|
|
|
*
|
|
Board of Directors of MetLife, but not in each Directors
individual capacity(6)
|
|
|
220,255,199
|
|
|
|
22.3
|
%
|
All Directors and Executive Officers, as a group(7)
|
|
|
3,358,645
|
|
|
|
*
|
|
|
|
|
* |
|
Number of shares represents less than one percent of the number
of shares of common stock outstanding at February 14, 2011. |
|
(1) |
|
Each Director and Executive Officer has sole voting and
investment power over the shares shown in this column opposite
his or her name, except as indicated in notes (2), (3) and
(4) below. |
70
|
|
|
(2) |
|
Includes shares held by the MetLife Policyholder Trust allocated
to the Directors and Named Executive Officers in their
individual capacities as beneficiaries of the trust, as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Held in
|
|
|
|
Shares Held in
|
|
|
|
Shares Held in
|
|
|
Policyholder
|
|
|
|
Policyholder
|
|
|
|
Policyholder
|
Name
|
|
Trust
|
|
Name
|
|
Trust
|
|
Name
|
|
Trust
|
|
Henrikson
|
|
|
509
|
|
|
Satcher
|
|
|
260
|
|
|
Toppeta
|
|
|
344
|
|
Price
|
|
|
10
|
|
|
Mullaney
|
|
|
111
|
|
|
Wheeler
|
|
|
10
|
|
|
|
|
|
|
Directors and Executive Officers as of February 14, 2011,
as a group, were allocated 1,264 shares as beneficiaries of
the MetLife Policyholder Trust in their individual capacities.
The beneficiaries have sole investment power and shared voting
power with respect to such shares. Note (6) below describes
additional beneficial ownership attributed to the Board of
Directors as an entity, but not to any Director in an individual
capacity, of shares held by the MetLife Policyholder Trust. |
|
(3) |
|
Includes shares that are subject to options which were granted
under the 2000 Directors Stock Plan, the 2000 Stock Plan or
the 2005 Stock Plan and are exercisable within 60 days of
February 14, 2011. The number of such options held by
Director and Named Executive Officer is shown in the following
table: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
Number of
|
|
|
Options
|
|
|
|
Options
|
|
|
|
Options
|
|
|
Exercisable
|
|
|
|
Exercisable
|
|
|
|
Exercisable
|
Name
|
|
within 60 days
|
|
Name
|
|
within 60 days
|
|
Name
|
|
within 60 days
|
|
Henrikson
|
|
|
1,273,335
|
|
|
Price
|
|
|
6,836
|
|
|
Mullaney
|
|
|
202,526
|
|
Burwell
|
|
|
553
|
|
|
Sicchitano
|
|
|
1,536
|
|
|
Toppeta
|
|
|
483,484
|
|
Grisé
|
|
|
178
|
|
|
Kandarian
|
|
|
190,167
|
|
|
Wheeler
|
|
|
354,534
|
|
Keane
|
|
|
1,210
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All Directors and Executive Officers as of February 14,
2011, as a group, held 2,949,380 options exercisable within
60 days of February 14, 2011. |
|
(4) |
|
Includes shares deferred under the Companys nonqualified
deferred compensation program (Deferred Shares) that the
Director or Executive Officer could acquire within 60 days
of February 14, 2011, such as by ending employment or
service as a Director, or by taking early distribution of the
shares with a 10% reduction as described on page 59. The
number of such Deferred Shares held by Director and Named
Executive Officer is shown in the following table: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
Number of
|
|
|
|
Number of
|
|
|
Deferred
|
|
|
|
Deferred
|
|
|
|
Deferred
|
|
|
Shares
|
|
|
|
Shares
|
|
|
|
Shares
|
|
|
That Can Be
|
|
|
|
That Can Be
|
|
|
|
That Can Be
|
|
|
Acquired
|
|
|
|
Acquired
|
|
|
|
Acquired
|
Name
|
|
within 60 Days
|
|
Name
|
|
within 60 Days
|
|
Name
|
|
within 60 Days
|
|
Henrikson
|
|
|
48,058
|
|
|
Keane
|
|
|
15,599
|
|
|
Price
|
|
|
8,455
|
|
Burwell
|
|
|
11,735
|
|
|
Kelly
|
|
|
1,179
|
|
|
Satcher
|
|
|
2,018
|
|
Castro-Wright
|
|
|
8,826
|
|
|
Kilts
|
|
|
4,871
|
|
|
Mullaney
|
|
|
9,122
|
|
Grisé
|
|
|
5,072
|
|
|
Kinney
|
|
|
6,819
|
|
|
Toppeta
|
|
|
44,138
|
|
Hubbard
|
|
|
11,182
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Does not include Deferred Shares to the extent the Company would
delay payment in order to comply with Section 409A, as
described on page 59. |
|
(5) |
|
Each of Mr. Kelly and Mr. Kilts beneficially own and
have sole voting and investment power over 1,610 shares and
145 shares, respectively, of Series B Preferred Stock.
Each ones ownership interest represents less than 1% of
the number of Series B Preferred Stock outstanding as of
February 14, 2011. Holders of Series B Preferred Stock
do not vote in the election of Directors, and otherwise have
limited voting rights. |
|
(6) |
|
This information is given as of February 18, 2011. The
Board of Directors of MetLife, as an entity, but not any
Director in his or her individual capacity, is deemed to
beneficially own the shares of MetLife common stock held by the
MetLife Policyholder Trust because the Board will direct the
voting of those shares on certain matters submitted to a vote of
shareholders. This number of shares deemed owned by |
71
|
|
|
|
|
the Board of Directors is reflected in Amendment No. 44 to
Schedule 13D referred to below under the heading
Security Ownership of Certain Beneficial Owners on
page 73. |
|
(7) |
|
Does not include shares of MetLife common stock held by the
MetLife Policyholder Trust that are beneficially owned by the
Board of Directors, as an entity, as described in note (6), but
includes the shares allocated to the Directors in their
individual capacities, as described in note (2). Includes
2,949,380 shares that are subject to options that are
exercisable within 60 days of February 14, 2011 by all
Directors and Executive Officers of the Company as of
February 14, 2011, as a group, including the shares that
are subject to options described in note (3). |
Deferred
Shares Not Beneficially Owned and Deferred Share
Equivalents.
Deferred Shares that could not be acquired within 60 days
of February 14, 2011 are not considered beneficially owned.
Deferred cash compensation or auxiliary benefits measured in
share value (Deferred Share Equivalents) are also not
deemed beneficially owned because their payment is not made in
MetLife common stock. Each, however, aligns the Directors
and Named Executive Officers interests with the interests
of the Companys shareholders since the value of Deferred
Shares and Deferred Share Equivalents depends upon the price of
MetLife common stock. The table below sets forth information on
the Directors and Named Executive Officers Deferred
Shares that could not be acquired within 60 days and their
Deferred Share Equivalents, as of February 14, 2011.
|
|
|
|
|
|
|
Deferred Shares
|
|
|
Not Beneficially Owned
|
Name
|
|
and/or Deferred Share Equivalents
|
|
C. Robert Henrikson
|
|
|
191,152
|
|
Sylvia M. Burwell
|
|
|
6,957
|
|
Cheryl W. Grisé
|
|
|
10,527
|
|
R. Glenn Hubbard
|
|
|
2,452
|
|
Alfred F. Kelly, Jr.
|
|
|
4,713
|
|
James M. Kilts
|
|
|
19,514
|
|
Hugh B. Price
|
|
|
37,392
|
|
David Satcher
|
|
|
9,601
|
|
Steven A. Kandarian
|
|
|
14,432
|
|
William J. Mullaney
|
|
|
44,571
|
|
William J. Toppeta
|
|
|
57,466
|
|
William J. Wheeler
|
|
|
79,073
|
|
72
Security Ownership of Certain
Beneficial Owners
The following persons have reported to the SEC beneficial
ownership of more than 5% of MetLife common stock:
|
|
|
|
|
|
|
|
|
|
|
Amount and
|
|
|
|
|
Nature of
|
|
|
|
|
Beneficial
|
|
Percent of
|
Name and Address of Beneficial Owner
|
|
Ownership
|
|
Class
|
|
Beneficiaries of the MetLife Policyholder Trust(1)
|
|
|
220,255,199
|
|
|
|
22.3
|
%
|
c/o Wilmington
Trust Company, as Trustee
Rodney Square North
1100 North Market Street
Wilmington, Delaware 19890
|
|
|
|
|
|
|
|
|
American International Group, Inc. and ALICO Holdings LLC(2)
|
|
|
78,239,712
|
|
|
|
7.9
|
%
|
180 Maiden Lane
New York, New York 10038
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The Board of Directors of the Company has reported to the SEC
that, as of February 18, 2011, it, as an entity, had shared
voting power over 220,255,199 shares of common stock held
in the MetLife Policyholder Trust. The Boards report is in
Amendment No. 44, filed on February 24, 2011, to the
Boards Schedule 13D. MetLife created the trust when
Metropolitan Life Insurance Company, a wholly-owned subsidiary
of MetLife, converted from a mutual insurance company to a stock
insurance company in April 2000. At that time, eligible
Metropolitan Life Insurance Company policyholders received
beneficial ownership of shares of common stock, and MetLife
transferred these shares to a trust, which is the record owner
of the shares. Wilmington Trust Company serves as trustee.
The trust beneficiaries have sole investment power over the
shares, and can direct the trustee to vote their shares on
matters identified in the trust agreement that governs the
trust. However, the trust agreement directs the trustee to vote
the shares held in the trust on some shareholder matters as
recommended or directed by MetLifes Board of Directors
and, on that account, the Board, under SEC rules, shares voting
power with the trust beneficiaries and the SEC has considered
the Board, as an entity, a beneficial owner under the rules. |
|
|
|
In connection with MetLifes acquisition
(Acquisition) of American Life Insurance Company from
ALICO Holdings LLC (Seller), a subsidiary of American
International Group, Inc. (AIG), and Delaware American
Life Insurance Company from AIG, on November 1, 2010,
MetLife, Seller and AIG entered into an Investor Rights
Agreement, dated as of November 1, 2010, setting forth the
rights and obligations of the parties with respect to
78,239,712 shares of common stock and other securities of
MetLife issued to Seller as consideration for the Acquisition.
Pursuant to the Investor Rights Agreement, Seller and AIG
agreed, and certain permitted transferees of such securities
will agree, to vote any and all of the securities of MetLife
that were received as part of the consideration for the
Acquisition, and all shares received or to be received upon
conversion or settlement of securities included in such
consideration (collectively, Covered Securities), in the
same proportion as the shares of common stock or such other
voting securities voted by all other holders of MetLifes
common stock and other voting securities (Voting
Covenant). However, the Company may decide to waive this
proportionate-voting obligation to the extent that Seller
chooses to vote its shares in favor of the conversion of the
Convertible Preferred Stock into MetLife, Inc. common stock, if
and when MetLife shareholders vote on such a proposal. The
Investor Rights Agreement is included as Exhibit 4.1 to the
Form 8-K
filed by MetLife on November 2, 2010, and is incorporated
herein by reference. Shareholders are urged to read the Investor
Rights Agreement in its entirety. |
|
|
|
As a result of the Voting Covenant, (a) the issuance of the
Covered Securities has had, and will have, no effect on the
relative voting powers of the beneficial owners of
MetLifes common stock, including the Board of Directors of
MetLife, and (b) so long as and to the extent that Covered
Securities are held by |
73
|
|
|
|
|
persons bound by the Voting Covenant, the percentage of votes
cast at the direction of the Board of Directors is and will
effectively be the same as it would be if the Covered Securities
entitled to vote on the matter were not considered to be
outstanding for purposes of such vote. Accordingly, the Board
Directors disclaimed beneficial ownership of any of the Covered
Securities. |
|
(2) |
|
This information is based solely on the Schedule 13G filed
with the SEC on November 9, 2010 by AIG and Seller
(together, AIG Entities). The AIG Entities reported that
AIG has sole voting power to elect the managers of Seller and
accordingly has shared power to vote and dispose of any
securities owned by Seller. The AIG Entities each reported
shared voting and dispositive power over 78,239,712 shares
of common stock. |
|
|
|
The AIG Entities also reported that Seller owns
6,857,000 shares of Series B Contingent Convertible
Junior Participating Non-Cumulative Perpetual Preferred Stock of
MetLife (Convertible Preferred Stock) which will
automatically be converted into 68,570,000 shares of common
stock on the third business day after MetLife receives all
approvals of its shareholders necessary pursuant to
New York Stock Exchange rules to vote on such approval.
Under certain circumstances, the Convertible Preferred Stock
will convert into common stock. The AIG Entities reported that
if such a conversion occurs, Seller will own, when taken
together with the 78,239,712 shares it already owns, a
total of 146,809,712 shares of common stock. |
|
|
|
The shares of common stock owned by Seller do not include shares
of common stock that Seller is required to purchase pursuant to
the forward stock purchase contracts that form part of common
equity units (Equity Units) of MetLife issued to Seller
as part of the consideration for the Acquisition. These forward
stock purchase contracts will settle on three dates that are
currently expected to be October 10, 2012,
September 11, 2013 and October 7, 2014, but may be
postponed under certain circumstances. The number of shares of
common stock to be purchased pursuant to the stock purchase
contracts can vary from a minimum of 67,764,000 to a maximum of
84,696,000 shares of common stock, in the aggregate,
depending on the market price of the common stock during a
period prior to the settlement dates. Alternatively, Seller has
the right to purchase 67,764,000 shares of common stock
before October 10, 2012 and prior to the settlement dates
of the stock purchase contracts, provided that it has given
MetLife at least sixty-one days prior notice that it may
exercise such right. |
74
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
Transactions with Related
Persons
Procedures for
Reviewing Related Person Transactions.
The Company has established written procedures for the review,
approval or ratification of related person transactions. A
related person transaction includes certain financial
transactions, arrangements or relationships in which the Company
is or is proposed to be a participant and in which a Director,
Director nominee or Executive Officer of the Company or any of
their immediate family members has or will have a material
interest. Related person transactions may include:
|
|
|
Legal, investment banking, consulting or management services
provided to the Company by a related person or an entity with
which the related person is affiliated;
|
|
|
Sales, purchases and leases of real property between the Company
and a related person or an entity with which the related person
is affiliated;
|
|
|
Material investments by the Company in an entity with which a
related person is affiliated;
|
|
|
Contributions by the Company to a civic or charitable
organization for which a related person serves as an executive
officer; and
|
|
|
Indebtedness or guarantees of indebtedness involving the Company
and a related person or an entity with which the related person
is affiliated.
|
Under the procedures, Directors, Director nominees and Executive
Officers of the Company are required to report related person
transactions in writing to the Company. The Governance Committee
reviews, approves or ratifies related person transactions
involving Directors, Director nominees and the Chief Executive
Officer or any of their immediate family members. A vote of a
majority of disinterested Directors of the Governance Committee
is required to approve or ratify a transaction. The Chief
Executive Officer reviews, approves or ratifies related person
transactions involving Executive Officers of the Company (other
than the Chief Executive Officer) or any of their immediate
family members. The Chief Executive Officer may refer any such
transaction to the Governance Committee for review, approval or
ratification if he believes that such referral would be
appropriate.
The Governance Committee or the Chief Executive Officer will
approve a related person transaction if it is fair and
reasonable to the Company and consistent with the best interests
of the Company, taking into account the business purpose of the
transaction, whether the transaction is entered into on an
arms-length basis on terms fair to the Company, and
whether the transaction is consistent with applicable codes of
conduct of the Company. If a transaction is not approved or
ratified, it may be referred to legal counsel for review and
consultation regarding possible further action by the Company.
Such action may include terminating the transaction if not yet
entered into or, if it is an existing transaction, rescinding
the transaction or modifying it in a manner that would allow it
to be ratified or approved in accordance with the procedures.
The Board of Directors reviewed the transactions described below
under Related Person Transactions American
International Group, Inc. in connection with its approval
of such transactions, and has determined that the transactions
are consistent with the criteria set forth in the preceding
paragraph with respect to the approval of related person
transactions. However, the Companys procedures do not
contemplate separate review of related person transactions
involving persons other than Directors, Director nominees and
Executive Officers.
Related Person
Transactions
American International Group,
Inc. Pursuant to the Acquisition, MetLife
agreed to acquire Alico from AIG and Seller, a subsidiary of
AIG. The Acquisition was completed on November 1, 2010, and
resulted in Seller and AIG becoming the beneficial owners of 5%
or more of the outstanding common stock of MetLife.
To complete the Acquisition, MetLife paid to Seller
$7.2 billion in cash, after adjustments, and issued to
75
Seller common stock, Convertible Preferred Stock and Equity
Units.
Equity Units. The $3.0 billion aggregate
stated amount of Equity Units issued to Seller consisted of
(i) forward purchase contracts obligating the holder to
purchase a variable number of shares of MetLifes common
stock on specified future dates for a fixed price and
(ii) an interest in (x) $1.0 billion aggregate
principal amount of MetLifes 1.564% Series C Senior
Debentures due 2023, (y) $1.0 billion aggregate
principal amount of MetLifes 1.923% Series D Senior
Debentures due 2024 and (z) $1.0 billion aggregate
principal amount of MetLifes 2.463% Series E Senior
Debentures due 2045. On March 15, 2011, MetLife will
pay $55.83 million to Seller with respect to the Equity
Units. Under the terms of the Equity Units, the Series C
Senior Debentures, the Series D Senior Debentures and the
Series E Senior Debentures constituting part of the Equity
Units will each be subject to separate remarketings and sold to
investors. Holders of the Equity Units who elect to include
their Senior Debentures in a remarketing can use the proceeds
thereof to meet the obligations under the forward purchase
contracts to purchase MetLifes common stock. Approximately
67.8 million to 84.7 million shares of MetLifes
common stock, subject to adjustment, will be issuable upon the
settlement of the forward purchase contracts.
Investor Rights Agreement. In connection with
the Acquisition, MetLife, Seller and AIG entered into an
Investor Rights Agreement. The Investor Rights Agreement sets
forth certain registration rights MetLife granted to Seller in
connection with the securities issued to Seller as part of the
purchase price consideration, and sets forth certain agreements
with respect to Sellers ownership, voting and transfer of
these securities.
Indemnification and Indemnification
Collateral. The Acquisition Agreement provides
that Seller and MetLife will indemnify each other for losses
pursuant to the terms and conditions set forth therein.
Additionally, MetLife may be required to make certain other
payments to Seller, and Seller may be required to make certain
other payments to MetLife, pursuant to the terms and conditions
of the Acquisition Agreement, including certain post-closing
purchase price adjustments. For example, under certain
circumstances, MetLife will be obligated to pay
$300 million to Seller if MetLifes shareholders do
not approve a proposal to convert the
Convertible Preferred Stock into MetLife, Inc. common stock
before November 1, 2011. In addition, promptly after cash
is received by Seller, Seller must pay MetLife approximately
$300 million with respect to an estimated tax payment that
was paid by Alico to the Internal Revenue Service on
February 15, 2011. The payment may be made in cash or
MetLife securities. The estimated tax payment was payable by
Alico as a result of MetLifes decision to make certain tax
elections with respect to the Acquisition under
section 338(h)(10) and section 338(g) of the Internal
Revenue Code. At this time, MetLife cannot approximate the
aggregate dollar amount of such other payments that may become
payable.
Seller pledged to MetLife the Equity Units issued to Seller as
part of the purchase price consideration to secure payment of
Sellers obligations to MetLife under the Acquisition
Agreement and the ancillary agreements (the Indemnification
Collateral), including certain indemnification obligations.
Periodically, Seller is entitled to withdraw Indemnification
Collateral to the extent and in the amount and manner set forth
in the Acquisition Agreement.
AIG Guarantee. MetLife, Seller and AIG entered
into a letter agreement on October 29, 2010 relating to
AIGs guarantee obligations under the Acquisition Agreement
(the Restructuring Amendment). In the event Seller does
not have sufficient cash or other liquid assets to satisfy its
obligations to MetLife and certain of its affiliates and
representatives, including its indemnity obligations, on a
timely basis, the Restructuring Amendment provides, among other
things, that AIG will unconditionally guarantee by direct
payment to MetLife and such affiliates and representatives all
such obligations of Seller.
Special Asset Protection Agreement. MetLife
and Alico entered into a Special Asset Protection Agreement with
Seller on November 1, 2010 (Special Asset Protection
Agreement). The Special Asset Protection Agreement provides
for a loss sharing arrangement with respect to certain assets,
whereby, if there is a default in the payment of scheduled
interest or a default in the payment of principal or if an asset
under certain conditions is sold or restructured at a loss, and
the aggregate of any shortfalls exceeds $100 million,
Seller will be obligated to pay to Alico 50% of such shortfalls
in excess of $100 million. To the extent that Alico
76
receives any payments from Seller for an asset shortfall, Alico
will be obligated to pay Seller 50% of any recoveries on that
asset (net of certain items) until Seller has been reimbursed
for all such payments. With certain exceptions, the obligations
of Seller to make payments to Alico apply with respect to
payment defaults which arise until December 31, 2016,
unless, on that date, an asset has an uncured principal or
interest payment default. In that situation, Seller will remain
obligated to make any payments on that asset until the next
scheduled principal or interest payment, at which time, if the
payment default remains uncured, Seller will pay Alico the
excess of (i) 50% of the carrying value and all accrued but
unpaid interest on that asset, minus (ii) any payments made
by Seller with respect to that asset for which Alico has not
reimbursed Seller from any recoveries on that asset, subject to
certain other applicable offsets. At this time, MetLife cannot
approximate the aggregate dollar amount of any payments under
the Special Asset Purchase Agreement.
Transition Services Agreement. MetLife and AIG
also entered into a Transition Services Agreement on
November 1, 2010 (Transition Services Agreement),
pursuant to which each party agreed to provide to the other
party and its affiliates scheduled services and access to
certain facilities as well as certain migration services,
knowledge transfer services, assistance with negotiations of
third party vendor relationships and resuming services.
Furthermore, additional services that were provided prior to the
closing of the Acquisition and that were identified within
180 days of the closing of the Acquisition, will be
provided by the applicable party on a commercially reasonable
efforts basis. Scheduled services will be provided for the
agreed period of time and for an agreed extension period, with
increased fees for services provided during the extension
period. In general, the term for services will not exceed
24 months from the closing of the Acquisition, except with
respect to migration services (which may continue for a period
of up to three months following the termination of the related
service) or except as caused by delays or failures in connection
with the provision of services or completion of certain required
separation actions. Services can be terminated on
30 days advance written notice (or such other period
of time as agreed to by the parties in the applicable
schedule to the Transition Services Agreement) to the party
providing such service, subject to the service recipient paying
any scheduled termination fees. The Transition Services
Agreement also provides for a variety of indemnities, as well as
dispute resolution mechanisms. At this time, MetLife estimates
that approximately $80 to $95 million will be paid in
respect of services provided pursuant to the Transition Services
Agreement.
Ordinary Course Commercial Transactions. From
time to time, MetLife or its affiliates, on the one hand, and
AIG or its affiliates, on the other hand, may enter into
ordinary course commercial contracts or other arrangements on
substantially the same terms and conditions that prevail at the
time for comparable transactions with persons who are not
related persons.
The foregoing descriptions of the Acquisition Agreement, the
Special Asset Protection Agreement and the Transition Services
Agreements are not complete and are qualified by reference to
the Acquisition Agreement, filed with MetLifes Current
Report on
Form 8-K,
dated March 11, 2010.
The foregoing descriptions of the Restructuring Amendment and
the Investor Rights Agreement are not complete and are qualified
by reference to such documents, filed with MetLifes
Current Report on
Form 8-K,
dated November 2, 2010.
Executive Officers. A Company affiliate
employs a sister of Executive Group member Nicholas D. Latrenta,
Executive Vice President and General Counsel. The
employees employment began approximately 6 years
before Mr. Latrenta became an Executive Group member. The
employee is not an officer of the Company or any MetLife
affiliate, does not report directly or indirectly to
Mr. Latrenta, and does not report directly to any other
member of the Executive Group. In 2010, the employee
participated in compensation and benefit arrangements generally
applicable to similarly-situated employees, and earned
compensation of approximately $120,142.
A Company affiliate employs a brother of Executive Group member
Maria R. Morris, Executive Vice President,
Technology & Operations. The employees
employment began approximately 15 years before
Ms. Morris became an Executive Group member. The employee
is not an officer of
77
the Company or any MetLife affiliate, does not report directly
or indirectly to Ms. Morris, and does not report directly
to any other member of the Executive Group. In 2010, the
employee
participated in compensation and benefit arrangements generally
applicable to similarly-situated employees, and earned
compensation of approximately $216,960.
78
Director Independence
An Independent Director is a Non-Management Director who the
Board of Directors has affirmatively determined has no material
relationships with the Company or any of its consolidated
subsidiaries and is independent within the meaning of the New
York Stock Exchange Corporate Governance Standards. An
Independent Director for Audit Committee purposes meets
additional requirements of
Rule 10A-3
under the Exchange Act.
The Board of Directors has adopted categorical standards to
assist it in making determinations regarding Director
independence. The Board has determined that the Independent
Directors satisfy all applicable categorical standards. The
categorical standards are included in the Corporate Governance
Guidelines of the Company, which are available on MetLifes
website at www.metlife.com/
corporategovernance under the link Corporate
Governance Guidelines.
The Board has affirmatively determined that Sylvia Mathews
Burwell, Eduardo Castro-Wright, Cheryl W. Grisé, R.
Glenn Hubbard, John M. Keane, Alfred F. Kelly, Jr., James
M. Kilts, Catherine R. Kinney, Hugh B. Price,
David Satcher, Kenton J. Sicchitano and Lulu C. Wang are
all Independent Directors who do not have any material
relationships with the Company or any of its consolidated
subsidiaries. The Board also affirmatively determined in 2010
that Burton A. Dole, Jr. and William C. Steere, Jr.,
who retired as of the commencement of the 2010 Annual Meeting,
were Independent Directors who did not have any material
relationships with the Company or any of its consolidated
subsidiaries.
79
|
|
Item 14.
|
Principal
Accounting Fees and Services
|
Independent Auditor
The Audit Committee has appointed Deloitte & Touche
LLP (Deloitte) as the Companys independent auditor
for the fiscal year ending December 31, 2011, subject to
shareholder ratification. Deloitte has served as independent
auditor of MetLife and most of its subsidiaries, including
Metropolitan Life Insurance Company, for many years. Its long
term knowledge of the MetLife group of companies, combined with
its insurance industry expertise, has enabled it to carry out
its audits of the Companys financial statements with
effectiveness and efficiency.
In considering Deloittes appointment, the Audit Committee
reviewed the firms qualifications and competencies,
including the following factors:
|
|
|
Deloittes status as a registered public accounting firm
with the Public Company Accounting Oversight Board (United
States) (PCAOB) as required by the Sarbanes-Oxley Act of
2002 (Sarbanes-Oxley) and the Rules of the PCAOB;
|
|
|
Deloittes independence and its processes for maintaining
its independence;
|
|
|
the results of the independent review of the firms quality
control system;
|
|
|
the key members of the engagement team for the audit of the
Companys financial statements;
|
|
|
Deloittes approach to resolving significant accounting and
auditing matters including consultation with the firms
national office; and
|
|
|
Deloittes reputation for integrity and competence in the
fields of accounting and auditing.
|
The Audit Committee assures the regular rotation of the audit
engagement team partners as required by law.
The Audit Committee approves Deloittes audit and non-audit
services in advance as required under Sarbanes-Oxley and SEC
rules. Before the commencement of each fiscal year, the Audit
Committee appoints the independent auditor to perform audit
services that the Company expects to be performed for the fiscal
year and appoints the auditor to perform audit-related, tax and
other permitted non-audit services. The Audit Committee or a
designated member of the Audit Committee to whom authority has
been delegated may, from time to time, pre-approve additional
audit and non-audit services to be performed by the
Companys independent auditor. Any pre-approval of services
between Audit Committee meetings must be reported to the full
Audit Committee at its next scheduled meeting.
If the audit, audit-related, tax and other permitted non-audit
fees for a particular period or service exceed the amounts
previously approved, the Audit Committee determines whether or
not to approve the additional fees.
Based on this information, the Audit Committee pre-approves the
audit services that the Company expects to be performed by the
independent auditor in connection with the audit of the
Companys financial statements for the current fiscal year,
and the audit-related, tax and other permitted non-audit
services that management may desire to engage the independent
auditor to perform during the twelve month period following such
pre-approval. In addition, the Audit Committee approves the
terms of the engagement letter to be entered into by the Company
with the independent auditor.
Representatives of Deloitte will attend the 2011 Annual Meeting.
They will have an opportunity to make a statement if they desire
to do so, and they will be available to respond to appropriate
questions.
80
The following table presents fees for professional services
rendered by Deloitte for the audit of the Companys annual
financial statements, audit-related services, tax services and
all other services for the years ended December 31, 2010
and 2009.
Independent Auditors Fees for 2010 and 2009(1)
|
|
|
|
|
|
|
|
|
|
|
2010
|
|
2009
|
|
Audit Fees(2)
|
|
$
|
61.7 million
|
|
|
$
|
40.7 million
|
|
Audit-Related Fees(3)
|
|
|
7.9 million
|
|
|
|
7.2 million
|
|
Tax Fees(4)
|
|
|
7.0 million
|
|
|
|
3.0 million
|
|
All Other Fees(5)
|
|
|
2.8 million
|
|
|
|
0.3 million
|
|
|
|
|
(1) |
|
All fees shown in the table related to services that were
approved by the Audit Committee. |
|
(2) |
|
Fees for services to perform an audit or review in accordance
with auditing standards of the PCAOB and services that generally
only the Companys independent auditor can reasonably
provide, such as comfort letters, statutory audits, attest
services, consents and assistance with and review of documents
filed with the SEC. |
|
(3) |
|
Fees for assurance and related services that are traditionally
performed by the Companys independent auditor, such as
audit and related services for employee benefit plan audits, due
diligence related to mergers, acquisitions and divestitures,
accounting consultations and audits in connection with proposed
or consummated acquisitions and divestitures, control reviews,
attest services not required by statute or regulation, and
consultation concerning financial accounting and reporting
standards. |
|
(4) |
|
Fees for tax compliance, consultation and planning services. Tax
compliance generally involves preparation of original and
amended tax returns, claims for refunds and tax payment planning
services. Tax consultation and tax planning encompass a diverse
range of services, including assistance in connection with tax
audits and filing appeals, tax advice related to mergers,
acquisitions and divestitures, advice related to employee
benefit plans and requests for rulings or technical advice from
taxing authorities. |
|
(5) |
|
Fees for other types of permitted services. |
81
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
March 1, 2011
METLIFE, INC.
|
|
|
|
By
|
/s/ C.
Robert Henrikson
|
Name: C. Robert Henrikson
|
|
|
|
Title:
|
Chairman of the Board, President
|
and Chief Executive Officer
82
Exhibit Index
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
31
|
.1
|
|
Certification of Chief Executive Officer pursuant to Section 302
of the Sarbanes-Oxley Act of 2002.
|
|
31
|
.2
|
|
Certification of Chief Financial Officer pursuant to Section 302
of the Sarbanes-Oxley Act of 2002.
|
83